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Abstract 
 
Background: Schistosomiasis remains one of the most prevalent parasitic diseases in developing 
countries.  Goal and objectives: The potential relationship between Schistosoma mansoni and 
anaemia, was examined using Schistosomiasis Control Initiative (SCI) data on Ugandan children 
and a randomized clinical trial implemented by colleagues from the London School of Hygiene 
and Tropical Medicine (LSHTM) in Western Kenya. The impact of large-scale administration of 
chemotherapy on Schistosoma haematobium infection and associated morbidity was also 
evaluated using SCI data on Burkinabe children. Evaluation and validation of field applicable 
tools, such as ultrasound, for the cost-effective diagnosis of schistosomiasis morbidity using SCI 
baseline data from Malian children was another aim of this thesis. Furthermore, in combination 
with the ultrasound scans, microscopic examination of urine for detection of S. haematobium 
eggs, dipsticks for detection of haematuria, tests for circulating antigens and serology tests were 
examined for the cost-effective assessment of S. haematobium prevalence in an adult’s dataset 
from Ghana. Methods: Biostatistical analysis of afore mentioned data was applied. Principal 
findings: Results from SCI and LSHTM studies suggest that anaemia is associated with 
schistosomiasis in African children, and that such anaemia shows a significant improvement 
following chemotherapy. Results from the SCI study in Burkina Faso suggested that even a 
single round of mass chemotherapy can have a substantial impact on S. haematobium infection 
and its associated morbidity in children. Microscopy and haematuria dipsticks were suggested as 
sensitive and specific indicators of prevalence of S. haematobium infection in Ghanaian adults. 
Furthermore, ultrasound global scores were demonstrated to be valuable markers in children for 
morbidity caused by S. haematobium infection, but ultrasonographic examination is not a 
reasonable substitute for microscopy or dipsticks for determining the prevalence of this infection. 
Significance: Finally, the key findings from all the studies presented, emphasizing how these 
relate to one another, are discussed.  
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Chapter 1:  General introduction 
 
Schistosomiasis or Bilharzia as it is sometimes referred to, remains one of the most prevalent 
parasitic diseases in developing countries (Engels et al., 2002).  After malaria, 
schistosomiasis is the most important tropical disease in terms of human morbidity with 
significant economic and public health consequences (WHO, 1993).  Recently, at least three 
studies have also indicated that schistosomiasis is a much more serious public health problem 
than currently perceived.  A meta-analysis of performance-related symptoms and disability-
linked morbidities in schistosomiasis patients (King et al., 2005) suggest a 4 to 30 times 
greater chronic disability than originally estimated using disability-adjusted life years 
(DALYs).  Another study made similar observations about the frequency of clinical 
morbidity and also indicated an annual mortality of 280,000 cases directly attributable to 
schistosomiasis in sub-Saharan Africa (van der Werf et al., 2003), far greater than the 15,000 
p.a. worldwide estimated by the World Health Organization (WHO, 2004).  Furthermore, the 
most recent estimate in mid-2003 of 779 million people at risk and 207 million people 
infected with schistosomiasis translates to increases of 12.6 % and 7.2 % respectively 
(Steinmann et al., 2006) when compared with estimates from the mid-1990’s (Chitsulo et al., 
2000).  
 
The main forms of human schistosomiasis are caused by five species of flatworm in the 
genus Schistosoma, within the class trematodes which are: Schistosoma haematobium, which 
infects the urinary tract, Schistosoma mansoni, Schistosoma japonicum, 
Schistosoma intercalatum and Schistosoma mekongi which all infect the intestinal tract.  The 
studies presented in this thesis are confined to the first two species of schistosomes that are 
prevalent in humans in sub-Saharan Africa (S. haematobium and S. mansoni) conferring the 
greatest burden on human health (see Figure 1.1 for global distribution of schistosomiasis).  
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Figure 1.1 Global distribution of schistosomiasis 
Main foci: S mansoni—much of sub-Saharan Africa, northeast Brazil, Surinam, Venezuela, the Caribbean, lower 
and middle Egypt, the Arabic peninsula; S haematobium—much of sub-Saharan Africa, Nile valley in Egypt and 
Sudan, the Maghreb, the Arabian peninsula; S japonicum—along the central lakes and River Yangtze in China; 
Mindanao, Leyte, and some other islands in the Philippines; and small pockets in Indonesia; S mekongi–—central 
Mekong Basin in Laos and Cambodia; S intercalatum—pockets in west and central Africa. (From Gryseels et al., 
2006). 
 
1.1 Life cycle 
 
Schistosomes have indirectly transmitted life-cycles involving obligatory alternation of 
generations between sexual reproduction in a mammalian host, such as a human, and asexual 
reproduction within a molluscan (freshwater snail) host. In fresh water, free-living schistosome 
larvae (miracidia) hatch from eggs passed out in the urine or stool, depending on the species, 
which then  invade the intermediate snail hosts. There are different genera of snails according to 
the different schistosome species presented in the studies of this thesis. More precisely, 
intermediate host of S. haematobium are snails of the genus Bulinus while intermediate host of S. 
mansoni are snails of the genus Biomphalaria. Following the penetration in the snail, the 
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miracidium develops into sporocysts which in over about four to six weeks develop into stages 
infective to the mammalian definitive host through asexual replication where thousand of 
cercariae are produced. These cercariae are then released into the water, where they can infect by 
penetration of the skin, for example, children playing in the water; women collecting water or 
engaging in domestic chores; and men swimming, fishing, and irrigating crops. During the 
penetration process the cercariae lose their tale and transform into the larval stage: the 
schistosomulum which migrate to the lungs in three to four days. After penetration in the 
pulmonary capillaries schistosomula are carried to the systemic circulation and to the portal 
system. In the hepatic circulation schistosomes mature to adult, and in pairs they migrate to the 
vesical plexus (S. haematobium) and to the mesenteric veins (S. mansoni). Embryonated eggs are 
excreted in urine and/or faeces after approximately seventy days (S. haematobium) and thirty 
five days (S. mansoni) (Molyneux, 2006;Webster et al., 2008) (see Figure 1.2 for an illustrated 
summary of the human schistosomiasis life cycle).   It should be noted that the duration of the 
life cycle of human schistosomiasis depends on the schistosome species examined, on 
environmental factors such as temperature and water quality as well as on the number of 
miracidia that enter and survive in a snail.  
Figure 1.2 The Life Cycle of human schistosomiasis 
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Eggs are eliminated with feces or urine .  Under optimal conditions the eggs hatch and release miracidia , 
which swim and penetrate specific snail intermediate hosts .  The stages in the snail include 2 generations of 
sporocysts and the production of cercariae .  Upon release from the snail, the infective cercariae swim, 
penetrate the skin of the human host , and shed their forked tail, becoming schistosomulae .  The 
schistosomulae migrate through several tissues and stages to their residence in the veins ( , ).  Adult worms 
in humans reside in the mesenteric venules in various locations, which at times seem to be specific for each 
species .  Lifecycle and annotations are adapted from the Center for Disease Control and Prevention (CDC) 
website http://www.dpd.cdc.gov/dpdx/HTML/Schistosomiasis.htm (accessed August 2008). 
1.2 Schistosomiasis morbidity  
 
The schistosome life cycle has three phases in the human host, and all have their clinical 
implications. The first phase is host penetration by cercaria, which is usually manifested as a 
transient (hours) itchy eruption that occurs soon after exposure and is known as swimmer's itch 
or cercarial dermatitis.  
 
The second phase is schistosomulae tissue migration and maturation and is associated with 
transient (a few weeks to months) hypersensitivity, which gives rise to the syndrome of acute 
schistosomiasis, known as ‘Katayama’ fever. The disease starts suddenly with fever, fatigue, 
myalgia, malaise, non productive cough, eosinophilia, and patchy infiltrates on chest 
radiography.  Abdominal symptoms can develop later, caused by the migration and positioning 
of the mature worms. Most patients recover spontaneously after two to ten weeks, but some 
develop persistent and more serious disease with weight loss, dyspnoea, diarrhoea, diffuse 
abdominal pain, toxaemia, hepatosplenomegaly and widespread rash. 
 
The third phase is the chronic one where main lesions are due not to the adult worms but to eggs 
that are trapped in the tissues during the peri-vesical or peri-intestinal migration or after 
embolisation in the liver, spleen, lungs, or cerebrospinal system (Gryseels et al., 2006).  Human 
infection with S. mansoni is associated with chronic hepatic and intestinal fibrosis, whilst S. 
haematobium infections can lead to ureteric and bladder fibrosis, calcification of the urinary tract 
and bladder cancer due to the retention of schistosome eggs within tissues and inflammatory 
response to them (Vennervald et al., 2000).  
  15 
1.3 Schistosomiasis control 
 
There is currently no effective vaccine against human schistosomiasis.  
 
The tendency to urinate and defecate in and around water is an important behavioural 
characteristic of humans on which relies the schistosome parasite. The most striking fact relevant 
to control is that if human behaviour could be changed to stop contamination of water bodies 
with urine and faeces containing schistosome eggs, then transmission of the parasite would 
cease. This fact is central to many longer-term control efforts, including the education of 
children, to reduce water contamination (1st stage of life cycle in Figure 1.2). 
 
Environmental sanitation and safety of supply water constitute essential forms of schistosomiasis 
control. Water resource development and projects, as well as the consequent concentrations of 
human settlements and increased water contact, lead to heavy worm infections in people, more 
eggs reaching the water, and greater human pathology. The provision of safe water supplies and 
latrines is obviously useful, but for the prevention of schistosomiasis, safe contact sites are also 
needed (Fenwick, 2006a).   
 
Furthermore, within the snail, the parasite develops and multiplies asexually (3rd, 4th and 5th 
stages of life cycle in Figure 1.2). Particularly snails of the Bulinus and Biomphalaria molluscan 
genera thrive in areas frequented by humans. Indeed these species seem to favour habitats 
polluted with human excreta and the detritus of everyday living. The intricate relationship 
between snail and schistosome make this part of the life cycle vulnerable to control activities, 
and there is a long history of attempted snail control using chemicals (molluscicides) to kill 
snails as well as biological control of snails.  However, despite the clear evidence that the 
population of snails can be much reduced through molluscicides, the latter are not specific to 
killing just molluscs. For example, fish are also killed and therefore this measure of control can 
have deleterious impact on the environment and biodiversity.  
 
In areas where schistosomiasis is highly endemic therefore, the present goal is to mitigate the 
burden of the disease by controlling morbidity (Fenwick & Webster 2006). Chemotherapy with 
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praziquantel (PZQ) is the mainstay for schistosomiasis control, and will remain the drug of 
choice for several years. 
 
For instance, Egypt’s schistosomiasis control programme has achieved great success and a major 
impact on schistosomiasis prevalence and morbidity by using mass drug administration with 
praziquantel since 1996.  In May 2001, the World Health Assembly adopted resolution 54.19 
affirming schistosomiasis and soil transmitted helminthiasis as public health priority and setting 
the target of providing treatment to at least 75 % of school-age children at risk of morbidity by 
2010 (Colley et al., 2001). Since 2003 further, major efforts have being launched by the 
Schistosomiasis Control Initiative (SCI), the initial aim of which was to assist six sub-Saharan 
African countries to develop sustainable national schistosomiasis morbidity control programmes, 
through the provision and monitoring of praziquantel treatment, to 15 million children and other 
high risk groups over a period of five years. A primary objective of these SCI-supported control 
programmes was to achieve, and hence also demonstrate, a quantifiable reduction in 
schistosome-associated morbidity as a consequence of such chemotherapeutic intervention 
(Fenwick 2006b).   
1.4 Monitoring and evaluation and further research 
 
Since control operations require monitoring and evaluation strategies, the focus on morbidity 
control calls for careful validation of the direct and indirect indicators of schistosome-related 
morbidity (Hatz et al., 1990).  As there is no agreement regarding the list of sequelae that should 
be included in morbidity assessments (Michaud et al. 2004), further research into reliable 
markers for this purpose can contribute to better targeting of individuals at higher risk.  
Furthermore, good estimates of these specific epidemiological parameters, and knowledge of 
their associated uncertainty, would help towards implementing the optimal design of future 
control programmes for schistosomiasis and other parasitic diseases in general, as well as the 
proper evaluation of the current ones.  Kabatereine and others (Kabatereine et al., 2005) have 
also stressed the necessity to provide epidemiological descriptions of schistosomiasis on a 
countrywide basis in order to move towards control efforts while Wiest, 1996 emphasized the 
necessity of accurate assessment of morbidity in endemic communities and the determination of 
the impact of different interventions on schistosomiasis infection in order that governments and 
  17 
authorities make the right decisions given the often limited resources for the control of this 
parasitic disease.   
1.5 Diagnosis 
 
Diagnosis is central to all aspects of schistosomiasis. Decisions on individual and community 
treatment, estimations on prognosis and assessment of morbidity, evaluation of chemotherapy 
and control measures all build on the results from diagnostic tests.   
 
Schematically, three different categories of approaches for the diagnosis of schistosomiasis are 
known. Direct parasitological methods detect schistosome eggs in urine, stool or the rectal 
mucosa, and histological methods disclose schistosomula, adults worms or eggs in tissue 
biopses. Indirect methods, relying on clinical, biochemical or immunological disease markers, 
detect pathology typically or frequently associated with schistosome infections. Finally, 
immunological methods measure the immune response to certain schistosome antigens or the 
concentration of parasite-derived antigens in blood or urine (Jordan et al., 1993). Some of these 
available direct parasitological, indirect and finally immunological diagnostic methods are 
evaluated throughout this thesis.  
1.6 Thesis aims and structure 
 
The majority of the studies presented in this thesis (Chapters 2, 4 and 5) are targeted towards 
evaluation of recent mass human chemotherapy programmes through biostatistical analysis of 
surveillance and monitoring data of children provided from the country teams on Schistosoma 
intensity and associated morbidity.  Positive relationships between the intensity of infection and 
clinical manifestations as well as organ pathology are more pronounced in children in the early 
stages of the disease, whereas in adults, severe pathology may occur during a low intensity of 
infection (Richter, 2003).  Thus using mainly  data from school-aged children (6 to 14 and 10-21 
years old) here, pre-treatment baseline morbidity levels within these risk populations are defined 
and characterized (Chapters 2, 3, 4 and 5) so that any subsequent changes in morbidity caused by 
the intervention can be accurately determined (Chapters 2 and 4).  Data used throughout all this 
PhD thesis are uniquely detailed and together with appropriate statistical analysis should add 
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significantly to the gap which exists because of the limited large scale community screening of 
morbidity and rare broad geographic comparisons (Balen et al., 2006).  Indeed, further studies of 
geographical variations in morbidity have been proposed as one of the priorities for future 
research in schistosomiasis (WHO, 2000; Boisier et al., 2001). 
 
Data used in Chapters 2, 3, 4 and 5 are organized in hierarchical structure, with clustering within 
units.  More precisely, children cluster in the same school and schools cluster within districts.  In 
general, individuals who belong to the same ‘unit’ may share common genetic, behavioural, or 
social risk factors of disease.  They may also have similar exposures to environmental factors.  
The health outcomes of two individuals within the same unit will therefore correlate more highly 
than those of two individuals from different units (Carabin et al., 2003).  In addition, there are 
longitudinal cohorts while relations between individual and ‘supra-individual’ determinants are 
of particular interest, especially for investigating the reasons of variation between areas (Mauny 
et al., 2004).  In statistical terms, data used in all the afore mentioned Chapters of this PhD thesis 
raise the issue of correlated data analysis which can be tackled with hierarchical modeling.  
Initially popular in the social sciences, many hierarchical modeling studies are now published in 
health sciences (Shouls et al., 1996; Verheij, 1996; Bosma et al., 2001; Pickett & Pearl, 2001; 
Chaffin et al., 2007; Heijink et al., 2008; Ohman-Strickland et al., 2008; Szyszkowicz, 2008; Yu 
et al., 2008), as well as in infectious human diseases (Myers et al., 1996; Broome et al., 1999; 
Tinsman et al., 2001; da Silveira et al., 2005; Bortz & Nelson, 2006; Huang et al., 2006; Labbe 
& Verotta, 2006; Voss et al., 2007; Halkitis et al., 2008) although it is noteworthy that few as yet 
deal with parasitic diseases infecting humans (Mauny et al., 2004; Pion et al., 2006; Wang et al., 
2006; Levy et al., 2007; Werneck et al., 2007).  
 
Therefore, in this thesis hierarchical models are used extensively both in a frequentist and 
Bayesian framework in order to identify and characterise potential “markers” for predicting short 
or long-term morbidity from S. haematobium and S. mansoni infections (Chapters 2, 3, 4 and 5).  
Such models also aim to identify potential causal relationships and associations between 
pathologic changes such as macrohematuria and ultrasound scans and clinical manifestations 
such as intensity of infection induced by schistosomiasis egg excretion in stool or urine samples, 
(this approach would thereby provide ‘direct morbidity’ markers: Chapters 4 and 5) because 
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within defined age groups, intensity of infection is expected to be associated with morbidity 
(Richter, 2003).  Another aim of these models is to investigate nutritional consequences of 
schistosome infection and potential manifestations of schistosomiasis such as anaemia (this 
approach would thereby provide ‘indirect morbidity’ markers: Chapters 2, 3 and 4).  
 
Evaluation and validation of field applicable tools, such as ultrasound, for the cost-effective 
diagnosis of schistosomiasis morbidity in the context of large-scale schistosomiasis control 
programmes is another aim of this thesis (Chapters 5 and 6).  Furthermore, in combination with 
the ultrasound scans, microscopic examination of urine for detection of S. haematobium eggs, 
dipsticks for detection of haematuria, tests for circulating antigens and serology tests are 
examined for the rapid and cost-effective assessment of S. haematobium prevalence in an adult’s 
dataset.  The matter of effective diagnosis of schistosomiasis is of increasing importance, 
particularly with respect to the recent paper by King and others (2006) and the current progress 
of the treatment programmes.  One solution may therefore relate to the need for more 
sophisticated statistical methods to be developed and utilized in order to obtain more reliable 
empirical estimates of sensitivities and specificities of various diagnostic tests.  In this thesis, 
latent class analysis models are explored and applied to achieve such aims (Chapter 6). 
 
Chapters 2-6 have appeared or will shortly appear as papers in scientific journals and are 
included in this PhD thesis with slight modifications.  More precisely, Chapters 2 and 5 have 
been published in the American Journal of Tropical Medicine and Hygiene, Chapter 3 has been 
published in the International Journal for Parasitology, Chapter 4 has been published in the 
Journal of Infectious Diseases and Chapter 6 will shortly be published in the American Journal 
of Tropical Medicine; the original papers can be found in the appendix of this PhD thesis.  
Because it was intended that each chapter could be read by itself, some overlap between chapters 
is unavoidable. 
 
The thesis concludes with a general discussion of the novel results highlighted by the statistical 
analysis applied in all previous chapters (Chapter 7). 
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Chapter 2: Morbidity indicators of Schistosoma mansoni: 
relationship between infection and anaemia in Ugandan 
schoolchildren before and after praziquantel and albendazole 
chemotherapy 
 
Summary   
 
This study examines the potential relationship between Schistosoma mansoni and anaemia, using 
data obtained by the Schistosomiasis Control Initiative (SCI) before (baseline) and one year after 
(follow-up of) a chemotherapeutic treatment programme in Uganda.  Changes in haemoglobin 
(Hb) levels in 2,788 children in relation to their S. mansoni and/or hookworm infection intensity 
category and baseline anaemia status were analyzed. At baseline, significant predictors of 
childhood anaemia were intensities of S. mansoni and hookworm infection. At follow-up, 
moderate or heavy hookworm as well as heavy S. mansoni infections were important.  Children 
heavily infected with S. mansoni or hookworm had significantly lower Hb levels at baseline 
compared to those not infected.  Among anaemic children at the baseline survey, a significant 
increase in Hb counts of 0.83 g/dl after treatment was found.  These results suggest that anaemia 
is associated with schistosomiasis and hookworm in Ugandan children, and that such anaemia 
shows a significant improvement after chemotherapy. 
 
 
 
Key words: hierarchical models, anaemia, Uganda, Schistosoma mansoni, hookworm 
 
 
 
Note: A modified version of this chapter has been published as: Koukounari A, Fenwick A, 
Whawell S, Kabatereine NB, Kazibwe F, Tukahebwa EM, Stothard JR, Donnelly CA, Webster 
JP (2006) Am J Trop Med Hyg 75, 278-86. See publications by the candidate (Appendix).  
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2.1 Introduction 
 
Anaemia is a common problem throughout the world and of enormous public health concern in 
developing countries, but its aetiology is very complex making the effect of any one factor 
difficult to assess.  Malaria plays a key causative role for anaemia among young African 
children, although HIV infection, haemoglobinopathies, intestinal helminths, in particular that of 
hookworm infection, poor nutritional status and micronutrient deficiencies are also likely to 
make important additional contributions (Crawley, 2004).  Schistosomiasis is a parasitic disease 
of profound medical and veterinary importance, second only to malaria in terms of parasite-
induced human morbidity and mortality, with some 600 million people exposed and 200 million 
infected at any time throughout the tropical world (Engels et al., 2002).  The relative role of 
schistosomiasis as a causative agent for anaemia, however, particularly as compared to that 
known for hookworm infection, remains controversial (Stephenson & Holland, 1987; 
Stephenson, 1993; Olsen et al., 1998; Nokes et al., 1999; Coutinho et al., 2005).  Preston and 
Dargie (1975), for instance, provided convincing evidence that schistosomiasis causes anaemia 
in experimental animals (Preston & Dargie, 1975), although, whilst Foy and Nelson (1963), did 
acknowledge that anaemia was generally associated with heavy schistosome infections, they 
doubted that early or light infections were of importance (Foy & Nelson, 1963).  There is, 
nevertheless, a general consensus for the need for further epidemiological research into the 
potential role of schistosomiasis as a causative agent for anaemia (Foy & Nelson, 1963; Latham 
et al., 1983).  
 
Since 2003, the Schistosomiasis Control Initiative (SCI) has assisted six sub-Saharan African 
countries with the objective to develop sustainable national schistosomiasis morbidity control 
programmes and reach at least 75 % of school-aged children and other high-risk group, through 
mass deworming using praziquantel for schistosomiasis and albendazole for intestinal helminths.  
Such control programmes thereby provide a unique opportunity to assess the potential role of 
schistosomiasis and/or other intestinal helminths as causative agents of anaemia morbidity, 
together with the potential ameliorative impact of chemotherapy on a large scale.  This may be 
particularly pertinent in terms of identifying and evaluating morbidity associated with S. mansoni 
(intestinal schistosomiasis), which is frequently very difficult to assess and quantify precisely 
  22 
except in the most severe or late chronic cases (Lengeler et al., 1991; Utzinger et al., 1998; 
Brouwer et al., 2003; Vennervald & Dunne, 2004).  Moreover, because demonstration of 
successful morbidity control is feasible only if there are reliable morbidity markers capable of 
showing reversion within the time-frame of disease surveillance, it is vital to identify S. mansoni 
morbidity indicators for sustainable disease control and for evaluating the success of intervention 
(Richter, 2003; Booth et al., 2004).  
 
Using uniquely detailed data arising from the Ugandan National Schistosomiasis Control 
Programme, before and one year following praziquantel and albendazole chemotherapy, here the 
aim of this chapter was to evaluate the potential relationship between S. mansoni infection, anti-
helminthic chemotherapy, and anaemia as well as to assess the extent to which schistosomiasis is 
a cause of anaemia. 
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2.2 Materials and methods 
 
2.2.1 Study sites, sampling and cohort design.  Parasitological and morbidity data 
were collected on a cohort of 4351 Ugandan children, aged 6 to 14 years old, randomly-sampled 
from 37 schools situated in eight districts just before and one year following implementation 
(2003 and 2004 respectively), as part of ongoing monitoring and evaluations of the SCI 
programme in Uganda.  The eight districts were selected to represent the Albert Nile (Nebbi, 
Arua, and Moyo), Lake Victoria (Bugiri, Busia and Mayuge) and Lake Albert basins (Masindi 
and Hoima).  Further details on these districts and their inhabitants are provided elsewhere 
(Kabatereine et al., 1999; Kabatereine et al., 2003).  
 
Schools were chosen on the basis of existing S. mansoni data for schoolchildren from Uganda 
(SCI-National Survey of Bilharziasis) and parasitological stratification with different categories 
of infection prevalence, classified as low (< 10 %), medium (11-50 %) and high prevalence (> 50 
%) within each district, which also allowed pooling in order to reach sample sizes technically 
detailed elsewhere (Brooker et al., 2004).  Fixed cohort structure was recruited at each school to 
allow comparisons to be made across schools and districts.  Required sample sizes were 
calculated using the EpiSchisto software tool 
(http://www.schoolsandhealth.org/epidynamics.htm) using an expected reduction in mean 
intensity of 60 % (S. mansoni) following chemotherapy to achieve 80% statistical power and a 
significance level of 5 %.  The value of 60 % was chosen as a conservative estimate of the 
expected reduction over a two-year period (two annual treatments).  An overall drop-out rate of 
40 % over the course of the monitoring period was also allowed.  
 
As it was not logistically possible to survey all schools within the same month, surveys were 
staggered.  Children were identified at follow-up using a named roll call as well as retrieval of 
SCI individual treatment cards with unique code identifier given to the children the previous year 
as well as hardcopy of a group cohort photograph to ensure that children remember to which 
group they were reassigned.  Before the one year follow-up visit a pre-survey team re-registered 
the children and also sensitized the children to ensure that as many children as possible in the 
cohorts were at school the day of survey.  All children enrolled into this study were interviewed 
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and examined by appropriately trained Ministry of Health field workers.  Administration of 
praziquantel and albendazole was according to WHO guidelines (praziquantel 40mg/Kg and 
single 400 mg albendazole tablet).  Ethical clearance was obtained from the Ugandan National 
Council of Science and Technology and Imperial College London.  For ethical reasons, it was 
not appropriate to include any untreated control groups in the study design. 
 
2.2.2 Parasitological and anaemia morbidity data.  A single stool sample was 
collected from each individual and 41.7 mg processed to make duplicate Kato-Katz slides for 
microscopic determination of schistosome and/or hookworm infection and, where applicable, 
egg per gram counts.  For comparative reasons between the two successive years of study, where 
the second measurement of the Kato-Katz smear was missing, S mansoni prevalence and 
individual intensities were calculated using a single thick Kato-Katz smear although we are 
aware that we miss a certain proportion of infections for assessment of individuals’ infection 
status, by this way.  Anaemia was defined (according to WHO guidelines), as a dichotomous 
variable taking the value 1 for children from 5 to 11 years old with Hb less than 11.5 g/dl and for 
children between 12 and 14 years old with Hb less than 12.0 g/dl.  Further details for other 
indicators included and methodology followed in the SCI questionnaires are given elsewhere 
(Brooker et al., 2004).  All Kato-Katz smears were read within one hour of preparation so that 
hookworm eggs could be easily seen.  
 
S. haematobium is known not to be endemic in these areas of Uganda (Stothard et al., 2006).  
However, for absolute confirmation, urine from all children sampled was also tested for micro-
haematuria using haemastix dipsticks and all urine sampled from children from the 11-year-old 
cohort was pooled for concentration of schistosome eggs using a Pitchford & Visser funnel and 
no S. haematobium egg was observed.  Therefore it is almost certain that S. haematobium was 
absent within this cohort.  The prevalence of Trichuris trichura and Ascaris lumbricoides is 
unevenly distributed in the country with prevalence greatest in south-western Uganda and such 
infections were also examined from the faeces of all children sampled (Kabatereine et al., 2005).  
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Nutritional assessment data (i.e. weight and height) and blood samples for haemoglobin levels 
(Hb) were obtained from each individual by the finger-prick method, as this provides a sufficient 
sample for accurate Hb measurement using a Hemocue photometer (Parker et al., 1997).  
 
2.2.3 Statistical analyses.  Because of clustered data with a natural hierarchical structure, 
linear hierarchical models were chosen in order to model changes in Hb levels from baseline to 
follow-up and hierarchical logistic regression models in order to model the risk of being 
anaemic.  Additionally, because schistosomiasis occurs focally, heterogeneity in the degree of 
endemicity among schools has to be accounted for (Van der Werf et al., 2003).  In such 
circumstances, ordinary least squares regression can overestimate the precision associated with 
an analysis yielding spuriously statistically significant results (i.e. a type 1 error).  Hierarchical 
models permit combination of exposures to group and individual factors which is important in 
epidemiological analyses of infectious disease data (Verbeke & Molenberghs, 2000; Mauny et 
al., 2004).  The hierarchical logistic regression models were fitted to data coming from children 
with complete records at each time point of interest.  Due to variable cohort recovery success, 
attributable to frequent population movements within Uganda, the remainder of the statistical 
analyses were restricted to children with complete records from both time-points of interest, and 
no replacements were used for missing subjects.  Summary reports, figures and analyses are 
based on data from all available subjects.  A comparison between the baseline characteristics of 
children successfully followed-up and those that dropped out in the second year of the study was 
performed through chi-square tests with regard to all the parameters examined in this study.  
Frequency tables were obtained using SAS V8 (SAS Institute Inc., Cary, NC, USA).  A forward 
selection procedure was used for the evaluation of the remaining variables in the final models.  
 
An association of anaemia with parasitic infections (schistosome and hookworm) was studied 
after simultaneously adjusting for potential confounders in the statistical models used. Indices of 
the anthropometric status of the studied children based on the 1978 CDC/WHO growth reference 
curves were computed using the Nutstat program within Epi Info V 3.3.  Body Mass Index is 
considered an indicator of acute under-nutrition (thinness or wasting) and is generally associated 
with failure to gain weight or a loss of weight (Gorstein et al., 1994).  The Z-score cut-off point 
recommended by WHO, CDC, and others to classify low anthropometric levels is 2 SD units 
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below the reference median for this specific index.  Cut-off of -2 Body Mass Index Z-scores 
(BMIZ) were calculated to classify underweight children and finally this categorical variable was 
incorporated in all models as a potential predictor.  Initially, the impact of parasitic infections, 
sex, and nutritional status as defined from Z-scores at baseline and follow-up was examined 
using two-level multivariate logistic regression models with level-one: the children and level-
two: the schools.  Three-level multivariate logistic regression models were also tested with level-
three: the districts but as it was proved that the districts were rather homogeneous in the risk of 
being anaemic, this random effect was not finally included in the models.  Nutritional status was 
included in the baseline hierarchical logistic regression model as generally malnutrition in 
children is the consequence of a range of factors that are often related to poor food quality, 
insufficient food intake and severe and repeated infectious diseases, or frequently some 
combinations of the three.  The same variable (BMI Z-score at baseline) was included in the 
hierarchical logistic regression model referring to 1-year post-praziquantel and albendazole 
treatment, as in this study the duration of this period did not produce a nutritional impact.  
Finally, in both hierarchical logistic regression models the BMI Z-score at baseline was not 
significant, and therefore it was omitted from these models.  Age was included in both 
hierarchical logistic regression models (baseline and follow-up) as a categorical variable. 
 
Two separate hierarchical linear modeling analyses were carried out to determine any change in 
the children’s Hb levels in relation to their schistosomiasis and/or hookworm infection intensity 
category, controlling at the same time for age and sex and anaemia status (as defined above).  
Children’s Hb levels at baseline and 1-year post-treatment were modeled through three-level 
hierarchical models where level-one represented the two periods of interest; level-two: the 
children and level-three: the schools.  The validity of the distributional assumptions of this model 
was examined using plots of level one, level two and level three residuals against their normal 
scores (see Figures 2.1, 2.2 and 2.3).  To take into account the paired data structure, a dummy 
variable corresponding to the second year of study was included as a covariate in the model.  The 
aim of this model was to quantify the adjusted overall change of Hb from baseline to follow-up 
and to quantify average Hb counts of different groups of children at baseline. 
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Changes in Hb levels in relation to their baseline schistosomiasis and/or hookworm infection 
intensity category and anaemia status from baseline to 1-year follow-up were modeled through 
two-level hierarchical models with level-one: the children and level-two: the schools.  The aim 
of this approach was to compare the average change in Hb counts over the two examined periods 
between different groups of children. Baseline anaemia status was also included in the 
explanatory part of the model to be able to examine rises in Hb levels in anaemic and not 
anaemic subjects as earlier recommended (Latham et al., 1983).  It was attempted to control for 
the fact that by adjusting for baseline anemia the effect of moderate or heavy infection for 
S.mansoni or hookworm may be underestimated if the type of anemia in the uninfected group is 
predominantly mild and self-limiting.  Therefore, the two-way interaction terms of intensity of S. 
mansoni and of hookworm infections with anaemia status were also tested, and, as none of these 
were significant, they were then omitted from the model.  To test the statistical significance of 
the fixed effects, Wald tests were used, whilst likelihood ratio tests were performed for the 
random effects.  All of the hierarchical models presented in this study are random intercepts 
models with multiple independent variables and were obtained using Mlwin (Multilevel Models 
Project, Institute of Education, London, UK).  
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2.3 Results 
 
Because of drop-outs during the second year of the study, baseline and follow-up data 
concerning the Hb counts were available from 2,788 children, aged 6 to 14 years old, from 36 
schools out of the 37 schools initially visited at baseline, over the period 2003 and 2004 
inclusive.  In school Tonya in Hoima district, Hb counts were measured neither at baseline nor at 
follow-up so this specific school was not included in this analysis. Table 2.1 presents the health 
indicators of children surveyed during this period.  Over the 12 months between examinations, 
overall prevalence significantly decreased for single S. mansoni, hookworm and A. lumbricoides 
infections as well as for co-infections of S. mansoni and hookworm and finally for anaemia.  For 
both years of the study the prevalences of severe anaemia were negligible and therefore these 
cases were not examined further here. Similarly, overall point prevalences, at both time points, 
for T. trichura and A. lumbricoides were very low.  The arithmetic mean intensities for all 
subjects (negatives and positives) for S. mansoni and hookworm infections decreased 
significantly 1-year post-praziquantel and albendazole treatment. A significant increase in 
haemoglobin concentration was also observed during the study period. 
 
Table 2.1 Health characteristics of children in 2003 to 2004 successfully followed up for one 
year. 
                                  * Sample sizes are provided into parentheses for each examined outcome    
                                     § Severe anaemia: Hb<7 g/dl 
                              
¶
 (…-…) are 95% CI’s                      
 
 
 
 2003 2004 p-values 
Parasitology*    
% infected with S. mansoni (n = 2,619) 43.9 (42.0 - 45.8)¶ 28.8 (27.1 - 30.5) <0.001 
% infected with hookworm  (n = 2,617) 52.1 (50.2 - 54.0) 24.0 (22.4 - 25.7) <0.001 
% infected with T. trichura  (n = 2,617) 2.3 (1.8 - 2.9) 2.3 (1.7 - 2.9) 0.917 
% infected with A. lumbricoides (n =2,613) 2.4 (1.8 - 3.0) 1.5 (1.0 - 1.9) 0.006 
% co - infected with  S. mansoni and hookworm 23.9 (22.2 - 25.5) 8.3 (7.2 - 9.4) <0.001 
Mean S. mansoni intensity (epg)  239.3 (215.8 - 262.7) 75.7 (64.6 - 86.7) <0.001 
Mean hookworm intensity (epg) 307.2 (253.8 - 360.6) 79.4 (66.5 - 92.3) <0.001 
Haematology (n = 2788)    
Mean haemoglobin (g/dl) 11.4 (11.4 - 11.5) 11.7 (11.6 - 11.7) <0.001 
% anaemic 50.0 (48.1 - 51.8) 45.8 (44.0 - 47.7) <0.001 
% severely anaemic§ 0.3 (0.1 - 0.5) 0.2 (0.0 - 0.3) 0.405 
  29 
 
Table 2.2 shows that there were significant differences between the children that were 
successfully followed up and the drop-outs with reference to their age, sex, home district and 
schistosomiasis infection.  Children of age 6 and 11 years old or above as well as children living 
in Arua and Mayuge proved most difficult to recruit into the cohort in the second year of the 
study.  The largest recovery cohort failure was observed in children heavily infected with S. 
mansoni at baseline. 
 
The results of the hierarchical multivariate logistic regression model for the probability of a child 
being anaemic at baseline are presented in Table 2.3.  This model included intensities of S. 
mansoni and hookworm infections and the analysis controlled for age, and sex, allowing also for 
assessment of the extent of between-school variation in anaemia prevalence.  At follow-up, there 
were very few children who were heavily infected with hookworm and therefore the 
convergence of the fitting algorithm in some of the models led to merge the heavy and moderate 
hookworm intensities into one category.  Moreover, there were very few children that were 9 and 
10 years old (only 2 children were 9 and none of these was 10 years old) within the cohort with 
these ages who caused problems to some of the models fits and again we decided to exclude 
them from all analyses.  This was performed in all models presented in this study so that they can 
be comparable.  Also for a similar reason, different intensities of co-infections of schistosomiasis 
and hookworm are not specifically examined here as overall there were too few co-infected 
children falling in different categories of intensities of the two infections in this cohort to support 
model fitting. 
 
Table 2.3 shows that children moderately or heavily infected with S. mansoni were marginally 
significantly more likely to be anaemic than those uninfected with S. mansoni. Children 
moderately or heavily infected with hookworm were significantly more likely to be anaemic than 
those uninfected with hookworm.  The school-level variance at the bottom of the same table 
shows that schools differed significantly in the baseline prevalence of anaemia observed.  
Whether the effects of the intensities of schistosomiasis and hookworm infections varied by age, 
sex or state of weight were also tested.  For this reason the relevant two-way interaction terms 
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were incorporated in the model and as none of these were significant, these estimates are not 
presented here. 
 
Table 2.2 Comparison of children successfully followed up and drop outs 
Variable Categories Drop outs Followed up p-
valuesf 
Intensity of  
S. mansoni 
infection 
Uninfected 
Lightly Infecteda 
Moderately Infectedb 
Heavily Infectedc 
Missing 
786 (50.3%) 
245 (15.7%) 
171 (10.9%) 
295 (18.9%) 
66 (4.2%) 
1512 (54.2%)* 
426 (15.3%) 
314 (11.3%) 
440 (15.8%) 
96 (3.4%) 
0.034 
 
Intensity of 
hookworm 
infection 
Uninfected 
Lightly Infectedd 
Moderately/Heavily  Infectede 
Missing 
736 (47.1%) 
724 (46.3%) 
37 (2.4%) 
66 (4.2%) 
1289 (46.2%) 
1330 (47.7%) 
72 (2.6%) 
97 (3.5%) 
0.527 
Age >=11 years old  
8 years old  
7 years old 
 6 years old 
Missing 
422 (27.0%) 
360 (23.0%) 
352 (22.5%) 
401 (25.7%) 
28 (1.8%) 
707 (25.4%) 
739 (26.5%) 
683 (24.5%) 
654 (23.5%) 
5 (0.2%) 
<0.001 
 
Sex 
       Male 
       Female  
       Missing 
723 (46.3%) 
702 (44.9%) 
138 (8.8%) 
1406 (50.4%) 
1380 (49.5%) 
2 (0.1%) 
<0.001 
 
Anaemia 
       Not Anaemic  
       Anaemic 
      Missing 
754 (48.2%) 
809 (51.8%) 
- 
1395 (50.0%) 
1393 (50.0%) 
- 
0.260 
District Nebbi 
Arua 
Bugiri 
Busia 
Hoima 
Masindi 
Mayuge 
Moyo 
Missing 
148 (9.5%) 
  74 (4.7%) 
218 (14.0%) 
188 (12.0%) 
233 (14.9%) 
212 (13.6%) 
261 (16.7%) 
229 (14.7%) 
- 
414 (14.9%) 
44 (1.6%) 
380 (13.6%) 
440 (15.8%) 
322 (11.6%) 
366 (13.1%) 
332 (11.9%) 
490 (17.6%) 
- 
<0.001 
 
alightly infected with S. mansoni:1--99 epg, bmoderately infected with S. mansoni: 100--399 epg, c heavily infected 
with  S. mansoni: >=400 epg, 
dlightly infected with hookworm: 1--1999 epg, emoderately/heavily infected with hookworm: >=2000 epg, 
fp-value for chi-square test, *column percentages are given in the parentheses. 
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Table 2.3 Adjusted odds ratios from hierarchical multivariate logistic regression model for 
baseline prevalence of anaemia (n = 2,682) 
Fixed effects 
Variable Categories Adjusted odds ratio (95% CI) p-
values 
Intensity of  
S. mansoni infection 
at baseline 
Uninfected 
Lightly Infecteda 
Moderately Infectedb 
Heavily Infectedc 
1 
0.958 (0.753 - 1.219) 
1.274 (0.962 - 1.686) 
1.309 (0.993 - 1.725) 
 
0.727 
0.091 
  0.056 
Intensity of 
hookworm infection 
 at baseline 
Uninfected 
Lightly Infectedd 
Moderately/Heavily Infectede 
1 
1.142 (0.965 - 1.352) 
2.219 (1.312 - 3.752) 
 
0.123 
0.003 
Age at baseline 
        >=11 years old  
    8 years old  
    7 years old 
    6 years old 
1 
1.464 (1.175 - 1.823) 
1.824 (1.453 - 2.290) 
2.212 (1.755 - 2.788) 
 
<0.001 
<0.001 
<0.001 
Sex 
       Male 
       Female  
1 
0.908 (0.774 - 1.064) 
 
0.230 
Random 
effects 
σ
2 S.E. 
 
School-level 
variance 
0.291 0.083 
 
             alightly infected with S. mansoni at baseline:1--99 epg, bmoderately infected with S. mansoni at baseline: 100--399 
epg,  
             c
 heavily infected with  S. mansoni at baseline: >=400 epg, 
            dlightly infected with hookworm at baseline: 1--1999 epg, emoderately/heavily infected with hookworm: at baseline 
>=2000 epg 
 
 
Results from the hierarchical logistic regression model for the probability of a child being 
anaemic at 1-year follow-up are presented in Table 2.4.  Children heavily infected with S. 
mansoni at follow-up were significantly more likely than uninfected children to be anaemic.  
Age, gender and moderate or heavy hookworm infections were also significant predictors.  
Finally, schools varied in the prevalence of anaemia observed at follow-up.  
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Table 2.4 Adjusted odds ratios from hierarchical multivariate logistic regression model  
for follow-up prevalence of anaemia (n = 2,696) 
               alightly infected with S. mansoni at follow-up:1--99 epg, bmoderately infected with S. mansoni at follow- up: 100--
399 epg, c heavily infected with  S. mansoni at follow-up: >=400 epg, 
          
dlightly infected with hookworm at follow-up: 1--1999 epg, emoderately/heavily infected with hookworm at follow-
up: >=2000 epg 
 
Table 2.5 contains the estimates of the three-level hierarchical model for Hb counts before and 
after praziquantel and albendazole treatment.  Normal plots of the different levels-residuals 
appeared fairly linear (see Figures 2.1, 2.2 and 2.3), which suggested that the assumption of 
normality and the selection of a linear hierarchical model were reasonable.  An overall increase 
of 0.061 g/dl in the Hb level after chemotherapeutic treatment was not significant (p=0.115).  
Children heavily infected with S. mansoni had significantly lower Hb counts (0.322 g/dl), 
(p<0.001) compared to uninfected children at baseline.  Children with moderate or heavy 
hookworm infection at baseline had significantly lower Hb counts (0.595 g/dl), (p<0.001) than 
those not infected after controlling for S. mansoni intensity, age, sex and anaemia status.  The 
random effects variance components indicate that much of the variation is between children 
within a school, but there was also statistically significant variation between schools.  The total 
variance is 1.758, the sum of the three variance components [Var(v0k), Var(u0jk) and Var(ε0ijk)]. 
Of the total variability in Hb counts, 0.122/1.758=6.94% was situated at the school level while 
0.551/1.758=31.34% arose between children within a school. 
Fixed effects 
Variable Categories Adjusted odds ratio (95% CI) p-
values 
Intensity of 
schistosomiasis infection 
at follow-up 
Uninfected 
Lightly Infecteda 
Moderately Infectedb 
Heavily Infectedc 
1 
1.158 (0.905 - 1.483) 
1.203 (0.866 - 1.672) 
1.567 (1.038 - 2.365) 
 
0.244 
0.272 
  0.032 
Intensity of hookworm 
infection at follow-up 
Uninfected 
Lightly Infectedd 
Moderately/Heavily Infectede 
1 
1.037 (0.842 - 1.276) 
4.289 (1.468 - 12.530) 
 
0.732 
0.008 
Age at follow-up 
        >=12 years old  
    9 years old  
    8 years old 
    7 years old 
1 
         0.697 (0.560 - 0.868) 
         0.760 (0.607 - 0.950) 
         1.184 (0.941 - 1.489) 
 
0.001 
0.015 
0.147 
Sex 
       Male 
       Female  
1 
0.837 (0.713 - 0.983) 
 
0.029 
Random effects σ2 S.E.  
School-level variance 0.367 0.100  
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Table 2.5 Estimates from three-level hierarchical model for haemoglobin counts before and after 
chemotherapeutic treatment (n = 2,682) 
Fixed effects Parameter Coefficient 
(S.E.) 
p-values 
Intercept γ00 11.854 
(0.083) 
<0.001 
Baseline Intensity of schistosomiasis infection (Reference category’ Uninfected’)   
Lightly Infected* γ01 -0.073 
(0.055) 
0.183 
Moderately Infected γ02 -0.153 
(0.068) 
0.024 
Heavily Infected γ03 -0.322 
(0.072) 
<0.001 
Baseline Intensity of hookworm  infection (Reference category’ 
Uninfected’) 
   
Lightly Infected γ04 -0.046 
(0.041) 
0.262 
Moderately/Heavily γ05 -0.595 
(0.139) 
<0.001 
Gender (Reference category Male)    
Female γ06 0.097 
(0.042) 
0.115 
Baseline Age (Reference category >=11 years old)     
8 years old γ07 -0.319 
(0.052) 
<0.001 
7 years old γ08 -0.509 
(0.053) 
<0.001 
6 years old γ09 -0.615 
(0.069) 
<0.001 
Effect of follow-up (relative to baseline)
 
 -Linear Coefficient of time  γ10 0.061 
(0.039) 
 0.115 
Random effects   
Level-3 (i.e. between schools) variance   
)( 02 kv vVar=σ
 
0.122 
(0.032) 
 
Level-2 (i.e. between children within a school) variance   
)( 02 jku uVar=σ
 
0.551 
(0.038) 
 
Level-1 (i.e. measurement occasions within a child) variance   
)( 02 ijkVar εσ ε =  1.085 (0.034) 
 
Deviance 15398.82  
*Categories of intensities of infections are identical as for those in previous tables 
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Figure 2.1 Normal plot of level-one residuals of hierarchical model in Table 2.5 
 
 
Figure 2.2 Normal plot of level-two residuals of hierarchical model in Table 2.5 
 
 
Figure 2.3 Normal plot of level-three residuals of hierarchical model in Table 2.5 
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Figure 2.4 shows 36 level-three residuals plotted one for each school with the schools ordered 
according to the rank of their posterior mean.  It indicates that most of them have approximately 
average Hb counts that cannot be distinguished statistically.  The school with the lowest intercept 
residual (at the bottom left) and mean Hb count was Kibiro school in Hoima district.  At baseline 
the S. mansoni and hookworm point prevalences in this school were 94.87% and 10.26%, while 
at follow-up these decreased to 87.18% and 2.56%, respectively.  The school with the highest 
intercept and mean Hb count was Arua Public in the Arua district.  The raw data for this school 
showed that S. mansoni and hookworm prevalence at baseline were 22.86% and 25.71% and 
decreased to 14.29% and 2.86% respectively at follow-up. 
 
Figure 2.4 Caterpillar plot: 36 level-three residuals from model presented in Table 2.5 
(Bars represent 95% CIs and the triangles level-three residuals)  
 
 
 
Finally, Table 2.6 contains the estimates of the two-level hierarchical model for the change of Hb 
counts between the two years of the study.  It indicates that most risk groups had a relatively 
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slowed reduction or actual increase in Hb counts after praziquantel and albendazole 
chemotherapy compared to the reference group (baseline uninfected, non-anaemic, >=11-year-
old).  More precisely, children heavily infected with S. mansoni at baseline had a smaller 
decrease by 0.229 g/dl in their Hb counts in comparison with the uninfected with S. mansoni.  
Among children found to be anaemic at the baseline survey, Hb counts increased significantly by 
0.834 (i.e. 1.240 – 0.406) g/dl after treatment.  
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Table 2.6 Estimates from two-level hierarchical model for the change of haemoglobin counts  
(n = 2,682) 
Fixed effects Parameter Coefficient 
(S.E.) 
p-values 
Intercept γ00 -0.406 
(0.103) 
<0.001 
Baseline intensity of schistosomiasis infection (Reference category’ Uninfected’)   
Lightly Infected* γ01 -0.061 
(0.076) 
0.428 
Moderately Infected γ02 -0.004 
 (0.090) 
0.963 
Heavily Infected γ03 0.229 
(0.089) 
0.010 
Baseline intensity of hookworm  infection (Reference 
category’ Uninfected’) 
   
Lightly Infected γ04 0.021 
(0.054) 
0.694 
Moderately/Heavily Infected γ05 0.274 
(0.160) 
0.087 
Gender (Reference category Male)    
Female γ06 0.030 
(0.050) 
0.552 
Baseline Age (Reference category >=11 years old)     
                                                 8 years old γ07 0.015 
(0.070) 
 0.824 
                                                 7 years old γ08 0.028 
(0.071) 
 0.694 
                                                 6 years old γ09 -0.161 
(0.073) 
 0.028 
  
Baseline anaemia(Reference category non anaemic children) 
   
Anaemic γ10 1.240 
(0.052) 
    <0.001 
Random effects Variance 
components 
 
Level-2 (i.e. between schools) variance 
  
)( 02 jku uVar=σ
 
0.180 
(0.048) 
 
Level-1 (i.e. between children within a school) variance  
 
)( 02 ijkVar εσ ε =
 
1.660 
(0.046) 
 
Deviance 9076.5  
*Categories of intensities of infections are identical as for those in previous tables 
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2.4 Discussion 
 
Friedman and others recommended that future research aimed to quantify a relationship between 
schistosomiasis and anaemia should include an adequate follow-up period and include 
individuals with a range of infection intensities (Friedman et al., 2005).  To my knowledge, this 
study represents the first longitudinal examination into the occurrence of anaemia in a cohort of 
children infected with S. mansoni and hookworm in Uganda using a uniquely detailed large 
dataset arising from the National Control Schistosomiasis Programme within the country.  The 
aim of this chapter was to examine the relationship of S. mansoni and hookworm infection to 
anaemia and Hb levels while the effectiveness of practical interventions to control or reduce the 
severity of such anaemia was also evaluated.  
 
Helminth infections at a young age may induce, amongst other factors, pro-inflammatory 
mediators that are detrimental to protein metabolism, appetite and erythropoiesis and the WHO 
therefore recommends the use of anti-schistosome treatment (Crawley, 2004).  In Uganda, it has 
been proven that drug distribution in schools is excellent and community-directed treatment is a 
feasible health approach for mass drug distribution in poor remote communities (Kabatereine et 
al., 2006).  This study provides further convincing evidence to show that young children may 
benefit from deworming in terms of increased Hb and consequently reduced anaemia levels.  In 
particular, whilst these data clearly demonstrate that, while there was association between 
anaemia and both schistosomiasis and hookworm infection at baseline, by the follow-up data, the 
probability of anaemia was only associated with heavy S. mansoni and moderate or heavy 
hookworm infections (Tables 2.3 & 2.4).  
 
However, whereas the first hierarchical model of Hb counts (Table 2.5) showed that treatment 
arrests the drop in Hb, it suggests that without iron replacement, Hb levels probably will not rise.  
Additionally, the second hierarchical model (Table 2.6) revealed a drop in Hb counts in the 
comparison group of baseline uninfected, non-anaemic, >=11-year-old children.  One could 
speculate that this could reflect, for example an increased malaria infection rates at follow-up 
and/or a bad harvest during the second year of this study perhaps explained from the fact that 
there were more than 1.6 million internally displaced persons in Uganda’s north and east where 
malnutrition is one of the most pressing health concerns as a result of fighting between 
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government forces and rebels from the Lord’s Resistance Army (Nullis-Kapp, 2004).  It is likely 
that inadequate dietary iron was another factor contributing to this observed decline.  These 
results confirm the findings of Taylor et al (2001) in South Africa where through a randomized 
controlled trial provided two different anthelminthic treatment regimens twice at 6-monthly 
intervals combined with iron supplementation for one year in groups of 428 primary-school 
pupils (Taylor et al., 2001).  These authors observed a significant decrease in Hb levels of pupils 
receiving triple dose of albendazole and praziquantel only and a significant increase in Hb levels 
of pupils receiving three doses of these drugs and iron supplementation.  Such combined results 
thereby strengthen the argument of Stoltzfus et al (1998) that deworming programs should be 
combined with increased iron intake through supplementation, fortification or improved diet in 
order to reduce the incidence of anaemia substantially (Stoltzfus et al., 1998).  
 
Moreover, data from Beasley et al (1999) in rural Tanga, Tanzania and Friis et al., 2003 in 
western Kenya suggest that children most benefited from anthelminthic treatment in terms of 
increased Hb levels were those who were anaemic at baseline.  From the second hierarchical 
model of Hb counts presented in the study of this chapter (Table 2.6) a significant increase in the 
change of Hb counts and a stronger effect for anaemic children compared to non-anaemic was 
also found.  This same model also showed a slower reduction in Hb counts for heavily infected 
children with S. mansoni and moderately or heavily infected children with hookworm compared 
to uninfected after treatment, which suggests that the effect of anthelminthic treatment on Hb 
was mediated by reductions in intensities of S. mansoni and hookworm infections.  
 
Ethical reasons as well as the operational reality of the national control programme did not 
permit the inclusion of a control (i.e. untreated) group. Consequently, the study design did not 
allow estimation of the absolute impact of treatment only the relative impact in different groups.  
Therefore, in order to provide substantial support for the plausibility of the impact of the 
intervention, the epidemiological findings from the models presented in this study have now 
been further validated with quantitative predictions arising from mathematical models with very 
promising results (Kabatereine et al., 2007).  The high percentage of drop outs in the group of 
heavily infected children with S. mansoni (Table 2.1) due to frequent population movements 
within Uganda, might also add some bias to the epidemiological findings of this study.  
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Moreover, although malaria is a well known cause of anaemia and Plasmodium falciparum is 
almost holoendemic in the examined population here, this factor as well as dietary iron intake 
were not examined, but it is highly recommended that this information to be included in future 
evaluation follow-ups (Friedman et al., 2005).  Indeed the variance components of the linear 
hierarchical models (Tables 2.5 & 2.6) have shown that there remains substantial variability 
which is not explained by the models, and this might well be due to malaria and iron deficiency 
not being taken into account here. In addition to these, variables referring to mosquito control at 
the school/village level were not available, and future studies may benefit from their 
incorporation.  The hierarchical model did, however, show that Kibiro school in Hoima district, 
with significantly lower mean Hb count compared to the overall mean Hb count, had also very 
high S. mansoni prevalence, possibly due to its proximity to Lake Albert, the major source of 
transmission.  On the other hand, the school with significantly higher mean Hb count compared 
to the overall mean Hb count was situated in the northern part of the country, where S. mansoni 
and hookworm prevalences were moderately low.  These results agree with previous work on the 
distribution of S. mansoni in Uganda, which indicates that highest schistosomiasis prevalences 
are found close to the eastern shores of Lakes Albert and Victoria while areas of low or zero 
prevalence are found in the northeast of the country (Kabatereine et al., 2004).  
 
To conclude, the results of the study presented in this chapter, which derive from a large-scale 
national control programme, suggest that S. mansoni and hookworm infections may be related to 
anaemia in specific districts of Uganda and chemotherapy with praziquantel and albendazole 
may reduce anaemia.  Anaemia is therefore likely to represent a valuable marker for morbidity 
caused by heavy infection with S. mansoni, provided that other likely causes, hookworm, dietary 
iron intake and malaria are taken into consideration. 
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Chapter 3: Relationships between Schistosoma mansoni, 
Plasmodium falciparum infections and anaemia in Kenyan 
schoolchildren: a Bayesian hierarchical modeling approach 
 
Summary   
 
Anaemia is multi-factorial in origin and disentangling its aetiology remains problematic, as has 
been demonstrated in Chapter 2 of this PhD thesis.  In the current Chapter, I report cross-
sectional data on Schistosoma mansoni infection, haemoglobin (Hb), malaria parasitaemia, 
hookworm, Ascaris lumbricoides, and Trichuris trichiura infections, as well as undernutrition, 
among 1,523 schoolchildren enrolled in classes 5 and 6 (aged 10 to 21 years) in 30 primary 
schools in western Kenya. Bayesian hierarchical modelling was used to investigate putative 
relationships.  Children with a heavy S. mansoni or with Plasmodium falciparum infection, 
stunted children and girls were found to have lower haemoglobin concentrations.  Children 
heavily infected with S. mansoni were also more likely to be anaemic compared with uninfected 
children.  The findings of this study in combination with the findings of Chapter 2, further 
highlight the importance of intestinal schistosomiasis and/or malaria as contributors to reduced 
Hb levels among schoolchildren and help guide the implementation of integrated school health 
programmes in areas of differing parasite transmission. 
 
Keywords: Bayesian hierarchical models, anaemia, Kenya, Schistosoma mansoni, hookworm, 
Ascaris lumbricoides, Trichuris trichiura, malaria  
 
Note: A modified version of this chapter has been published as: Koukounari A, Estambale BB, 
Kiambo Njagi J, Cundill B, Ajanga A, Crudder C, Otido J, Jukes MC, Clarke SE, Brooker S 
(2008) Int J Parasitol 38, 1663-71. See publications by the candidate (Appendix).  
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3.1 Introduction 
 
As discussed in Chapter 2, anaemia remains one of the most intractable public health problems in 
Africa, contributing to a quarter of Africa’s nutrition-related Disability Adjusted Life Years 
(DALYs) lost (World Health Organization, 2002).  Several studies have highlighted the 
contribution of parasitic diseases to childhood anaemia.  Recent meta-analyses of malaria 
intervention trials among African children, for example, provide compelling evidence that both 
symptomatic and asymptomatic malaria contributes to anaemia (Geerligs et al., 2003; 
Korenromp et al., 2004).  The effect of hookworm infection is also well documented, with risk of 
anaemia correlated with intensity of infection (Stephenson, 1993; Olsen et al., 1998; Brooker et 
al., 1999); in contrast, the contributory role of schistosomiasis remains unclear (Desai et al., 
2005b; Friedman et al., 2005a) as also discussed in Chapter 2.  However, there are surprisingly 
few published studies describing the relative contribution of all the different parasitic infections 
mentioned above in populations of school-aged children (Olsen et al., 1998; Tatala et al., 1998; 
Friis et al., 2003; Leenstra et al., 2003; Leenstra et al., 2004; Desai et al., 2005a; Friedman et al., 
2005b). Investigation of this issue is particularly relevant for anthelminthic treatment 
programmes through school health programmes.  In particular, the same suite of school-based 
interventions will not be relevant everywhere, and the selection of intervention options will need 
to be guided by an informed understanding of the epidemiology of parasite-related anaemia 
(Crawley, 2004), as well as of the geography of infection (Brooker et al., 2007).   
 
The aim of the present study was to examine the relationships of haemoglobin (Hb) 
concentration and anaemia with S. mansoni infection using a similar statistical methodological 
approach as the one employed in Chapter 2 (i.e. hierarchical modeling) controlling at the same 
time for hookworm, Ascaris lumbricoides, Trichuris trichiura and malaria infections in school 
children in western Kenya but within a Bayesian framework.  Adjustment for nutritional and 
socioeconomic status (SES) has also been taken into account here as they might influence 
anaemia risk (Ong'echa et al., 2006).  By employing a Bayesian approach for the statistical 
modeling of the Hb counts and of anaemia prevalence, the model specification via Markov chain 
Monte Carlo (MCMC) algorithms offers flexibility in fitting complex models and enables 
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estimates for the whole distribution of the unknown parameters, including point and interval 
estimates, to be derived.  
 
3.2 Materials and methods 
 
3.2.1 Study sites, sampling and design.  Data were collected between February and 
March 2005 in 30 primary schools in Bondo district in western Kenya.  Previous studies in 
western Kenya have reported a medium prevalence of S. mansoni and A. lumbricoides infections 
(Brooker et al., 2000; Thiong'o et al., 2001) and a high prevalence of hookworm and T. trichiura 
infections.  Malaria transmission is intense and perennial (Beier et al., 1994), with two seasonal 
peaks, March-May and November-December, following the long and short rainy seasons 
respectively.  
 
This study used cross-sectional, baseline data from a stratified, cluster-randomised placebo-
controlled trial of the impact of antimalarial intermittent preventive treatment (IPT) among 
schoolchildren in order to compare and validate results reported in Chapter 2.  The trial design 
and protocol of the current study are described elsewhere (Clarke et al., 2008).  Briefly, sample 
size was estimated on the basis of the expected impact of IPT on anaemia, using the methods for 
cluster-randomised trial design proposed by Hayes and Bennett (1999).  The 30 study schools 
were randomly selected from primary schools in Usigu and Maranda Divisions with ≥ 150 pupils 
in total and > 15 pupils per class and located more than 5 km from the shores of Lake Victoria, 
so as to minimise the effect of S. mansoni which is generally only prevalent along the shoreline 
(Brooker et al., 2001; Handzel et al., 2003).  No stratification by intestinal nematode was 
undertaken because of their relatively homogeneous distribution (Handzel et al., 2003) but 
schools were stratified according to past school examination performance.  This study presents 
data from the baseline survey on a sub-sample of children enrolled in classes 5 and 6 (age range 
10 to 21 years) for whom complete data on anaemia, helminth infection, malaria parasitaemia, 
nutritional status and SES were available.  
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Ethical clearance for the current study was obtained from the ethics committee of the Kenyatta 
National Hospital, Kenya and from the London School of Hygiene and Tropical Medicine, UK. 
Permissions were obtained from the Ministry of Education, and the district education and health 
authorities, and headteachers.  Prior to the start of the study, a series of meetings were held in 
participating schools to explain the nature and purpose of the trial and to obtain individual 
informed parental consent from the parents or legal guardians of children enrolled in study 
schools.  
3.2.2 Parasitological and anaemia morbidity data.  
A slide was declared negative after examination of 100 high-powered fields.  Stool samples 
provided by each child were examined microscopically using the semi-quantitative Kato-Katz 
technique and intensity of infection was expressed as eggs/gram of faeces.  Malaria parasite 
prevalence and parasite densities were estimated in Giemsa-stained thick blood films, assuming 
an average white blood cell count of 8,000 per µl, with species identification carried out on 
Giemsa-stained thin films.  Finger-prick blood samples were obtained from all children to assess 
Hb levels and malaria parasitaemia.  Haemoglobin was measured in the field using a portable 
photometer (Haemocue, Angelholm, Sweden).  
 
Height was measured to the nearest 0.1 cm using a Leicester portable fixed base stadiometer 
(Chasmors, UK) and weight was measured to the nearest 0.1 kg using an electronic balance.  A 
simple questionnaire was administered to pupils to obtain data on key socio-economic variables 
including: structure of the house, type of overall light, ownership of bicycle, use of bednet as 
well as education of the child’s guardian. 
 
3.2.3 Statistical analyses.  An index of SES was constructed from asset and education 
variables using principal component analysis (Filmer & Pritchett, 2001).  Data were available for 
1453 (92%) of the 1577 children in 30 schools.  Analysis was done using the PROC PRINCOMP 
command in SAS version 9.1 (SAS Institute Inc., Cary, NC, USA).  For the index of SES, the 
first principal component explained 28% of the variance in the asset and education variables with 
the greatest weight given to the presence of a permanent house structure (0.43), and the lowest 
weight to the presence of a traditional house structure (-0.39), respectively.  Weights for each 
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variable were derived from the first principal component and applied to each child to derive a 
SES index (Table 3.1).  Children were then assigned to a group on the basis of their value on the 
index.  Following the approach of Filmer and Pritchett (2001), children were classified into a 0-
39 percentile, 40-79 percentile and upper 20 percentile, which are referred to as ‘most poor’, 
‘poor’ and ‘least poor’, respectively.   
 
Table 3.1 Scoring Factors and summary statistics for variables entering the computation of the 
first principal component 
Asset & education variables  Scoring 
Factors 
Mean SD 
Own metal roof 0.386 0.666 0.472 
Own cement floor 0.423 0.283 0.451 
Traditional house structure -0.389 0.328 0.470 
Semi-permanent house structure  -0.015 0.396 0.489 
Permanent house structure 0.425 0.277 0.448 
Original light of house/Electric- Generator  0.133 0.021 0.142 
Original light of house/Pressure 0.045 0.019 0.138 
Original light of house/Hurricane 0.297 0.385 0.487 
Original light of house/Tin -0.343 0.575 0.495 
Highest education of who you live with/Primary -0.200 0.418 0.493 
Highest education of who you live with/Secondary 0.135 0.302 0.459 
Highest education of who you live with/Post-secondary 0.123 0.038 0.191 
Highest education of who you live with/Schooled 0.046 0.170 0.376 
Own bicycle 0.157 0.788 0.409 
Own bednet 0.120 0.095 0.293 
 
Each variable takes the value 1 if true, 0 otherwise. Scoring factor is the ‘weight’ assigned to each variable in the linear combination of 
the variables that constitute the first principal component. The first eigenvalue is 4.76; the second eigenvalue is 2.72; the proportion of 
variance explained is each eigenvalue divided by the sum of the eigenvalues.; based on the obtained results and a screeplot, it was 
decided to retain one principal component. SD stands for standard deviation.  
 
Anthropometric indices were calculated on the basis of the 2000 Centres for Disease Control and 
Prevention (CDC) Growth Charts, and analysed as binary variables.  Children were classified as 
stunted if z-scores of height-for-age were less than 2 SD below the CDC median. Body mass 
index, which is weight (kg)/height (cm)2, was also calculated and a cut-off of -2 Body Mass 
Index Z-scores (BMIZ) were calculated to classify underweight children.  Data management and 
bivariate relationships between mean Hb concentration and key predictors examined were 
obtained using SAS V 9.1 (SAS Institute Inc., Cary, NC, USA). 
 
Bayesian hierarchical modelling was used to assess associations between anaemia, Hb and 
parasitic infection, including children and schools as random effects drawn from some common 
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prior distribution with unknown parameters.  Children within each school as well as the results 
from different schools were treated as ‘exchangeable’ in the sense that their joint probability 
densities should be invariant to permutations of the indexes (Gelman et al., 2004).  
 
In Bayesian analysis, the proposed model of the observed data is combined with the prior 
distribution of all the unknown model parameters to give the posterior distributions for all 
unknowns. MCMC methods (Gilks et al., 1996) are used to sample from the posterior 
distributions of the unknown parameters. Analysis was conducted using WinBUGS which 
employs the Gibbs sampler to form the posterior distribution for each unknown parameter by 
drawing samples from their full conditional distributions (Spiegelhalter et al., 2003) to fit 
models.  An advantage of the Bayesian hierarchical approach is that prior information can be 
incorporated in the model in probabilistic form.  However, in the absence of any prior knowledge 
about the model parameters, the choice of non-informative improper priors is dictated by 
pragmatic conditions (Diggle et al., 2002).  Model convergence was evaluated on the basis of 
inspection of sample traces, which all showed a reasonable degree of convergence to a stationary 
distribution.  Figure 3.1 illustrates two examples of such trace plots for the parameters of heavy 
intensity of S. mansoni infection: a) in the linear hierarchical Bayesian model for the Hb counts 
(see Figure 3.1a) and b) in the logistic hierarchical Bayesian model for the anaemia risk (see 
Figure 3.1b).  Trace plots for the rest of the estimated parameters in both Bayesian hierarchical 
models also, eventually reached stationary distributions. 
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Figure 3.1 Trace plots for the parameters of heavy intensity of S.mansoni infection in final 
Bayesian hierarchical models 
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Bayesian normal hierarchical models were fitted on Hb because there is a two-level data 
structure applied to cross-sectional data.  Individual subjects were classified at the lower level for 
older children with data on helminth infection and age range 10-21 years old was classified by 
cluster at the higher level. It was assumed that individual i (=1,…,n) - where n = 1,523 can 
belong in any of j (=1,…,n2) - where n2 = 30 schools. Hb at a child level may be affected by 
those childrens’ characteristics (age, sex, intensities of helminth infections, nutritional and socio-
economic status) but may also vary according to which school these children are enrolled in.  
Specifically for Hb, a random intercepts normal model was used which can be written as:  
 
ijHb ~ ( )τµ ,ijnormal , 
with jijij uX += βµ  and )001.0,001.0(~ gammaτ , 
),0(~
juj normalu τ  and )001.0,001.0(~ gammajuτ . 
a. Trace plot (or history plot) of the parameter for 
heavy intensity of S.mansoni infection from 
linear hierarchical Bayesian model presented in 
Table 3.2. It is apparent from this plot that the 
processes from both chains (blue and red lines) 
look stationary which strengthens our belief that 
the MCMC simulations of the assumed model 
have converged. 
b. Trace plot (or history plot) of the parameter for 
heavy intensity of S.mansoni infection from 
logistic hierarchical Bayesian model presented in 
Table 3.3. It is apparent from this plot that the 
processes from both chains (blue and red lines) 
look stationary which strengthens our belief that 
the MCMC simulations of the assumed model 
have converged. 
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where µ ij is given by the sum of the product of Xij with β - this constitutes the fixed part of the 
model, and uj- constitutes the random part of the model.  More precisely, Xij is a vector of 
individual-level characteristics, β is a vector of k estimated parameter coefficients and uj is the 
error term at the school-level which represents each school’s difference from the overall 
population mean as its mean is set to 0. τ represents the precision (1/variance) of the normal 
distribution of the response Hb whereas τuj represents the precision (1/variance) of the normal 
distribution of the uj’s.  For both variance components, the usual practice of specifying a gamma 
prior distribution to the corresponding precision parameters which is proper and close to being 
uniform on log (τ), has been followed.  
 
For the vector of the k estimated parameter coefficients it was assumed: 
 
( )∝kp β  1 
 
Where p(βk) symbolizes the prior distribution of the k estimated parameters and is proportional 
to 1.  
 
In order to examine the prevalence of anaemia with associated covariate vectors, the single 
outcome of the probability that a child is anaemic was chosen, as estimated by a hierarchical 
Bayesian logistic regression model.  The survey responses anaemiaij were labeled as 1 for 
children i being anaemic (if Hb < 11.0 g/dL) in school j and 0 otherwise; they were modeled 
independently with Pr(anaemiaij=1)=logit-1((Xij)β).  The analysis presented is based on a prior 
distribution for β that is independent and locally uniform in the k parameters; that is p(β1, …, 
βk)∝1.  Specifically for the risk of being anaemic, a random intercepts logit link model was used 
which can be written as: 
 
ijanaemia ~ ( )ijpBernoulli , 
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with jijij uXplogit += β)(  and )001.0,001.0(~ gammaτ , 
),0(~
juj normalu τ and )001.0,001.0(~ gammajuτ  
 
where pij is the probability of being anaemic.  The rest of the notation remains identical to the 
normal hierarchical Bayesian models which were employed for the analysis of the Hb levels.  In 
these aforementioned regression models, the same predictors of anaemia prevalence as those in 
the models of Hb counts were used.  
 
To compare model complexities and goodness of fit, the deviance information criterion (DIC) of 
(Spiegelhalter et al., 2002) was also monitored.   
 
3.3 Results 
 
Data on Hb, helminth infection and malaria parasitaemia were available for 1,523 children, aged 
10 to 21 years old in the 30 schools (Table 3.2).  Overall 13.5%, (95% confidence interval (CI): 
11.8-15.2) of these children were anaemic at the time of survey and the mean Hb concentration 
was estimated to be 12.43 g/dL (95% CI: 12.35-12.50).  
 
76.9% of children were infected with at least one parasitic helminth infection.  Hookworm was 
the most prevalent helminth infection (47.3%); 14.1% were infected with S. mansoni, 23.7% 
with A. lumbricoides and 12.9% with T. trichiura.  A total of 34.7% of children were infected 
with Plasmodium falciparum with a further 0.3% having mixed infections with P. falciparum 
and Plasmodium malariae.  The prevalences of P. falciparum, hookworm and S. mansoni were, 
respectively, 35.8%, 41.2% and 12.4% in the 10-12 years old age group, 34.4%, 51.2% and 
14.7% in the 13-15 years old age group and 25.9%, 46.3% and 20.4% in the older age group (i.e. 
>= 16 years old).  
 
3.3.1. Bayesian hierarchical normal model of haemoglobin. Table 3.3 contains 
the posterior means and 95 % credible intervals of the final two-level Bayesian normal 
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hierarchical model for the Hb of children with complete data on all covariates.  According to this 
model, the posterior mean for the overall mean Hb was estimated to be 12.52 g/dL (95% 
Bayesian credible interval (BCI): 12.28 to 12.76).  On average, girls had lower mean Hb 
compared with boys by 0.18 g/dL.  Older children tended to have higher mean Hb than children 
aged 10-12 years.  Stunted children compared with non-stunted children had lower mean Hb by 
0.34 g/dL.  From the 95 % BCIs of all the parasitic infections, only children heavily infected 
with S. mansoni had significantly lower mean Hb by an average of 0.51 g/dL, (95% BCI: -0.94 
to -0.10) and children infected with malaria had significantly lower mean Hb by an average of 
0.16 g/dL, (95% BCI: -0.32 to -0.01) compared with uninfected children, respectively.  Although 
there was no evidence of a significant effect of the intensities of single hookworm, T. trichiura or 
A. lumbricoides infection, adjustment for these was still allowed and thus they were finally 
included in the model.  The two-way interaction terms of intensities of helminth infections 
mentioned before, were also included and tested in the models in order to check for the effect of 
helminth co-infections on the mean Hb.  As none of these terms, as well as the SES, were found 
to be significantly associated with Hb levels and/or anaemia, they were omitted from the final 
model.  The random effects variance components indicate that most of the variance is between 
children within a school: of the total variability in Hb, 9.9 % (0.225/2.256) occurred at the school 
level while 90.0 % (2.031/2.256) occurred between children within a school.  
 
This is also illustrated by Figure 3.2 which presents a box plot of the level-two residuals among 
older children for each school, and indicates that most schools had similar Hb levels that could 
not be distinguished statistically, thereby confirming the suitability of assumptions for the chosen 
final model.  Interestingly, mean Hb was substantially higher in one school (#21) relative to 
other schools.  
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Figure 3.2 Box plot of school-level residuals from a Bayesian hierarchical model for Hb counts 
among older children. 
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Each box plot represents a school-level residual in this study. Numbers above each box plot are label 
identifiers for each school. This is a plot in which the posterior distributions of all u2s are summarised side by 
side. Boxes represent inter-quartile ranges and the solid black line at the (approximate) centre of each box is 
the mean of each specific u2; the arms of each box extend to cover the central 95 per cent of the distribution - 
their ends correspond, therefore, to the 2.5 % and 97.5 % quantiles. The horizontal straight line in the middle 
of the graph represents the overall mean of the u2s which is set to 0. 
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Table 3.2 Mean Hb concentration and prevalence of anaemia according to infection status and 
other characteristics in 1,523 schoolchildren aged 10-21 years (univariate analysis). 
 
aNA, not available; b Socio-economic status or SES data were missing for 119 children;  cIntensity of helminth 
infection was classified in light, moderate and heavy according to WHO recommended thresholds: Schistosoma 
mansoni infection, 1-99, 100-399 and ≥ 400 eggs per gram of faeces (epg); hookworm, 1-1,999, 2,000-3,999 and ≥ 
4,000 epg; Trichuris trichiura, 1-999, 1,000-9,999 and ≥ 10,000 epg; and Ascaris lumbricoides, 1-4,999, 5,000-
49,999 and ≥ 50,000 epg. BMIZ stands for Body Mass Index Z-score; HAZ stands for Height for Age Z-score and 
CI, confidence interval.] 
Variable Children No 
(%) 
Mean Hb level, g/dL  
(95% CI) 
Anaemia prevalence (%) 
(95% CI) 
Sex 
   Male 
   Female 
       
786 (51.6) 
737 (48.4) 
 
12.51 (12.40 to12.61) 
12.34 (12.23 to12.45) 
 
13.2 (10.9 to 15.6) 
13.7 (11.2 to 16.2) 
Age 
   10-12 years old 
   13-15 years old 
   >=16 years old 
 
573 (39.0) 
896 (61.099) 
54 (3.7) 
 
12.29 (12.17 to 12.41) 
12.52 (12.42 to 12.62) 
12.44 (12.08 to 12.80) 
 
13.1 (10.3 to 15.9) 
13.8 (11.6 to 16.1) 
11.1  (2.7 to 19.5) 
Classification of SES (n=1404b) 
Least poor 
Poor 
Most poor 
 
281 (20.01) 
560 (39.89) 
563 (40.10) 
 
12.42 (12.24 to 12.61) 
12.45 (12.34 to 12.58) 
12.40 (12.28 to 12.53) 
 
12.81 (8.90 to 16.72) 
13.93 (11.06 to 16.79) 
13.14 (10.35 to 15.93) 
Classification of BMIZ 
   Not underweight 
   Underweight 
 
 1430 (93.9) 
  93 (6.1) 
 
12.44 (12.36 to 12.52) 
12.22 (11.92 to 12.52) 
 
13.2 (11.4 to 14.9) 
18.3 (10.4 to 26.1) 
Classification of HAZ 
   Not stunted 
   Stunted 
 
 1323 (86.9) 
  200 (13.1) 
 
12.48 (12.40 to 12.56) 
12.10 (11.88 to 12.31) 
 
12.8 (11.0 to 14.6) 
18.0 (12.7 to 23.3) 
Intensity of hookworm  infection c 
   Not Infected 
   Lightly Infected  
   Moderately Infected 
   Heavily Infected 
 
     803 (52.7) 
 691 (45.4) 
  15 (1.0)    
  14 (0.9 )    
 
     12.42 (12.31 to 12.53) 
12.45 (12.35 to 12.56) 
12.21 (11.60 to 12.83) 
11.87 (11.34 to 12.40) 
 
       14.0 (11.6 to 16.3) 
12.9 (10.4 to 15.4) 
13.3 (0.0 to 30.5) 
14.3 (0.0 to 32.6) 
Intensity of S. mansoni infection c 
   Not Infected 
   Lightly Infected  
   Moderately Infected 
   Heavily Infected 
 
1309 (86.0) 
    91 (6.0) 
    76 (5.0) 
    47 (3.0) 
 
12.44 (12.36 to 12.53) 
12.41 (12.11 to 12.71) 
12.54 (12.21 to 12.87) 
11.79 (11.28 to 12.30) 
 
13.2 (11.4 to 15.1) 
11.0 (4.6 to 17.4) 
13.2 (5.6 to 20.8) 
25.5 (13.1 to 38.0) 
Intensity of T.trichiura infection c 
   Not Infected 
   Lightly Infected  
   Moderately Infected 
   Heavily Infected 
 
   1326 (87.1) 
 188 (12.3) 
     8 (0.5)    
     1 (0.1)     
 
12.41 (12.33 to 12.50) 
12.47 (12.26 to 12.69) 
13.26 (12.30 to 14.23) 
12.80 NAa 
 
13.4 (11.6 to 15.3) 
14.4 (9.4 to 19.4)          
0.0 NAa 
0.0 NAa 
Intensity of A. lumbricoides  infection c 
   Not Infected 
   Lightly Infected  
   Moderately Infected 
   Heavily Infected 
 
1162 (76.3) 
236 (15.5) 
125 (8.2) 
0 (0.0) 
 
12.46 (12.37 to 12.55) 
12.34 (12.16 to 12.52) 
12.27 (12.04 to 12.50) 
0.0    NA a 
 
13.6 (11.6 to 15.6) 
13.1 (8.8 to 17.5) 
12.8 (6.9 to 18.7) 
0.0    NA a 
Malaria spp. infection 
   Not Infected 
   Infected 
 
989 (69.9) 
534 (35.1) 
 
12.49 (12.40 to 12.58) 
12.31 (12.18 to 12.44) 
 
12.8 (10.8 to 14.9) 
14.6 (11.6 to 17.6) 
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Table 3.3 Estimated posterior mean differences in mean Hb concentration for the effects of 
selected explanatory variables from a final Bayesian hierarchical model (n = 1,523). 
 
a95% Bayesian credible intervals (BCIs) are different from classical 95% confidence intervals (CIs) in various ways, 
one of which is: in their interpretation: we say there is a 95% probability that the true parameter lies in a 95% BCI 
where this is certainly not the interpretation of a 95% CI. In a long series of 95% CIs, 95% of those should contain 
the true parameter value - unlike the Bayesian interpretation we cannot give a probability for whether a particular CI 
contains the true value  
bThese are significant differences compared with the reference category in the sense that the probability is at least 
95% that these parameters lie within the BCI, which is significant. 
BMIZ stands for Body Mass Index Z-score; HAZ stands for Height for Age Z-score 
 
  
Variable Mean  95% BCI a 
Fixed part of the model 
Intercept 12.520 (12.280 to12.760) 
Sex (Reference category: ‘Male’) 
   Female 
   
-0.183 
 
(-0.330 to -0.036) b  
Age (Reference category: ‘10-12 years old’) 
   13-15 years old 
   >=16 years old 
 
0.222 
0.417 
 
(0.064 to 0.377) b  
(0.012 to 0.832) b  
Classification of BMIZ (Reference category:’ Not  wasted’) 
   Wasted 
 
-0.244 
 
(-0.544 to 0.062) 
Classification of HAZ (Reference category:’ Not  stunted’) 
   Stunted 
 
-0.347 
 
(-0.564 to -0.128) b  
Intensity of hookworm  infection (Reference category: ‘Not 
Infected’) 
   Lightly Infected  
   Moderately Infected 
   Heavily Infected 
 
  
0.050 
-0.310 
-0.516 
 
 
(-0.102 to 0.197) 
(-1.048 to 0.419) 
(-1.277 to 0.233) 
Intensity of Schistosoma mansoni  infection (Reference category: 
‘Not Infected’) 
   Lightly Infected  
   Moderately Infected 
   Heavily Infected 
 
 
-0.113 
 0.068 
-0.513 
 
 
(-0.417 to 0.189) 
(-0.268 to 0.414) 
(-0.942 to -0.097) b 
Intensity of Trichuris trichiura  infection (Reference category: ‘Not 
Infected’) 
   Lightly Infected  
   Moderately Infected 
   Heavily Infected 
 
 
0.105 
0.834 
0.110 
 
 
(-0.121 to 0.336) 
(-0.195 to 1.857) 
(-2.649 to 2.890) 
Intensity of Ascaris lumbricoides  infection (Reference category: 
‘Not Infected’) 
   Lightly Infected  
   Moderately Infected 
 
 
-0.164 
-0.206 
 
 
(-0.372 to 0.047) 
(-0.480 to 0.073) 
Malaria spp infection (Reference category: ‘Not Infected’) 
   Infected 
 
-0.159 
 
(-0.315 to -0.009) b  
Random part of the model   
Level-2 (i.e. between schools) variance 0.225 (0.114 to 0.413) 
Level-1 (i.e. between children within a school) variance 2.031 (1.889 to 2.186) 
  54 
 
3.3.2. Bayesian logistic regression model of anaemia.  Table 3.4 presents the 
hierarchical logistic regression model of anaemia risk and shows that only children with heavy S. 
mansoni intensities were more likely to be anaemic, defined as Hb < 11.0 g/dL, compared with 
uninfected children (Odds ratio: OR = 2.3, 95% BCI: 1.1 to 4.3; Table 3.3).  There was no 
evidence that other predictors were significantly associated with the risk of anaemia.  
 
Table 3.4 Estimated posterior odds ratios for prevalence of anaemia (Hb < 110g/L) for the 
effects of selected explanatory variables from final Bayesian hierarchical logistic 
regression model (n = 1,523). 
Variable Odds 
ratio 
95% BCI 
Fixed part of the model 
Main effects 
Sex (Reference category: ‘Male’) 
   Female 
 
1.073 
 
(0.787 to 1.405) 
Age (Reference category: ‘>=10-12 years old’) 
   13-15 years old 
   >=16 years old 
 
1.095 
0.688 
 
(0.804 to 1.462) 
(0.218 to 1.547) 
Intensity of hookworm  infection (Reference category: ‘Not 
Infected’) 
   Lightly Infected  
   Moderately Infected 
   Heavily Infected 
 
  
0.895 
1.156 
1.165 
 
 
(0.645 to 1.208) 
(0.121 to 3.708) 
(0.132 to 3.861) 
Intensity of Schistosoma mansoni  infection (Reference category: 
‘Not Infected’) 
   Lightly Infected  
   Moderately Infected 
   Heavily Infected 
 
 
0.825 
 1.004 
2.292 
 
 
(0.360 to 1.442) 
(0.426 to 1.969) 
(1.070 to 4.258) a  
Intensity of Ascaris lumbricoides  infection (Reference category: 
‘Not Infected’) 
   Lightly Infected  
   Moderately Infected 
 
 
1.060 
1.057 
 
 
(0.680 to1.584) 
(0.582 to 1.748) 
Malaria spp infection (Reference category: ‘Not Infected’) 
   Infected 
 
1.136 
 
(0.821 to 1.540) 
Random part of the model   
Level-2 (i.e. between schools) variance 0.288 (0.088 to 0.630) 
 
 a
 this is a significant odds ratio of heavily infected children with S. mansoni compared with uninfected children 
in the same sense as denoted in Table 3.2. 
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3.4 Discussion 
 
Helminth infections, undernutrition and malaria have a large impact on the survival and quality 
of lives of school-aged children in Africa.  Understanding the direct and indirect consequences of 
these factors on lower Hb levels and anaemia is important, as findings may help guide the suite 
of school-based interventions in endemic areas where polyparasitism is the norm (Raso et al., 
2004; Pullan & Brooker, 2008).  Analysis in this Chapter found evidence that heavy intensity of 
S. mansoni infection, being stunted and malaria parasitaemia were significantly associated with 
lower mean Hb (Table 3.3), although only heavy intensity of S. mansoni infection was 
significantly associated with the risk of anaemia among schoolchildren over 10 years of age 
(Table 3.4).  Such results underscore current efforts to control helminths and malaria as part of 
integrated school health programmes (Brooker et al., 2008). 
 
Although the cross-sectional design hampers the interpretation of the findings reported in this 
study, especially the direction of causality, the use of hierarchical Bayesian modelling allows the 
incorporation of both individual- and school-level factors, the omission of one or the other 
leading to biased estimates (Congdon, 2001).  Furthermore, the results of this study are 
consistent with previous studies which report similar associations (Stoltzfus et al., 1997b; Olsen 
et al., 1998; Leenstra et al., 2004; Desai et al., 2005a) as well as with the findings presented in 
Chapter 2 where I also found statistically significant associations of heavy intensities of S. 
mansoni infection  with mean lower Hb and anaemia prevalence before treatment. 
 
Potential mechanisms through which S. mansoni may contribute to anaemia include: (i) blood 
loss caused by the rupture of blood vessels surrounding the intestine by the spined schistosome 
eggs; (ii) splenic sequestration; (iii) autoimmune hemolysis; and (iv) anaemia of inflammation 
which is typically characterized by decreased RBC production induced by pro-inflammatory 
cytokines (Friedman et al., 2005a; Tolentino and Friedman, 2007).  In addition, it is possible that 
the importance of S. mansoni infection is likely to be greater than estimated here since only 
schools located more than 5 km from the lake shore were sampled to purposively minimize 
confounding by S. mansoni in the intervention trial.  
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By contrast, hookworm infection, a major attributable factor for anaemia in schoolchildren in 
other areas of East Africa (Stoltzfus et al., 1997a; Lwambo et al., 2000) including Uganda where 
in Chapter 2 I also found statistically significant associations of moderate and heavy intensities 
of hookworm infections with lower mean Hb levels and anaemia prevalence, was not associated 
either with lower Hb or with anaemia in the present study.  The current finding, which is 
consistent with previous studies in western Kenya (Olsen et al., 1998; Handzel et al., 2003), is 
probably due in part to the low intensity of hookworm infection in this study area, and highlights 
how different factors contribute to anaemia in different parasite transmission settings.  
 
However, the difference in Hb between children infected with malaria and those uninfected, 
though significant, was small.  There was not found any evidence of an increased risk of anaemia 
in children co-infected with multiple helminth species and/or malaria.  This finding is in 
contradiction with a similar study from Leyte, in The Philippines (Ezeamama et al., 2005) which 
suggested that even low-intensity polyparasite infections were associated with increased odds of 
having anemia. 
 
The results of the linear hierarchical approach applied here (Table 3.3), indicate that a high 
degree of variation remains to be explained and that there are other factors beyond what was 
measured in this study which still need to be considered.  One advantage of a hierarchical 
approach over conventional statistical approaches is the partitioning of the unexplained variance 
into variability between clusters and individual level variation within clusters, which shows that 
most of the residual variation within the study population examined here was attributable to 
individual level variation occurring between children.  More precisely, although dietary iron 
insufficiency is very likely to impact on Hb and anaemia (Olivares et al., 1999), no information 
was available on iron status of the children included in the study.  Nutritional variables such as 
stunting and wasting, representing chronic and severe acute undernutrition, respectively, may not 
adequately capture moderate, current undernutrition which may also explain variation in mean 
Hb levels.  Reported age is also often uncertain and may be inaccurate.  This may have 
implications for the reliability of the derived HAZ and BMIZ scores.  A further source of 
variation not measured in this study is the effect of menarche in adolescent girls (Leenstra et al., 
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2004).  When interaction terms of age and sex were fitted to the model these were not found to 
be significant, however as described above, reported age may be both unreliable and too crude a 
proxy for individual variation in the timing of onset of menarche.  Similarly, the SES index used 
here may not fully capture socio-economic variability within the population as it was based on 
a small number of assets and relied on reporting by schoolchildren.  A final source of individual 
variation which was not taken into account in this study was genetic traits such as sickle-cell and 
other haemoglobinopathies (Tolentino and Friedman, 2007).        
 
In conclusion, the current study demonstrated that lower mean Hb levels were significantly 
associated with heavy intensity of S. mansoni, chronic undernutrition and malaria and that 
anaemia was associated with heavy intensity of S. mansoni.  Such findings validate the results 
reported in Chapter 2 where it was concluded that anaemia is likely to represent a valuable 
marker for morbidity caused by heavy intensity of S. mansoni infection.  Results from both 
Chapters 2 and 3 have important implications for the control of anaemia among African 
schoolchildren and can help guide the design of appropriate interventions.  Integrated school 
health programmes which include deworming, micronutrients and potentially malaria control, 
will help alleviate the anaemia burden faced by the school-aged children of Africa.  Further 
research is required to identify the optimal packages and to identify areas where different 
packages of interventions may be required. 
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Chapter 4: Schistosoma haematobium infection and 
morbidity before and after large-scale administration of 
praziquantel in Burkina Faso 
 
Summary   
 
In sub-Saharan Africa 112 million people are infected with Schistosoma haematobium with the 
most intense infections in children aged 5 to 15 years.  In the current Chapter I describe a 
longitudinal epidemiological study that evaluated the relationship between S. haematobium 
infection and associated morbidity in children before and after large-scale administration of 
praziquantel for schistosomiasis and albendazole for soil-transmitted helminth infections.  At 
baseline, higher intensities of S. haematobium infection were observed in children with anaemia 
and/or severe microhaematuria, but there was no apparent association between the risk of 
undernutrition and S. haematobium infection intensity. Significant reductions in the prevalence 
and intensity of S. haematobium infection one year post-treatment were, however, observed.  
Children who benefited the most from anthelminthic treatment in terms of increased 
haemoglobin counts were those who had anaemia at baseline and those with highly positive 
microhaematuria scores at baseline.  In conclusion, this study suggests that even a single round 
of mass chemotherapy can have a substantial impact on S. haematobium infection and its 
associated morbidity in children. 
 
Keywords: schistosomiasis, Schistosoma haematobium, morbidity, control programme, 
chemotherapy, hierarchical models, West Africa 
 
Note: A modified version of this chapter has been published as: Koukounari A, Gabrielli AF, 
Touré S, Bosqué-Oliva E, Zhang Y, Sellin B, Donnelly CA, Fenwick A, Webster JP (2007)  J 
Infect Dis. 196: 659-69. See publications by the candidate (Appendix).  
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4.1 Introduction  
 
Improving the health of school-aged children, particularly in developing countries, has emerged 
as a policy priority in international health (The World Bank, 1993; Stoltzfus et al., 1997).  Over 
the past two decades significant progress has been made in improving child survival, resulting in 
more children reaching primary school age.  However, human infections with one of the five 
parasitic helminths of the family Schistosomatidae still represent a significant segment of the 
global burden of illness with approximately 200 million people infected and with highest 
intensities in children aged 5 to 15 years old (Steinmann et al., 2006).  Schistosomiasis causes 
granuloma formation, and both reversible and irreversible damage to the urinary and/or intestinal 
tracts, depending on the infecting species (Mahmoud, 2001).  New estimates of schistosomiasis-
related disability indicate the need to reassess priorities for treating this chronic infection in areas 
where it is endemic (King et al., 2005). 
Praziquantel has been established in several controlled trials as a safe and effective drug for the 
treatment of infection with all human schistosome species (Kardaman et al., 1983; Nokes et al., 
1999; King et al., 2002; Kabatereine et al., 2003).  The dramatic reduction in its price since 1990 
by over 90 %, from US$4 to treat a person to approximately US$0.30, has led to the resolution of 
many of the challenges surrounding large-scale chemotherapy campaigns (Lammie et al., 2006) 
and through the Schistosomiasis Control Initiative (SCI) over 20 million treatments were carried 
out in 2005/2006 in 6 sub-Saharan African countries (Garba et al., 2006; Kabatereine et al., 
2006).  As mentioned previously in Chapter 2 of this PhD thesis, one of the primary objectives of 
these SCI-supported control programs is to achieve, and hence also demonstrate, a quantifiable 
reduction in schistosome-associated morbidity as a consequence of chemotherapeutic 
intervention.  
The aim of the present study was to evaluate the relationship between Schistosoma haematobium 
infection and associated morbidity in children before and after large-scale administration of 
praziquantel and albendazole (against soil-transmitted-helminths) by the national Burkinabé 
helminth control program.  A secondary aim was to identify those individuals whom one may 
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predict to show the greatest improvements in nutritional status and haemoglobin (Hb) 
concentrations after chemotherapy.  
4.2 Materials and methods 
 
4.2.1 The control programme, study sites, sampling and cohort design. Both 
Schistosoma mansoni and S. haematobium are endemic throughout Burkina Faso (Poda et al., 
2004). The SCI-supported schistosomiasis control program was implemented during 2004 and 
has treated 3.322.564 school age children in the 13 regions of the country through October 2006. 
Further details about the national Burkinabé helminth control program have been described 
elsewhere (Gabrielli et al., 2006). 
For the present study, parasitological and morbidity data were collected on a cohort of 1727 
Burkinabé children 6 to 14 years old, randomly sampled from 16 schools before and 1 year after 
chemotherapy (2004 and 2005 respectively).  The schools included in these surveys were 
randomly selected from all schools in four Regional Health Directorates known a priori to be 
places where schistosomiasis is highly endemic.  Details concerning the sample size calculations 
and cohort design have been described in Chapter 2 of this PhD thesis as well as in previous 
studies (Brooker et al., 2004; Koukounari et al., 2006). 
4.2.2 Parasitological and morbidity measures.  All children enrolled in the study 
were interviewed by appropriately trained personnel Ministry of Health. Ethical clearance was 
obtained from the Ministry of Health, Burkina Faso and Imperial College London. 
Stool examination.  A single stool sample was collected from each child and 41.7 mg processed 
to make duplicate Kato Katz slides for microscopic determination of intestinal helminths 
infections.  Individual egg output was expressed as eggs per gram of faeces (epg) calculated as 
the arithmetic mean of the two individual slide counts whenever these were available.  
Urine examination.  One urine specimen was collected from each child to determine the 
prevalence and intensity of S. haematobium infection by the filtration method.  The intensity of 
S. haematobium infection was expressed as the number of eggs per 10 ml of urine.  To determine 
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the presence and severity of microhaematuria, all urine specimens were tested for presence of 
detectable blood with urine reagent strips (Bayer Hemastix ®).  The results were recorded semi-
quantitatively: negative; trace hemolysed; weakly positive (+), moderately positive (++) and 
highly positive (+++).  
 
Nutritional assessment.  Heights and weights were measured to determine Height-for-Age Z-
scores (HAZ) and Body Mass Index Z-scores (BMIZ).  All measures were taken with height 
poles and electronic balances in the morning and children were barefoot, wearing only light 
indoor clothing.  A low BMIZ is the index of choice for the assessment of recent undernutrition, 
resulting in thinness or wasting, while a low HAZ represents long-term growth and nutritional 
status resulting in shortness or stunting.  Z-scores for each nutritional index were calculated from 
Centre for Disease Control (National Center for Health Statistics) reference values using EpiInfo 
version 2000 (Centers for Disease Control and Prevention [CDC], Atlanta, GA) (Ogden et al., 
2002).  
 
Anaemia assessment.  Blood samples for Hb concentrations were obtained from each individual 
by the finger prick method using a photometer Hemocue (Hemocue AB, Angelholm, Sweden) 
(Parker et al., 1997).  Anaemia was defined according to WHO guidelines (UNICEF/United 
Nations University/World Health Organization(WHO), 2001). 
 
4.2.3 Statistical analyses.  Differences between drop-outs and children successfully 
followed-up were tested by univariate analysis using a Wilcoxon 2-sample test for means and a 
Chi2 test, or a Fisher’s exact test if there was a small expected value, for proportions.  SAS 
software was used (version 8; SAS Institute Inc., Cary, NC, USA).   
 
As mentioned in Chapters 2 and 3 of this PhD thesis, hierarchical models are often applicable to 
modeling of data from complex surveys of a population with a hierarchical structure used to 
explain relations between individual and ‘supra-individual’ determinants.  A two-level linear 
hierarchical model assuming normally distributed errors was fitted to the logarithmically 
transformed baseline S. haematobium egg counts (ln(x+1)), using Gibbs sampling for all 
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parameters in order to quantify any associations with anaemia, measures of nutritional status and 
microhematuria while adjusting at the same time for demographic factors such as age and sex.  
In this way I tested whether children with pathology, potentially induced by S. haematobium 
infection, had higher S. haematobium egg counts before treatment.  I used a similar model to 
quantify changes in S. haematobium egg counts from baseline to one-year follow-up.  Mlwin 
software (version 2.01, Multilevel Models Project, Institute of Education, University of London, 
UK) was used. Boxplots of the S. haematobium egg counts at baseline were used for validation 
and comparison of the significant findings from the model described above.   
 
Changes in Hb concentration and in HAZ and BMIZ-scores over time were evaluated using two-
level linear hierarchical models of raw change scores between baseline and the 1-year follow-up 
time point.  With this approach, I aimed to compare the average change in each of the studied 
outcomes over the studied period between different groups of children.  All of the models 
presented were also adjusted for age and gender. P-values < 0.05 were considered to be 
significant. I have also plotted HAZ and BMIZ-scores at baseline versus HAZ and BMIZ-scores 
at 1-year follow-up time point to examine observed trends.  
 
An additional three-level hierarchical linear modeling analysis was performed to determine any 
change in the children’s Hb concentrations.  With this model, I aimed to quantify the adjusted 
overall change of Hb from baseline to follow-up and to quantify average Hb concentrations of 
different groups of children at baseline as well as to examine whether the intensity of S. 
haematobium infection was associated with lower Hb concentrations. 
 
Logistic random intercepts regression models were fitted in order to examine whether the 
intensity of S. haematobium infection was associated with an increased risk of thinness and 
shortness at baseline while adjusting for potential confounders.   
4.3 Results  
 
A total of 1,727 children from 16 schools were recruited at baseline. Of these, 1131 (65%) were 
successfully re-traced at 1-year follow-up time point and 321 new children were recruited into 
  63 
the cohort during the second year of the study (data not shown).  There were significant 
differences between the children who were successfully followed-up and the drop-outs, 
according to their demographic characteristics and nutritional status as defined by baseline 
thinness and shortness as well as by baseline Hb concentrations (Table 4.1).  The children who 
dropped-out were of an older mean age than those successfully followed up, and boys proved 
most difficult to recruit into the cohort during the second year of the study.  All children who 
dropped-out were wasted and stunted at baseline and had slightly higher mean Hb 
concentrations.  No other baseline characteristic measured varied significantly between children 
followed up and those who dropped out. 
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Table 4.1  Baseline characteristics of Burkinabé schoolchildren followed-up for one year, and 
not followed-up, sd = standard deviation; e/10 ml = eggs per 10 ml liter; epg = eggs per gram 
faeces. 
aAnaemia was defined for all tables displayed (according to WHO guidelines), as Hb less than 11.5 g/dL for children 
from 5 to 11 years old and for children between 12 and 14 years old  as Hb less than 12.0 g/dL. 
 
Table 4.2 presents the health indicators of children surveyed at baseline and successfully 
followed up 1 year after treatment.  During the 12 months between examinations, the overall 
prevalences of S. haematobium, S. mansoni and hookworm infections decreased significantly 
(p<0.001).  For both years examined, Ascaris lumbricoides infection was absent and the 
prevalence of Trichuris trichura infection was estimated to be 1.1% at baseline and totally absent 
1 year later.  Because prevalences, and co-infections with S. haematobium, were so low for the 
intestinal helminth species at both time points such data were not analyzed further here.   
 
A significant increase in mean Hb concentration (p<0.001) and a significant decrease in the 
prevalence of anaemia (p=0.021) were also observed between 2004 and 2005.  Finally the 
unadjusted observed changes in both recent and chronic undernutrition from baseline to follow-
up were not significant (p=0.135 and p=0.093 respectively).  
 Followed up for 1 year Drop outs p-values 
Demographic characteristics    
Mean age 9.8 (n=1131) 11.3 (n=686) <0.001 
% male 55.0 (n=1131) 62.0 (n=686) 0.004 
Parasitology    
% infected with S. haematobium 53.9 (n=1124) 54.1 (n=690) 0.953 
% infected with S. mansoni 6.2 (n=536) 5.8 (n=432) 0.810 
% infected with hookworm 6.3 (n=556) 4.3 (n=418) 0.174 
Mean (sd) S. haematobium intensity 
(e/10 ml) 
83.6 (229.2) 94.2 (234.6) 0.728 
Mean (sd) S. mansoni intensity (epg) 8.0 (73.9) 11.3 (76.1) 0.869 
Mean (sd) hookworm intensity (epg) 12.5 (90.7) 3.3 (21.0) 0.158 
Haematology    
% anaemica  65.8 (n=1130) 66.4 (n=687) 0.390 
Mean (sd) haemoglobin (g/dL) 11.0 (1.4) 11.1 (1.4) 0.036 
Nutritional status    
% wasted 32.8 (1131) 100.0 (n=686) <0.001 
% stunted 13.3 (n=1131) 100.0 (n=686) <0.001 
Hemastix test (n=1124) (n=692) 0.460 
% of negative  50.4 53.5  
% of trace  12.9 10.7  
% of children with ‘+’  6.8 5.6  
% of children with ‘++’ 9.3 8.9  
% of children with ‘+++’ 20.6 21.4  
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Table 4.2  Health characteristics of children at baseline and post-treatment (2004-2005) 
successfully followed up for one year. 
a
sample sizes are provided into parentheses for each examined outcome                         
 
Table 4.3 presents the results of the model of the change in S. haematobium egg counts for 1 year 
post treatment as well as differences in S. haematobium egg counts between different groups of 
children at baseline.  This model indicated that compared with baseline counts, there was on 
average an overall significant decrease in the S. haematobium egg counts by 52%, 1 year after 
treatment (p<0.001).  At baseline, only children aged 10 and 12 years old had significantly 
higher S. haematobium egg counts, compared to those who were 14 years old (p=0.035 and 
p=0.007 respectively) after controlling for sex, nutritional and anaemia status and 
microhaematuria test scores.  Children with ‘+++’, ‘++’, ‘+’ and trace microhaematuria scores 
had on average significantly higher S. haematobium egg counts than those of children with 
negative scores at baseline, by 4107%, 1470%, 462% and 242% respectively.  Additionally, 
children with anaemia at baseline had significantly higher S. haematobium egg counts (by 11%) 
than children without anaemia (p=0.026). Boys also had significantly higher S. haematobium egg 
counts (by 11%) than girls at baseline (p=0.020).   
 
 2004 2005 p-values 
Parasitology    
% infected with S. haematobium (n=1,124)a 53.9 (51.0 – 56.8) 5.8 (4.4-7.2) <0.001 
% infected with S. mansoni (n=536) 6.2 (4.1–8.2) 0.2 (0.0 – 0.6) <0.001 
% infected with hookworm  (n=555) 6.3 (4.3 – 8.3) 1.6 (0.6 - 2.7) <0.001 
Mean S. haematobium intensity (e/10 ml) 83.6 (70.1 – 97.0) 0.9 (0.4 – 1.5) <0.001 
Mean S. mansoni intensity (epg) 8.0 (1.8 – 14.3) 0.0 (0.0 – 0.1) <0.001 
Mean hookworm intensity (epg) 12.5 (4.9 – 20.0) 0.8 (0.2 – 1.3) <0.001 
Haematology (n=1,131)    
Mean haemoglobin (g/dl)  11.0 (10.9 – 11.1) 11.3 (11.2 – 11.3) <0.001 
% anaemic  65.8 (63.0 – 68.5) 61.6 (58.8 – 64.4) 0.021 
Microhaematuria as diagnosed by  hemastix test 
(n=1,124) 
  <0.001 
% of negative 50.4 (47.5-53.4) 89.5 (87.7-91.3)  
% of trace 12.9 (10.9-14.9) 4.9 (3.6-6.2)  
% with ‘+’ 6.8 (5.3-8.2) 2.3 (1.4-3.2)  
% with ‘++’ 9.3 (7.6-11.0) 1.1 (0.5-1.7)  
% with ‘+++’ 20.6 (18.2-22.9) 2.2 (1.4-3.1)  
Nutritional status (n=1,131)    
% of thinness or wasting 32.8 (30.1-35.5) 35.1 (32.3-37.9) 0.135 
% of shortness or stunting 13.3 (11.3-15.2) 11.9 (10.0-13.7) 0.093 
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Table 4.3 Estimates from two-level hierarchical model for S. haematobium egg counts among 
1,130 Burkinabé schoolchildren at baseline and post-treatment (2004-2005). 
aanaemia is defined for all tables displayed (according to WHO guidelines), as Hb less than 11.5 g/dL for children from 5 to 11 years old and for 
children between 12 and 14 years old as Hb less than 12.0 g/dL, bWasting denotes reduced body weight for height and is defined as body mass index 
Z-score<-2 for all tables displayed, cStunting denotes reduced body length in relation to a reference standard and is defined as height for age Z-
score<-2 for  all tables displayed. 
 
Figure 4.1a shows that children with the most severe microhaematuria scores harboured higher 
intensities of S. haematobium infection than children who were negative for microhaematuria at 
baseline. Children with anaemia at baseline also harboured slightly higher S. haematobium 
intensities than those without anaemia (Figure 4.1b).  
 
Fixed effects Coefficient (95% CIs) p-
values 
Effect of follow-up relative to baseline 
  
Follow-up year 1 -52% (-57% to -47%) <0.001 
Gender (Reference category ‘female’)   
Male 11% (2% to 21%) 0.020 
Baseline Age (Reference category ‘14 years old’)   
13 years old 9%(-19% to 45%)  0.572 
12 years old 45% (11% to 90%)  0.007 
11 years old 25% (-4% to 63%)  0.095 
10 years old          32% (2% to 72%)  0.035 
9 years old 24% (-4% to 61%)  0.106 
8 years old 22% (-6% to 59%)  0.143 
7 years old 2% (-24% to 37%)  0.906 
6 years old 19% (-27% to 92%)  0.488 
Baseline anaemia (Reference category ‘non anaemic’)   
Anaemica              11% (1% to 21%) 0.026 
Baseline haematuria (Reference category ‘negative’)   
trace  242% (191% to 302%) <0.001 
‘+’ 462% (357% to 592%) <0.001 
‘++’ 1470% (1176% to 1833%) <0.001 
‘+++’ 4107% (3493% to 4827%) <0.001 
   Baseline thinness or wasting (Reference category ‘non wasted’)   
wastedb 4% (-6% to 14%) 0.463 
 Baseline shortness or stunting (Reference category ‘non stunted’)   
stuntedc -13% (-26% to 2%) 0.089 
Random effects Variance components (S.E) 
Level-2 (i.e. between schools) variance 0.008 (0.004) 
Level-1 (i.e. measurement occasions within a child) variance 0.190 (0.006) 
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Figure 4.1 Box plots on the logarithmically transformed (base e) S. haematobium egg counts 
of only positive subjects n=613 Burkinabé schoolchildren 2004. (a) Box plot for log S. 
haematobium egg counts with respect to different microhematuria test scores at baseline. (b) 
Box plots for log S. haematobium egg counts with respect to anaemia status at baseline 
  
 
 
 
 
 
(a) 
(a) 
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Results from the two-level logistic regression model for the probability of being wasted did not 
suggest associations with any baseline characteristics examined other than age. In particular, 
there was a trend toward younger children to be less likely to be wasted, although none of the 
other odds ratios (ORs), except for those for 10-year-old children, were significantly different 
from the ORs for the 14-year-old children (p=0.022). Furthermore, the two-level logistic 
regression model of the probability of being stunted at baseline suggested a trend toward younger 
(b) 
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children being less likely to be stunted; the OR for 6 to 12-year-old children was significantly 
different from that for the 14-year-olds.  In addition, children with anaemia were almost 1.5 
times more likely than those without anaemia to be stunted at baseline (p=0.034; data not 
shown).   
 
Table 4.4 contains estimates from the two-level linear multilevel models for changes in BMIZ 
and HAZ during the period studied.  The effect for the 14-year-old comparison group was a 
decrease in BMIZ of 0.519 units, which was of borderline significance (p=0.053).  This suggests 
that there was no dramatic change over the period studied in this group.  However, children who 
were 7, 8 and 10 years old at baseline had a greater decrease in BMIZ, compared with 14-year-
olds.  The coefficients of the continuous variables that refer to the baseline BMIZ and HAZ-
scores indicated that BMIZ increased for wasted children, whereas, BMIZ decreased for stunted 
children more than that of children with no nutritional problems.  These results can be obtained if 
one multiplies the coefficients of BMIZ and HAZ by -2 (i.e. cut-off score that defines wasting 
and stunting respectively).  
 
The effect for the 14-year-old comparison group was a non-significant (p=0.214) increase in 
HAZ-score of 0.143 units.  Compared with 14-year-olds, 6-year-olds had a significantly greater 
increase, while the 12-year-olds had a decrease in HAZ (significantly different from that of 14-
year-olds).  Boys had a significantly smaller increase in HAZ than girls.  Likelihood ratio tests 
indicated a better fit in both models mentioned above when I included BMIZ and HAZ as 
explanatory continuous variables and not the relevant categorical ones that would denote wasting 
and stunting if BMIZ or HAZ was, respectively, less than 2 SD below the CDC median.   
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Table 4.4 Estimates from two-level hierarchical model for the change of body mass index 
(BMIZ) and Height for Age (HAZ) Z-scores (n = 1,130) 
Fixed effects Coefficient (95 % CIs) 
for the change of BMIZ 
 p-values Coefficient (95 % CIs) 
for the change of HAZ 
 p-values 
Intercept -0.519 (-1.003 to -0.035) 0.053 0.143 (-0.073 to 0.359) 0.214 
Baseline intensity of S.haematobium  
infection (Reference category’ 
uninfected’) 
    
lightly infected 0.060 (-0.133 to 0.253) 0.543 0.032 (-0.059 to 0.124) 0.490 
heavily infected 0.218 (-0.030 to 0.465) 0.085 0.078 (-0.040 to 0.196) 0.193 
Gender (Reference category’ female’)   
  
Male 0.011 (-0.100 to 0.122) 0.850 -0.066 (-0.119 to -0.013) 0.015 
Baseline Age (Reference category’ 14 
years old’)  
   
 
13 years old -0.120 (-0.649 to 0.410) 0.658 -0.134 (-0.388 to 0.119)  0.300 
12 years old -0.375 (-0.816 to 0.067) 0.097 -0.236 (-0.447 to -0.025)  0.029 
11 years old -0.396 (-0.835 to 0.043) 0.077 -0.177 (-0.386 to 0.033)  0.099 
10 years old -0.483 (-0.915 to -0.051) 0.029 -0.008 (-0.215 to 0.198)  0.936 
9 years old -0.347 (-0.778 to -0.084) 0.115 0.000 (-0.206 to 0.206))  0.999 
8 years old -0.448 (-0.879 to -0.017) 0.042 0.051 (-0.155 to 0.257) 0.625 
7 years old -0.642 (-1.083 to -0.201) 0.004 -0.033 (-0.244 to 0.178)  0.757 
6 years old -0.483 (-1.051 to 0.085) 0.096 0.428 (0.157 to 0.699) 0.002 
Baseline anaemia(Reference category 
‘non anaemic’) 
0.005 (-0.114 to 0.123) 0.939 -0.041 (-0.098 to 0.015) 0.153 
Baseline haematuria (Reference 
category ‘negative’) 
    
trace  -0.166 (-0.389 to 0.057) 0.144 -0.063 (-0.169 to 0.043) 0.243 
‘+’ -0.147 (-0.416 to 0.123) 0.286  -0.014 (-0.142 to 0.114) 0.829 
‘++’ 0.054 (-0.208 to 0.317) 0.685  -0.027 (-0.152 to 0.097) 0.669 
‘+++’ -0.110 (-0.356 to 0.136) 0.383 -0.058 (-0.174 to 0.059) 0.334 
Baseline BMIZ-score -0.588 (-0.628 to -0.548) <0.001 0.054 (0.035 to 0.073) <0.001 
Baseline HAZ-score 0.184 (0.135 to 0.232) <0.001 -0.138 (-0.161 to -0.115) <0.001 
Random effects Variance components (S.E) Variance components (S.E) 
Level-2 (i.e. between schools) variance 0.155 (0.065) 0.009 (0.004) 
Level-1 (i.e. between children within a 
school) variance 
0.846 (0.036) 0.194 (0.008) 
 
The standard errors (and confidence intervals) obtained from the present analysis (i.e. estimates 
from models presented in Table 4.4) provide details on the level of precision achieved with the 
observed data.  This relationship (albeit without the benefits of adjustments for demographic 
factors) can also be seen from plots of baseline BMIZ/HAZ versus follow-up BMIZ/HAZ 
(Figure 4.2a and Figure 4.2b). 
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Figure 4.2 Scatter plots of anthropometric z-scores at baseline versus anthropometric z-scores at 
follow-up year 1 
Scatter plot of BMIZ scores at baseline versus BMIZ-scores at 
follow-up year 1
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Table 4.5 contains the estimates of two three-level hierarchical models for Hb concentrations 
before and after chemotherapeutic treatment, taking into account adjustment and non-adjustment 
for microhaematuria scores.  From the former model it was estimated that an overall increase of 
0.092 g/dl in Hb concentration after treatment was not significant (p=0.146).  Children with 
‘+++’ microhaematuria scores had significantly lower Hb concentrations (0.318 g/dL; p=0.016) 
than microhaematuria negative children at baseline.  Children who were 6, 7, 8 and 10 years old 
at baseline had significantly lower Hb concentrations, (p=0.024, p<0.001, p=0.019 and p=0.008 
respectively) than those who were 14 years old after controlling for intensity of S. haematobium 
infection, sex, haematuria, wasting and thinness.  From the alternative model, which did not 
adjust for microhaematuria scores, estimates of the parameters mentioned previously remain 
approximately the same but the effect of S. haematobium infection intensity became significant, 
such that children who were heavily infected with S. haematobium at baseline had significantly 
lower Hb concentrations (0.220 g/dL; p=0.024) than uninfected children.  This suggests that 
because the variable of microhaematuria scores is related both to Hb concentration and the 
intensity of S. haematobium infection, two different causal effects of S. haematobium infection 
on Hb concentrations are indicated.  Two-way interaction terms were also tested but because 
they were not significant they were finally omitted from the models presented.  Also, variances 
in all three levels of the second model were higher than the corresponding ones in the first model 
which implies that microhaematuria scores variable explains some of the variability in the 
studied outcome across all three levels of the models presented.  
 
Finally, Table 4.6 contains estimates from the two-level linear multilevel model for the change in 
Hb concentration over the course of the period studied.  This model suggested that the change 
varied significantly as a function of the following baseline characteristics: anaemic status, ‘+++’ 
microhaematuria score and age.  The effect for the comparison group (baseline uninfected, male, 
14 years old, not anaemic, negative microhaematuria score, not wasted, and not stunted) was a 
decrease in Hb concentrations of 0.128 g/dL which was not significant (p=0.747).  Significant 
increases in Hb concentration during the period studied were observed among children with 
anaemia at baseline (increase by 1.360 g/dL-[that is 1.488-0.128 g/dL]; p<0.001) and among 
children with ‘+++’ microhaematuria scores at baseline (increase by 0.233 g/dL [that is 0.361-
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0.128 g/dL]; p=0.039).  Marginally significant decreases in Hb concentration during the same 
period were observed in children who were 12 years old at baseline; these children had a greater 
decrease by 0.733 g/dL, (that is -0.605-0.128 g/dL; p=0.055) in Hb concentration than 14- year-
old children.  In addition, 9-year-old had a significantly greater decrease in Hb concentration by 
0.847 g/dL, (that is -0.719-0.128 g/dL; p=0.019).   
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Table 4.5 Estimates from three-level hierarchical models for haemoglobin concentration before 
and after treatment taking into account adjustment and non adjustment for microhaematuria  
scores (n = 1,124) 
Fixed effects Coefficients (95 % 
CIs) with adjustment 
for Microhaematuria 
p-
values 
Coefficients (95 % 
CIs) without 
adjustment for 
Microhaematuria 
p-
values 
Intercept 11.473 (11.067 to 11.879) <0.001 11.480 (11.074 to 
11.886) 
<0.001 
Effect of follow-up relative to baseline     
follow-up year 1 0.092 (-0.031 to 0.215)    0.146 0.093 (-0.030 to 0.216) 0.139 
Baseline intensity of S.haematobium  
infection (Reference category 
’uninfected’) 
    
lightly infected  -0.107 (-0.311 to 0.097) 0.303 -0.079 (-0.238 to 0.080) 0.332 
heavily infected  -0.084 (-0.354 to 0.186) 0.542 -0.220 (-0.410 to -0.030) 0.024 
Gender (Reference category female)     
Male -0.035 (-0.158 to 0.088) 0.577 -0.039 (-0.162 to 0.084) 0.538 
Baseline Age (Reference category 14 years 
old)  
    
13 years old -0.026 (-0.383 to 0.331)  0.888 -0.037 (-0.396 to 0.322) 0.838 
12 years old -0.136 (-0.489 to 0.217)  0.452 -0.138 (-0.493 to 0.217) 0.445 
11 years old -0.334 (-0.683 to 0.015)  0.061 -0.353 (-0.704 to -0.002) 0.048 
10 years old -0.468 (-0.813 to -0.123)  0.008 -0.471 (-0.818 to -0.124) 0.008 
9 years old -0.296 (-0.643 to 0.051)  0.095 -0.290 (-0.639 to 0.059) 0.103 
8 years old -0.425 (-0.780 to -0.070)  0.019 -0.415 (-0.772 to -0.058) 0.022 
7 years old -0.817 (-1.205 to -0.429)  <0.001 -0.816 (-1.206 to -0.426) <0.001 
6 years old -0.693 (-1.297 to -0.089)   0.024 -0.685 (-1.289 to -0.081) 0.026 
Baseline haematuria (Reference 
category ‘negative’) 
    
trace  0.108 (-0.115 to 0.331) 0.344   
‘+’ 0.135 (-0.149 to 0.419) 0.352   
‘++’ 0.229 (-0.063 to 0.521) 0.124   
‘+++’ -0.318 (-0.577 to -0.059) 0.016   
Baseline thinness or wasting (Reference 
category ‘non wasted’) 
    
Wasted -0.042 (-0.162 to 0.078) 0.488 -0.042 (-0.162 to 0.078) 0.491 
Baseline shortness or stunting 
(Reference category ‘non stunted’) 
    
Stunted -0.149 (-0.351 to 0.053) 0.148 -0.155 (-0.359 to 0.049) 0.135 
Random effects Variance components (S.E)  
from model with adjustment for 
Microhaematuria 
 
 
Variance components (S.E)  
from model without 
adjustment for 
Microhaematuria 
Level-3 (i.e. between schools) variance 0.136 (0.056) 0.140 (0.057) 
Level-2 (i.e. between children within a 
school) variance 
0.514 (0.051) 0.519 (0.051) 
Level-1 (i.e. measurement occasions within 
a child) variance 
1.106 (0.047) 1.116 (0.047) 
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Table 4.6 Estimates from two-level hierarchical model for the change of haemoglobin counts  
(n = 1,130)  
Fixed effects Coefficient (95 % CIs) p-values 
Intercept -0.128 (-0.888 to 0.633) 0.747 
Baseline intensity of S.haematobium  infection (Reference 
category’ uninfected’) 
  
lightly infected -0.081 (-0.350 to 0.187) 0.553 
heavily infected -0.258 (-0.602 to 0.086) 0.141 
Gender (Reference category female)   
Male 0.050 (-0.105 to 0.205) 0.529 
Baseline Age (Reference category 14 years old)    
13 years old -0.625 (-1.364 to 0.114)  0.097 
12 years old -0.605 (-1.222 to 0.013)  0.055 
11 years old -0.435 (-1.049 to 0.179)  0.165 
10 years old -0.464 (-1.067 to 0.140)  0.132 
9 years old -0.719 (-1.321 to -0.117)  0.019 
8 years old -0.284 (-0.886 to 0.318)  0.355 
7 years old   -0.139 (-0.753 to 0.475)  0.657 
6 years old -0.788 (-1.575 to -0.002)   0.050 
Baseline anaemia(Reference category ‘non anaemic’)   
Anaemic 1.488 (1.323 to 1.653) <0.001 
Baseline haematuria (Reference category ‘negative’)   
Trace 0.106 (-0.204 to 0.415) 0.504 
‘+’ -0.029 (-0.404 to 0.345) 0.878 
‘++’ 0.010 (-0.354 to 0.375) 0.955 
‘+++’ 0.361 (0.019 to 0.702) 0.039 
Baseline thinness or wasting (Reference category ‘non 
wasted’) 
  
Wasted -0.057 (-0.226 to 0.112) 0.506 
Baseline shortness or stunting (Reference category ‘non 
stunted’) 
  
Stunted 0.004 (-0.225 to 0.234) 0.971 
Random effects Variance components 
(S.E) 
Level-2 (i.e. between schools) variance 0.123 (0.062) 
Level-1 (i.e. between children within a school) variance 1.647 (0.070) 
 
 
4.4 Discussion 
 
Among the different schistosomes infecting humans, S. haematobium is responsible for the 
largest number of infections.  It has been estimated that in sub-Saharan Africa 112 million people 
are infected with S. haematobium, compared with 54 million infected with S. mansoni (van der 
Werf et al., 2003).  However, S. haematobium remains largely unstudied, particularly in 
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comparison to S. mansoni, primarily due to the more demanding conditions for laboratory 
maintenance of the former.  This is also reflected in the paucity of research examining the 
potential effectiveness of praziquantel against S. haematobium under various experimental and 
clinical circumstances (Botros et al., 2005).  To my knowledge, the data presented in this 
Chapter represent the first longitudinal study in Africa that reports on the relationship between S. 
haematobium infection and its associated morbidity as a whole, by use of a uniquely detailed 
large dataset from 16 randomly selected schools across the entire national territory of Burkina 
Faso.  Moreover, these data have the potential to provide important evidence characterizing 
urinary schistosomiasis-associated morbidity, particularly in a population such as that of 
Burkinabé, where the prevalence of hookworms and other soil-transmitted helminthiasis is 
estimated to be very low.  Although previous studies have tended to focus on the impact of large-
scale control programmes on intense transmission of  S. haematobium infection solely with 
regard to Hb concentrations and anaemia (Guyatt et al., 2001; Nagi, 2005) or reference to 
parasitological measures only (Magnussen et al., 2001; Saathoff et al., 2004), or to S. 
haematobium morbidity indicators before and after treatment (Prual et al., 1992), the present 
study examines all these issues together and also adjusted for potential differences in 
demographic characteristics as well as potential confounders.   
 
In this Chapter I have demonstrated that children with anaemia, or children with more severe 
microhaematuria scores at baseline, had higher S. haematobium infection intensities (Table 4.3, 
Figure 4.1), which suggests that heavy intensities of S. haematobium infection can be associated 
with anaemia and haematuria.  I also provide evidence that heavy infections of urinary 
schistosomiasis are associated with lowered Hb concentrations and, as a consequence, with 
potential anaemia, given that the models in Table 4.5 indicate that S. haematobium infection 
might be associated with anaemia in 2 different ways.  More precisely, haematuria which, as 
demonstrated previously is associated to S. haematobium infection, can be an important cause of 
blood and iron loss which also may lead to anaemia (Beasley et al., 1999; Nagi, 2005).  The data 
used in the current study suggest significant reductions in the prevalence and, more importantly, 
intensity of infection of S. haematobium as well as in percentages of children with positive 
microhematuria scores 1 year after treatment (Tables 4.2 & 4.3). 
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The children who most benefited from anthelminthic treatment in terms of increased Hb 
concentration were those with anaemia at baseline and those who had ‘+++’ microhaematuria 
scores at baseline (Table 4.6), which confirms similar findings in other endemic settings 
(Stephenson et al., 1985) and presented previously in Chapter 2 of this PhD thesis where 
chidlren’s data from Uganda were examined.  The mechanisms by which treatment for S. 
haematobium infection allows Hb concentrations to increase in children with anemia may be the 
decrease in blood in urine that results from reduction in the intensity of S. haematobium infection 
(Parraga et al., 1996).  
 
Growth and nutritional status have been proposed to represent the most sensitive indicators of 
health in children (Stephenson, 1993).  Furthermore, one of the factors emphasized in the World 
Development Report 1993 is the relationship between parasitic infections and malnutrition 
(World Bank, 1993).  In this Chapter I also examined whether greater S. haematobium egg 
counts were associated with increased risks of wasting or stunting at baseline, adjusting for 
demographic characteristics and other potential predictors such as microhaematuria and anaemia 
status.  The results of the current study did not suggest any significant association between the 
risk of undernutrition and intensity of S. haematobium infection, with only age being revealed as 
a significant factor.  Younger children tended to be less likely to be wasted or stunted than the 
14-year-old children, which could imply prior malnutrition in these older children as has been 
reported elsewhere (Stoltzfus et al., 1997).  In the aforementioned study, the authors also 
reported that in Zanzibari boys, the association between microhaematuria and poor growth was 
only marginally significant (Stoltzfus et al., 1997) which is in line with the findings reported in 
the current Chapter that, in the Burkinabé children, changes in the BMIZ depended only on age, 
whereas changes in the HAZ scores depended on age and sex (Table 4.4).  A more plausible 
explanation for the lack of statistical association between the intensity of S. haematobium 
infection and stunting may relate to dropout bias towards stunted children (Table 4.1); this means 
that it is difficult to make a definitive conclusion regarding the relationship between urinary 
schistosomiasis and stunting in the population examined here (Stephenson, 1993).  
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Nevertheless, it must be considered, as it has been mentioned previously in Chapter 2 of this PhD 
thesis that essential methodological constraints inherent in the present study design - in particular 
the lack of a control group, which was necessary for ethical reasons, could result in some 
potential bias towards the estimation of the absolute impact of the treatment, thereby allowing 
only the relative impact of the treatment in different groups of children to be calculated.  
However, even though these data were obtained from a large-scale control programme and 
studies such as the one presented here are generally difficult to execute in terms of design, 
methodology and sampling, I believe that these results will be of substantial value in estimating 
the total benefit that control of schistosomiasis can provide to communities (Kabatereine et al., 
2007). 
 
This study shows that praziquantel can have a substantial impact on S. haematobium infection 
and associated disease when delivered as part of a large-scale control programme in a country 
such as Burkina Faso, which was indeed the first country in the WHO African Region to achieve 
nationwide coverage with anthelminthic drugs against three major neglected tropical diseases: 
lymphatic filariasis, schistosomiasis and soil-transmitted helminthiasis (WHO Regional Office 
for Africa-press release).  The findings presented in this Chapter suggest a dramatic reduction in 
the prevalence and intensity of S. haematobium infection, an improvement in Hb concentration 
in certain groups of children, and reductions in schistosome-related morbidity in a cohort of 
Burkinabé schoolchildren which demonstrate that mass chemotherapy can offer a practical 
strategy for the control of S. haematobium infection and its associated morbidity. 
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Chapter 5: Assessment of ultrasound morbidity indicators for 
schistosomiasis in the context of large-scale programmes, 
illustrated with experiences from Malian children 
 
Summary  
 
In the current Chapter, morbidity indicators for both Schistosoma haematobium and Schistosoma 
mansoni infections were assessed; the evaluation of the appropriateness of the WHO guidelines 
for ultrasound in schistosomiasis in the context of large-scale control interventions was another 
topic of this Chapter.  Abdominal and urinary tract ultrasonography (US) was performed on 
2,247 and 2,822 school children respectively from 29 randomly-selected schools in Mali, before 
the implementation of mass anthelminthic drug administration.  Using two-level logistic 
regression models, associations of potential factors with the risk of having positive ultrasound 
global score (morbidity indicative of S. haematobium infection), abnormal image pattern scores, 
dilatation of the portal vein and/or enlarged liver (morbidity indicative of S. mansoni infection) 
were examined.  The WHO protocol was found useful for detection of S. haematobium 
pathology but overestimated the risk of portal vein dilatation and left liver lobe enlargement 
associated with S. mansoni infection.  In conclusion, I would recommend ultrasonography to be 
included in large-scale control interventions, where logistics allow, but cautiously.  
 
Keywords: hierarchical models, ultrasound, Mali, Schistosoma mansoni, Schistosoma 
haematobium  
 
 
Note: A modified version of this chapter has been published as: Koukounari A, Sacko M, Keita 
AD, Gabrielli AF, Landouré A, Dembelé R, Clements AC, Whawell S, Donnelly CA, Fenwick 
A, Traoré M, Webster JP. (2006) Am J Trop Med 75, 1042-52. See publications by the candidate 
(Appendix).  
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         5.1 Introduction 
 
As discussed in previous chapters of this PhD thesis, schistosomiasis remains one of the most 
prevalent parasitic diseases in developing countries and has significant economic and public 
health consequences (Chitsulo et al., 2000).  Recently, it has been estimated that the urinary type, 
resulting from infection with Schistosoma haematobium, causes haematuria in 70 million people 
and major bladder wall pathology in 18 million people in sub-Saharan Africa (van der Werf et 
al., 2004). Schistosoma mansoni, one of the etiological agents of the intestinal type of 
schistosomiasis, is responsible for bloody diarrhea in an estimated 4.4 million individuals and 8.5 
million people are estimated to have hepatomegaly due to the infection.  The death rate due to S. 
mansoni-related haematemesis could be up to 130,000 per year in sub-Saharan Africa (van der 
Werf et al., 2004). King and others have argued convincingly that additional subtle morbidities 
(i.e. symptoms such as anaemia, chronic pain, diarrhea, exercise intolerance, growth stunting 
and/or nutritional and cognitive impairment which have been difficult so far to quantify and are 
based on observed association rather than established causality) should be added to these 
estimates of disease burden (King et al., 2005).  
 
Since 1984 the WHO Expert Committee on the Control of Schistosomiasis has recommended a 
strategy for morbidity control, which is now feasible because of the availability of effective, 
affordable and safe single-dose drugs (World Health Organisation, 1985).  As a consequence, 
since 2003, the Schistosomiasis Control Initiative (SCI) has assisted six sub-Saharan African 
countries to develop and implement schistosomiasis morbidity control programmes, through the 
provision of health education and mass treatment, using praziquantel for schistosomiasis and co-
administering, where appropriate, albendazole for soil-transmitted helminthiasis.  The primary 
objective of these SCI-supported control programmes - as already discussed in previous chapters 
of this PhD thesis - is to achieve, and hence also demonstrate such an achievement, a quantifiable 
reduction in schistosome-associated morbidity as a consequence of such chemotherapeutic 
intervention.  Inherent within such an objective, it is therefore imperative to both define and 
characterize pre-treatment baseline morbidity levels within the risk populations, so that any 
subsequent changes in morbidity due to the intervention can be accurately determined (Gryseels 
& Polderman, 1991).  Furthermore, identification of sensitive and specific indicators of 
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schistosome-associated morbidity, that may be practically implemented within such large scale-
control programmes, as distinct from the individual clinical or research-based setting, should also 
prove invaluable in assisting identification of target populations for ongoing and future 
intervention (Kariuki et al., 2001).  Campagne and others also emphasized the need to validate 
indirect morbidity indicators in order to know the development of their predictive value during 
different stages of a schistosomiasis control programme (Campagne et al., 2001). 
 
Ultrasonography is currently the diagnostic tool of choice for detecting pathologic conditions 
associated with schistosomiasis, such as dilatation of the renal pelvis, bladder wall lesions, liver 
fibrosis and enlargement, and dilatation of the portal vein (Richter et al., 2003; Kabatereine et al., 
2004).  For detection of infection from S. haematobium, ultrasonography is an established 
method for detecting urinary tract pathology not only in the hospital setting (Abdel-Wahab et al., 
1978; Mongy et al., 1978; Browning et al., 1984; Devidas et al., 1989) but also in field-based 
studies (Hatz et al., 1992), with the advantage of being non-invasive, relatively simple to perform 
and very well accepted by communities, as well as of providing a direct image of the 
pathological changes (Hatz et al., 1990).  Additionally, ultrasonography gives sensitive and 
precise measurements of S. mansoni-associated pathologic changes (Richter et al., 2001; King et 
al., 2003).  In the attempt to objectively define and categorize the pathological changes 
associated with schistosomiasis, and to standardize the different scoring systems used in the past 
in different endemic areas (Richter et al., 2000; Hatz, 2001), successive “ultrasound consensus” 
meetings were held in Niamey, Niger in 1996 and Belo Horizonte, Brazil in 1997, leading to the 
revision of standardized scoring protocols and the development of the WHO-recommended US 
protocol (Niamey-Belo Horizonte protocol) (Richter et al., 2000).  Nevertheless, the prognostic 
features of individual ultrasonography findings in different disease-endemic situations (King et 
al., 2003), as well as whether ultrasonography can be incorporated into a mass chemotherapy 
programme in order to monitor morbidity, are still to be confirmed.  
 
The aim of this study was to assess indicators of US-detectable morbidity due to infection with 
both S. haematobium and S. mansoni in the context of large-scale control interventions targeting 
school-age children in Mali, prior to large-scale administration of praziquantel by the National 
Schistosomiasis Control Programme with support from SCI.  In Mali, both S. haematobium and 
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S. mansoni pose serious public health problems (Coulibaly et al., 2004).  Fishing, market 
gardening and rice cultivation all expose the population to the risk of occupational transmission, 
while children are regularly exposed through bathing and playing in ponds, streams and rivers.  
S. haematobium transmission is more widespread, occurring along river and streams as well as 
around ponds and in irrigation schemes (Vercruysse et al., 1994; Traoré et al., 1998).  The 
geographic distribution of S. mansoni infections is more restricted, mainly occurring in irrigation 
schemes, such as Office du Niger, Bandiagara, Sélingue and Baguinéda-Koulikoro (Vercruysse 
et al., 1994; Keita et al., 2005).  
 
The results obtained here should contribute to evaluate the appropriateness and the role of the 
full WHO protocol in the context of large-scale schistosomiasis control programmes.  Another 
aim of this study was to determine whether the numeric WHO cut-offs, originally derived from a 
healthy Senegalese population in a non-endemic S. mansoni area, contain bias in the estimation 
of the risk of dilatation of portal vein and enlargement of left liver lobe in a Malian setting.  This 
will be achieved here by comparison with local height-indexing of portal vein diameter (PVD) 
scores and longitudinal parasternal line scores (PSL) respectively, obtained from all children 
who had normal image patterns as assessed by US following recommendations of King and 
others (King et al., 2003).  
5.2 Materials and methods  
 
5.2.1 Study sites, sampling and design.  The Malian Ministry of Health, through its 
National Institute of Research in Public Health (Institut National de Recherche en Santé 
Publique (INRSP)) and its Disease Prevention and Control Division (Direction Nationale de la 
Santé), was charged with planning and implementing data collection with assistance from SCI.  
Baseline data collection was initiated in the Ségou region in late March 2004 and was completed 
in Bamako in the month of June 2004.  Ultrasonographic examination based on the WHO 
protocol was performed on children aged 7 to 14 (2,841 for S. haematobium and 2,820 for S. 
mansoni) from 29 schools.  These schools were randomly-selected from all schools located in 
three areas highly endemic for schistosomiasis: Bamako, Ségou and Baguinéda-Koulikoro 
(Figure 5.1).  All children enrolled in the study were interviewed by appropriately trained 
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Ministry of Health staff. Ethical clearance was obtained from the Ministry of Health, Mali and 
Imperial College, London.  
Figure 5.1 Location of sampled schools in Mali. Schools in Bamako and Koulikoro are in 
the upper box and schools in Ségou are in the lower box. 
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In schools from areas known to be endemic only for S. haematobium, the estimated sample size 
was calculated to be 180 individuals per sampling unit (usually a school) with 80 % power to 
detect a 70 % reduction in S. haematobium mean intensity over a two-year period (two annual 
treatments).  The expected reductions of 70 % in S. haematobium and 60 % in S. mansoni mean 
intensities over 2 annual treatments were calculated using the EpiSchisto software tool 
(http://www.schoolsandhealth.org/epidynamics.htm).  The figure of 180 was selected based on 
prevalence/intensity data from schools in various African countries with similar age ranges.   
 
Where both S. haematobium and S. mansoni infections were known a priori to be prevalent, the 
same methodology as for S. haematobium only was followed, although the number of surveyed 
children was increased to 300 per school with 80 % power because EpiSchisto simulations 
showed an expected reduction in mean S. mansoni intensity of 60 %. No schools were included 
in the present study in which S. mansoni infection only was prevalent.  
 
Whenever it was difficult to recruit the required number of children in any one school (usually 
because of the small size of the school), data from two (or more) adjacent schools were 
combined, provided that they appeared to be ecologically similar (e.g. with the same relative 
proximity to the nearest supposed focus of transmission).  For ethical reasons, it was not 
appropriate to include any untreated control groups.  Further technical details concerning the 
sample size calculations can be found elsewhere (Brooker et al., 2004).  
5.2.2 Parasitologic examination.  From each child, two urine specimens were collected 
on two consecutive days to determine the intensity of S. haematobium infection using filtration 
method. 10 ml of urine were passed through a Whatman (Brentford, United Kingdom) filter 
Paper (Ø=25mm) using a Millipore (Billerica, MA) Swinnex® filter support.  Filters were 
stained with 3 % ninhydrine and microscopically examined for eggs.  The intensity of S. 
haematobium infection was expressed as number of eggs per 10 ml of urine and the mean 
intensity of infection was the arithmetic mean of egg counts in the two urine samples.  To 
determine the presence and extent of microhaematuria (invisible haematuria), all urine specimens 
were tested for presence of detectable blood with urine reagent strips (Bayer Hemastix®).  The 
results were recorded semi-quantitatively: negative, +, ++ and +++.  Additionally, two faecal 
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specimens of 41.7 mg each were screened for S. mansoni by the Kato-Katz technique (Kato & 
Miura, 1954; Katz et al., 1972; Feldmeier & Poggensee, 1993).  Individual egg output was 
expressed as eggs per gram of faeces (epg), calculated as the arithmetic mean of the two 
individual slide counts.  
5.2.3 Ultrasound examinations.  Ultrasonographic assessments were performed with a 
portable ultrasonography device (Aloka SSD-500®).  A convex 3.5 Mhz transducer was used to 
detect pathological changes associated with both S. haematobium and S. mansoni infection.  All 
examinations were performed by the same clinician Prof Adama Keita, who was blind to 
schistosome infections status of the individual children.  US examinations were performed 
according to current WHO guidelines (Richter et al., 2000).  
 
Pathologic changes caused by S. haematobium was assessed by recording the shape of the 
urinary bladder, defining any lesions detected on the bladder wall and measuring the degree of 
dilation of the ureters and renal pelvis.  The exact coding of each of the above characteristics was 
made according to the recommendations of Richter and others (Richter et al., 2000).  Further 
categorization of pathological changes was performed by calculating the “global score” which 
serves as an index of severity of morbidity and lesions.  Children were provided with water and 
asked to drink abundantly before undertaking US examination, which took place only when the 
bladder was filled.  In case of detection of dilatation of the renal pelvis, which is suggestive of 
hydronephrosis, the child was re-examined after urination in order to rule out the possibility that 
such dilatation was due to bladder and urethral repletion. 
 
To characterize morbidity caused by S. mansoni, the size of the left liver lobe was measured in 
PSL.  Measurements of PVD were also recorded.  Liver patterns were graded from A to F, in 
order of the severity of the pathology they indicate. B0, B1 and B2 are most often grouped 
together, as are C1 and C2.  It should be noted, however, that the SCI protocol did not include 
periportal thickening measurements, due to concerns about both the reproducibility of 
measurements (Richter et al., 2001) and the time-consuming component of the examination.  
Therefore, interpretation of the final score for morbidity due to S. mansoni infection was based 
on assessment of image patterns and portal hypertension only.  Presence of ascites and 
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portosystemic collaterals was also recorded.  Detection of pathologic changes not caused by 
schistosomiasis was also recorded but is not discussed in the present study.  Individuals in need 
of health care were directed to the nearest medical facility. 
 
5.2.4. Ultrasonography protocol definitions.  The WHO protocol states that 
measurements of organ size and vein diameter should be height-adjusted, using standard 
reference measurements for healthy members of the same population group (Richter et al., 2000).  
King and others, found that the numeric WHO cut-offs derived from a healthy Senegalese 
population in an area not endemic for S. mansoni, seriously overestimated the risk of portal vein 
enlargement in Kenyan and Egyptian patients infected with S. mansoni (King et al., 2003).  In 
the current Chapter, I have also investigated this issue in a Malian setting as the Niamey 
workshop members anticipated the refinement of the guidelines through continued use and 
evaluation, by using alternative height-indexing of portal vein diameter scores obtained from all 
children that had normal image patterns as assessed by ultrasonography (n=2719).  With 
reference to the PSL measurement, the liver was considered enlarged, or much enlarged, if the 
height-adjusted value exceeded 2 or 4 SD in relation to the ‘normogram’ produced for a 
Senegalese population respectively (Yazdanpanah et al., 1997).  In addition, I also calculated 
local cut-off scores for liver left lobe enlargement and verified if the overestimation also applied 
to this parameter. 
 
At the end of all examinations, each child enrolled in the survey was treated with the WHO-
recommended dose of praziquantel (40mg/kg) for schistosomiasis and with albendazole 400 mg 
against intestinal helminths.  Side-effects were monitored, and adverse reactions following drug 
administration were infrequent: when present, these were minimal and transient, and no severe 
adverse experiences were observed.  
 
5.2.5. Statistical analysis.  Data from children with incomplete parasitologic or 
ultrasonographic records were excluded from analysis presented here and no replacements were 
made for missing subjects under the assumption that data were missing at random (Carpenter & 
Kenward, 2005).  Descriptive statistics for subject characteristics and outcomes were calculated 
using SAS version 8 (SAS Institute Inc., Cary, NC, USA). 
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To examine S. haematobium morbidity, I modelled the probability of a child having a positive 
individual global score using hierarchical multi-variable logistic regression.  Potential predictors 
included S. haematobium infection intensity category [light (defined as < 50 schistosome eggs 
per 10 ml of urine); or heavy (≥ 50 eggs/10 ml) (WHO Expert Committee on the Control of 
Schistosomiasis, 2002), microhaematuria, gender, and age.  The model structure was a two-level 
random intercept logistic regression model with level-one defined as the individual child and 
level-two the school, allowing for assessment of the extent of between-school variation in 
individual global scores. The model had the form: 
 
ijjjijijij eubwax +++=− )]1(log[ ππ  
 
where πij is the probability that child i in school j has a positive individual global score; xij and wj 
are vectors of individual- and school-level characteristics respectively; a and b are vectors of 
estimated parameter coefficients; )),0((~ 2uj Normalu σ  is an error term at the school level; and 
)),0((~ 2eij Normale σ  is an error term at individual level.  
 
To study the morbidity of S. mansoni, I used three hierarchical multi-variable logistic regression 
models where I aimed to model: (1) the probability of having abnormal image pattern scores; (2) 
the probability of having dilatation or marked dilatation as assessed by the PVD based on the 
Malian cut-off scores; and (3) the probability of having enlarged liver as assessed by the PSL 
measurements based on the Malian cut-off scores.  Potential predictors included S. mansoni 
infection intensity category [light (defined as 1 to 99 eggs per gram (epg) of faeces); moderate 
(100 to 399 epg), or heavy (≥ 400 epg) (WHO Expert Committee on the Control of 
Schistosomiasis, 2002), gender, and age.  The structure and form of the model used to assess 
each of these S. mansoni morbidity indicators, were identical to those used for evaluation of S. 
haematobium. 
 
All four models were constructed using the Mlwin software (version 2.01, Multilevel Models 
Project, Institute of Education, University of London, UK).  The method of estimation was the 
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second order penalized quasi-likelihood procedure (Goldstein & Rasbash, 1996), and first order 
marginal quasi-likelihood (MQL) estimates were used to provide the starting values for the 
estimation procedure, the stability of the algorithm and convergence criteria (Rasbash et al., 2004).  
The model structure was selected because of the hierarchical nature of the dataset, i.e. children were 
clustered in schools and observations from individuals within the same school were therefore not 
independent.  As discussed in previous chapters of this PhD thesis, multilevel models account for 
this dependence by partitioning the total variance in the data into variation between and variation 
within the higher-level units (Goldstein et al., 2002).  While partitioning of variance is 
straightforward in models with a continuous dependent variable and with a normally-distributed 
error at each level of the hierarchy, their extension to models with binary responses is more 
problematic.  For the school effect in each model I calculated the median odds ratio (MOR) to 
quantify the variation between schools (Larsen et al., 2000; Larsen & Merlo, 2005).  The MOR is 
always ≥ 1 and directly comparable with fixed-effects odds ratios.  More precisely, if the MOR is = 
1, there is no variation between clusters (no second-level variation).  If there is considerable between 
cluster variation, the MOR will be large. 
 
This quantification of the heterogeneity of the schools is not simply of technical value; the 
apportioned variances are of substantive interest in much of biomedical research as they give 
important insights to the level ‘at which the action lies’ (Browne et al., 2005) and for epidemiologic 
reasons (in this case quantification of the importance of the schools for understanding individual 
health) (Larsen & Merlo, 2005).  The percentage of total variation in the ultrasonographic global 
scores as well as in the liver image patterns, the PVD and the PSL, which are explained by each of 
the corresponding models presented here, was estimated using an R2 measure developed by Snidjers 
and Boskers (Snidjers & Bosker, 1999).  
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5.3 Results 
 
Schistosoma haematobium was prevalent in all the 29 schools surveyed, and S. mansoni was 
prevalent in 25 of these schools.  
 
5.3.1 Schistosoma haematobium.  Ultrasonographic examination was performed on 2,841 
children.  Of these, parasitological data were obtained from 2,822 children.  In 136 (4.8 %) of 2,822 
there was no second examination of urine and prevalence and mean intensity calculations were based 
on one urine filtration result for these children.  Overall, S. haematobium prevalence of infection was 
59% and the arithmetic mean intensity was 43.0 eggs/10 ml of urine.  At school-level, prevalence of 
infection ranged from 10.8% to 100.0% and arithmetic mean intensity from 0.7 to 202.5 eggs/10 ml 
of urine.  Girls accounted for 53% of children in the survey and approximately equal numbers of 
children were recruited in each year group from 7 to 14 years of age.  Bladder wall thickening and 
irregularities, bladder masses and pseudo-polyps were found in 6.0% of the children.  The 
prevalence of upper urinary tract (kidney) pathology was estimated to be 3.7%.  The prevalence of 
positive global scores was estimated to be 10.1%, while at the school-level this ranged from 1.0% to 
61.4%.  
 
The odds ratios (ORs) from two-level logistic regression analysis for the probability of having a 
positive ultrasonographic global score are shown in Table 5.1.  Children with either light or heavy S. 
haematobium infection intensities were more likely to have a positive ultrasonographic global score 
than uninfected children (light: OR=3.0, p=0.004 and heavy: OR=6.9, p<0.001).  Children with ‘+’, 
‘++’ and ‘+++’ microhematuria scores were significantly more likely to have positive 
schistosomiasis ultrasonographic global scores compared to microhematuria-negative children 
(OR=2.5, p=0.003; OR=3.1, p<0.001 and OR=5.0, p<0.001 respectively).  Boys showed 
significantly higher ultrasonographic morbidity global scores than girls (OR = 2.0, p<0.001).  Age 
was not a statistically significant indicator of S. haematobium morbidity, although there was a trend 
for older children to be more likely to have a positive schistosomiasis ultrasonographic global score.  
This table also shows that a relatively high MOR (2.6) is associated with between-school variation.  
Of the total variation in the global US score, 13.7% remained unexplained at the school-level and 
45.7 % remained unexplained at the child-level. 
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5.3.2 Schistosoma mansoni. Both ultrasonographic and parasitologic data were obtained 
from 2,247 (79.7%) of 2,820 children. Overall prevalence of infection was 27% and the overall 
arithmetic mean intensity was 119.5 epg. Calculations were based on two faecal smear examinations 
from all but four children, for whom the second measurement was missing. School-level prevalence 
of infection ranged from 0.0% to 96.0% and arithmetic mean intensity from 0.0 to 814.9 epg.  
 
A total of 2,820 children were examined by ultrasonography for S. mansoni-related pathologic 
changes.  Of these children, 96% had normal liver as assessed by liver image patterns.  Of the 
children who had abnormal liver image patterns, 84% had grade B patterns and 16% had grade C 
patterns.  Figure 5.2 shows that using the current WHO cut-off, 85 % of children had a 0 PVD score.  
In contrast, 96% children had a 0 PVD score using the cut-off derived from the data from the Malian 
children with normal liver image patterns was used. The difference between these two proportions 
was significant (p<0.001). Statistically significant differences were also found between the 
proportions of children allocated positive PVD scores of four and six using the two different cut-offs 
(both p<0.001).  
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Table 5.1 Odds ratios (OR) with 95% CI estimates and percentage of variation explained for 
two-level logistic model of prevalence of positive global score as measured by ultrasound 
using data set of children with complete parasitologic and ultrasound data on S. haematobium 
infection (n = 2,822) 
Fixed effects 
Variables Categories Odds ratios  95% CI p-value 
7 years old 1   
8 years old 1.200 0.632 - 2.277 0.578 
9 years old 0.932 0.481 - 1.808 0.836 
10 years old 1.369 0.743 - 2.523 0.314 
11 years old 1.537 0.836 - 2.828 0.168 
12 years old 1.231 0.659 - 2.301 0.515 
13 years old 1.226 0.659 - 2.283 0.520 
 
 
 
Age 
14 years old 1.626 0.865 - 3.056 0.130 
Not Infected 1   
Lightly Infected 3.004 1.424 – 6.339 0.004 
 
S. haematobium intensity infection 
Heavily Infected 6.862 3.036 - 15.508 < 0.001 
 Female 1   Gender 
Male 2.026 1.489 - 2.756 < 0.001 
 Negative 1   
Trace Hemolysed 1.600 0.781 - 3.278 0.199 
‘+’ 2.479 1.361 - 4.517 0.003 
‘++’ 3.068 1.751 - 5.374 < 0.001 
 
 
Results of Hemastix test  
‘+++’ 5.078 3.093 - 8.338 < 0.001 
Random effects     
School  Median odds 
ratio 
  
 
 2.572   
Variation %    
Total variance explained 40.63    
Total variance unexplained      
at school-level 13.66    
at child level 45.71    
 
 
In 99.9% of the children, no collateral vessels were detected and no free fluid was detected in 
abdomen.  Figure 5.3 shows that 50% of the children in the ultrasonographic cohort had left lobe 
hepatomegaly as assessed by PSL using the current WHO cut-off value.  A total of 41% of the 
children had an enlarged liver and 8% had a greatly enlarged liver.  Conversely, 99% did not have an 
enlarged liver when the cut-off value derived from the Malian children with normal liver image 
patterns was used.  Statistically significant differences were found between all proportions of 
children allocated null or positive PSL scores of one and two using the two different cut-off values 
(p<0.001).  
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Figure 5.2 Percentages of children with Portal Vein Scores based on different cut-off values 
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Table 5.2 shows the ORs from two-level logistic regression analysis for the probability of having 
abnormal image pattern scores as assessed from ultrasonography for S. mansoni infection.  Children 
with light, moderate or heavy S. mansoni infection intensities were more likely to have an abnormal 
liver image pattern than uninfected children (light: OR=2.6, p=0.023; moderate: OR= 1.3; p=0.62 
and heavy: OR=3.1, p=0.036).  There was a trend for older children to be less likely to have an 
abnormal liver image pattern, but these differences were only significant for 11-, 12- and 14-year-
olds, relative to 7-year-old children (OR=0.3, p=0.027; OR=0.3, p=0.036 and OR=0.2, p=0.016 
respectively).  Table 5.2 also shows that a high MOR (13.4) was associated with between-school 
variation. Of the total variation in the liver image pattern, 67.0% remained unexplained at the school 
level and 30.0% remained unexplained at the child level.
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Figure 5.3 Percentages of children with Longitudinal Parasternal Scores based on different cut-
off values 
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Table 5.2 Odds ratios (OR) with 95% CI estimates and percentage of variation explained for two-
level logistic model of prevalence of abnormal liver image patterns as measured by ultrasound using 
data set of children with complete parasitologic and ultrasound data on S. mansoni infection  
(n = 2,247) 
 
 
 
 
Fixed effects 
Variables Categories Odds ratios  95% CI p-value 
7 years old 1   
8 years old 0.550 0.209 - 1.450 0.226 
9 years old 0.412 0.152 - 1.120 0.082 
10 years old 0.523 0.202 - 1.353 0.182 
11 years old 0.305 0.107 - 0.875 0.027 
12 years old 0.323 0.112 - 0.926 0.036 
13 years old 0.516 0.189 - 1.404 0.196 
 
 
 
Age 
14 years old 0.224 0.066 - 0.755 0.016 
Not Infected 1   
Lightly Infected 2.622 1.144 - 6.008 0.023 
Moderately Infected 1.336 0.423 - 4.223 0.621 
 
S. mansoni intensity infection 
Heavily Infected 3.099 1.080 -8.895 0.036 
 Female 1   Gender 
Male 1.520 0.873 - 2.648 0.138 
Random effects     
School  Median odds 
ratio 
  
  13.444   
Variation %    
Total variance explained 3.388    
Total variance unexplained      
at school-level 66.981    
at child level 29.631    
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Table 5.3 Odds ratios (OR) with 95% CI estimates and percentage of variation explained for 
two-level logistic model of prevalence of having dilatation or marked dilatation as assessed by 
the ultrasound PVD score based on the Malian cut-off scores by using data set of children with 
complete parasitological and ultrasound data on S. mansoni infection (n=2,247) 
 
Table 5.3 shows the ORs from two-level logistic regression analysis for the probability of having 
dilatation or marked dilatation as assessed by ultrasonography for S. mansoni infection PVD height-
adjusted measurements based on the Malian cut-off value.  The ORs of having dilatation or marked 
dilatation as assessed by ultrasonographic PVD measurements for children with light, moderate or 
heavy S. mansoni infection intensities were not significantly different compared to uninfected 
children (P=0.418, 0.478 and 0.593 respectively).  There was a trend for older children to be more 
likely to have increased PVD, but these differences were only significant for 9-, 10-, 13- and 14-
year-old children, compared with 7-year-old children.  (OR=3.7, p=0.027; OR=3.3, p=0.043; 
OR=3.7, p=0.030 and OR=4.7, p=0.009 respectively).  The MOR to have an increased PVD was 4.4, 
which is still high OR and is associated with between-school variation.  Of the total variation in the 
Fixed effects 
Variables Categories Odds ratios  95 % CI p-value 
 7 years old 1   
8 years old 1.567 0.444 - 5.525 0.484 
9 years old 3.640 1.159 - 11.435 0.027 
10 years old 3.245 1.035 - 10.172 0.043 
11 years old 2.835 0.887 - 9.064 0.079 
12 years old 1.980 0.586 - 6.687 0.271 
13 years old 3.647 1.134 - 11.730 0.030 
 
 
 
Age 
14 years old 4.655 1.462 – 14.826 0.009 
Not Infected 1   
Lightly Infected 1.402 0.619 - 3.175 0.418 
Moderately Infected 1.408 0.547 - 3.621 0.478 
 
S. mansoni intensity infection 
Heavily Infected 0.774 0.303 -1.979 0.593 
 Female 1   Gender 
Male 2.250 1.373 - 3.687 0.001 
Random effects     
School  Median odds 
ratio 
  
  4.364   
Variation %    
Total variance explained 6.480    
Total variance unexplained      
at school-level 39.360    
at child level 54.159    
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PVD, 39.0% remained unexplained at the school level and 54.2% remained unexplained at the child 
level. 
 
Relative to modeling of the probability of having an enlarged liver as assessed by the PSL 
measurements based on the Malian cut-off scores, the algorithm did not converge.  Therefore, I was 
unable to provide any estimates and establish any associations for this measure. 
5.4 Discussion 
 
Ultrasonography has become an invaluable extension of the clinical investigation of patients with 
schistosomiasis and has provided direct evidence of the pathological changes associated with this 
infection (Hatz, 2001;Brouwer et al., 2004).  This evidence has been well validated in the individual 
patient clinical setting (Bahakim et al., 1986; Abdel-Wahab & Strickland, 1993; Lougue-Sorgho et 
al., 2002; de Celis et al., 2003) and the relatively small-scale research setting (Friis et al., 1996; 
Leutscher et al., 2000; van der Werf et al., 2004; Vennervald et al., 2005).  However, the overall aim 
of this study was to test the suitability of the full WHO-recommended ultrasonography protocol in 
the context of large-scale schistosomiasis control programmes.  There is a requirement to elucidate 
whether ultrasonography could, and indeed should, be incorporated into a mass chemotherapy 
programme in order to monitor morbidity associated with S. haematobium infection and, perhaps in 
particular, morbidity associated with the often more difficult to characterize S. mansoni infections in 
all but the most severe cases (Lengeler et al., 1991; Utzinger et al., 1998).  
 
The current study complements and furthermore expands upon previous ultrasonography-based 
studies within Africa on a number of aspects.  First, although previous published surveys (Kardorff 
et al., 1994; Kardorff et al., 1996; Kardorff et al., 1997; Vester et al., 1997; Frenzel et al., 1999; 
Boisier et al., 2001; King et al., 2003) have used ultrasonography to measure schistosomiasis-
associated morbidity both in children and in adults, indicative of long-term chronic infections, in this 
Chapter I assess ultrasonography in monitoring schistosomiasis morbidity for control programmes 
focused on children.  Although I recognize that measuring only children might be a limitation, if one 
considers the overall aim of this study, the results of the current Chapter still contribute to assessing 
the suitability of ultrasonography for more recent infections and targeting age groups for future 
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disease control programmes. This study should also provide a unique opportunity to clarify the 
relationship of early lesions to later ones through a subsequent comparison of the baseline findings 
presented here, particularly where there are identifiable cohorts, over extended period of time.  
Moreover, in terms of size of cohorts, a much larger number of individuals than typical of previous 
research or clinical-based studies is followed and used here. Finally, the current study has 
methodological advantages, particularly since I account for the interdependence of observations by 
partitioning the total variance into different components of variation due to various cluster levels in 
the data.  
 
Children are probably the most important age group for ultrasound detectable morbidity due to S. 
haematobium and the results obtained from Mali confirm that the current WHO protocol (Niamey-
Belo Horizonte protocol) is a suitable and valid public health tool because its scoring criteria 
performed acceptably well in defining ultrasound pathology due to urinary schistosomiasis. 
Sophisticated statistical models yielded significant associations between the global ultrasonography 
scores from the WHO protocol and several other morbidity predictors. A significant association 
between the degree of morbidity as defined by ultrasonography global scores and S. haematobium 
infection intensity and microhematuria was demonstrated. Boys had a higher prevalence of 
morbidity than girls and this has also been observed in the studies from Heurtier and others and 
Keita and others (Heurtier et al., 1986; Keita et al., 2001).  The results reported in this Chapter also 
indicated that there was considerable variation between schools in the prevalence of positive global 
scores, thus showing the focal clustering of morbidity due to urinary schistosomiasis also in areas of 
overall intense transmission.  In conclusion, ultrasonography global scores and microhematuria 
scores are likely to be valuable markers in children for morbidity caused by both light and heavy 
infections with S. haematobium.  The inclusion of ultrasonographic examinations in the routine 
monitoring and evaluation activities of control programmes against urinary schistosomiasis 
whenever resources are available, as in the case of middle-income countries (i.e. North and South 
Africa and potentially also some Middle-Eastern countries such as Iraq), is therefore recommended.  
In sub-Saharan Africa, such a recommendation should be weighted against the additional costs that a 
subsequent decision would bring (equipment, personnel, training) and the available national or 
external funds of the control programs.  
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With regards to intestinal schistosomiasis, the significant associations observed between liver image 
patterns with S. mansoni intensity of infection  confirms that liver image patterns are likely to be 
valuable markers for morbidity caused by light or heavy infections with S. mansoni, as suggested by 
King and others (King et al., 2003).  However although findings reported in this Chapter suggest that 
the current scoring criteria perform acceptably well in defining disease caused by S. haematobium 
infection, they also show in accordance with those of King and others (King et al., 2003), that the 
current WHO cut-offs can lead to serious overestimation of the risk of portal vein enlargement in 
patients infected with S. mansoni.  In addition, data used in this Chapter show that also the risk of 
left liver lobe enlargement may be overestimated by the WHO cut-offs.  Therefore, cut-offs norms 
should be recalculated at least in each endemic country from a subset of local individuals with 
‘pattern A’ prior to the implementation of the WHO protocol which also fulfills the 
recommendations included in the Niamey-Belo Horizonte protocol guidelines.  Further studies to 
confirm appropriate cut-off scores for these measurements are therefore required.  
 
Nevertheless, the observation that much of the variability in the liver image pattern remained 
unexplained, as well as the very high MOR, suggests that other variables might be needed to explain 
the between school heterogeneity.  Another explanation for this very high MOR and unexplained 
variation might be that among children with abnormal liver image patterns, 84 % were found to have 
grade B (coding for the earliest pathologic changes in the liver) which may not be schistosomiasis 
specific.  This same fact might also explain the unexpected finding here that older children have less 
likelihood of abnormal patterns than younger ones compared with other studies of schistosomiasis 
morbidity.  Therefore, liver image patterns of grade B may have represented a confounding factor in 
the analysis presented in the current Chapter.  Further studies are therefore needed to fully elucidate 
the relationship between liver fibrosis and schistosomiasis, with particular reference to the degree of 
association between pattern B and S. mansoni infection and to the role played by other factors in 
determining such fibrosis.  Likewise, in the case of hepatomegaly, I was unable to distinguish clear 
associations, which may have been due to the fact that these observed morbidities were likely to 
have been multifactorial, with S. mansoni infection being only one of a number of potential causes 
(Kabatereine et al., 2004).  There are often many factors (genetic and possibly most importantly 
malaria which is transmitted throughout the year in the whole of Mali) other than S. mansoni that can 
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determine liver enlargement, and their role and interaction with S. mansoni infection also requires 
further clarification.  
 
Although these data are on children and as such were expected to be less likely to demonstrate 
ultrasonography-detectable morbidity due to S.mansoni infection because of the amount of time of 
exposure associated with the time taken for fibrosis to build up, in contrast, they do show morbidity 
for this type of infection, suggesting that in these communities children may become infected early 
in life (Odogwu et al., 2006).  I predict that, in adults, the dynamics of exposure, treatment and host 
immunity would show even more ultrasonography-detectable S.mansoni morbidity than observed in 
this study. It might also be important to include the periportal thickening measurement in the 
ultrasonographic examinations when the adult population is examined to evaluate the performance of 
the whole protocol.  I predict that in adults infected with S .mansoni, the comparison between Malian 
and WHO cut-off values (derived in a similar way as previously described), would show significant 
differences in the estimations of risk of PVD and left liver lobe enlargement, since King and others 
(King et al., 2003) also observe the same pattern irrespective of age.  
 
For S.haematobium, as in high transmission areas such as those under study here, successive 
episodes of infection would result in recrudescence of urinary tract abnormalities detected by 
ultrasonography (Hatz et al., 1998), and I would expect to observe more severe pathology due to 
urinary schistosomiasis in young adults because of continuing reinfection. However, 
ultrasonography may not be the most appropriate tool to detect and define late-stage morbidity due 
to S. haematobium infection in older adults, because of decreased rates of reinfection in this age 
group, which leads to decreased development of new inflammatory bladder wall lesions 
pathognomonic of urinary schistosomiasis.  Thus, it would be interesting to conduct a survey on 
adults from the same communities of children described in this Chapter, and to investigate up to 
which age group ultrasonography is a suitable tool to monitor morbidity due to urinary 
schistosomiasis in a field setting. 
 
Thus for both intestinal and urinary schistosomiasis, it will be necessary to obtain longitudinal data 
to fully elucidate the natural history of morbidity related to infection, with the aim of formulating 
recommendations for treatment and retreatment based on such natural history and especially on its 
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evolution after large-scale administration of anthelminthic drugs.  Such work has been recently 
completed by INRSP, SCI and the National Schistosomiasis Control Programme (PNLSH) and 
analysis is underway and hopefully it will help the planning and evaluation of sustainable morbidity 
control.  
 
Conversely, if only parasitological measurements were incorporated into the monitoring process of 
schistosomiasis morbidity of a mass chemotherapy programme, the following three issues should be 
taken into consideration (Hatz et al., 1990): 1)  Diagnosis of infected individuals might be missed 
because of substantial day-to-day variation of egg output more importantly in S. mansoni and then in 
S. haematobium infections; some of the subjects could lack shed eggs at the time of the stool or the 
urine examination or simply eggs could be missed; 2)  Signs of disease could still be present even in 
the true absence of egg excretion.  Eggs could be trapped in lesions, especially in long standing 
infections.  Just after treatment, eggs could also be absent, but lesions would still be present.  In this 
case ultrasonography would still provide detection of irreversible lesions long time after treatment; 
3)  Confounding causes other than schistosomiasis on observed pathologic signs could be excluded 
by ultrasonography. Epidemiological importance of confounding causes of uropathy in areas where 
S. haematobium is endemic appears to be small, but reference to S. mansoni, information on this 
point is still lacking.     
 
In conclusion, the results of this study suggest that the current WHO protocol (Niamey-Belo 
Horizonte protocol) is a suitable and valid public health tool for urinary schistosomiasis for 
morbidity control programmes focused on children.  In the case of morbidity detection of intestinal 
schistosomiasis in large scale control interventions this same protocol is a useful tool provided that 
local cut-off values are used to define abnormal values and that results are interpreted with caution. 
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Chapter 6: Sensitivities and specificities of diagnostic tests and 
infection prevalence of Schistosoma haematobium estimated 
from data on adults in villages northwest of Accra in Ghana. 
 
Summary  
 
Substantial uncertainties surround the sensitivities and specificities of diagnostic techniques for 
urinary schistosomiasis. I used latent class (LC) modeling to address this problem.  In this study 220 
adults in three villages northwest of Accra region in Ghana were examined using five Schistosoma 
haematobium diagnostic measures: microscopic examination of urine for detection of S. 
haematobium eggs, dipsticks for detection of haematuria, tests for circulating antigens, serological 
antibody tests and ultrasound scans of the urinary system.  Testing of the LC model indicated non-
invariance of the performance of the diagnostic tests across different age groups while measurement 
invariance held for males and females and for the three villages.  I therefore recommend the use of 
LC models for comparison between, and the identification of, the most accurate schistosomiasis 
diagnostic tests. Furthermore, microscopy and haematuria dipsticks were indicated as the most 
appropriate techniques for detection of S. haematobium infection.   
 
Keywords: latent class models, diagnostic tests, Ghana, Schistosoma haematobium  
 
Note: A modified version of this chapter has been accepted for publication in the American Journal 
of Tropical Medicine and Hygiene by Koukounari A, Webster JP, Donnelly CA, Bray BC, Naples J, 
Bosompem K, Shiff C. 
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6.1 Introduction 
 
In spite of the prolific generation of new knowledge in the area of urinary schistosomiasis, such as 
that of global burden, treatment and associated morbidity (King, 2006; Koukounari et al., 2007; 
Midzi et al., 2008; Rudge et al., 2008), there remains the unsolved practical issue associated with the 
basic diagnosis of this important parasitic disease.  This relates to both the direct (i.e. microscopical 
examination of filters of urine for detection of S. haematobium eggs) as well as with the indirect (i.e. 
detection of haematuria, detection of schistosome-specific antibodies, detection of circulating egg 
antigens and ultrasound scans of the urinary system) diagnostic methods of this schistosome 
infection.  There are several reasons for the limitations in the diagnosis of urinary schistosomiasis 
infections, such as, for example daily variation in egg excretion levels and/or duration of infection 
influencing the potential accuracy of determining the correct current infection status (Hatz et al., 
1990).  
 
Haematuria (blood in urine) alone has been proposed as a valid indication of current infection in 
schistosomiasis endemic populations (van der Werf & de Vlas, 2004).  Microhaematuria can be 
detected by reagent strips (dipsticks) which recognize blood and protein.  However, for the 
distinction of an active from a previous infection, particularly after treatment, in many populations 
and individuals, the circulating schistosome antigen has been proposed as the most reliable test (Van 
Lieshout et al., 1992; Attallah et al., 1999).  In addition, although the serological diagnosis of 
schistosomiasis is generally accurate (el Missiry et al., 1990), it can also produce false negatives, 
particularly in patients with longstanding infections while elevated antibody levels can be still 
detectable many years after treatment (van Lieshout et al., 2000).  Ultrasound is currently the 
diagnostic tool of choice for detecting pathological conditions associated with urinary 
schistosomiasis, such as dilatation of the renal pelvis and bladder wall lesions, although its 
usefulness has been questioned, particularly in low transmission areas, because of its lack of 
specificity (Hatz, 2001; Ruiz et al., 2002).  In addition, large variations of sensitivity and specificity 
estimates have been observed among different endemic zones, age groups and sexes for all the 
aforementioned diagnostic methods of urinary schistosomiasis in several studies (Amis et al., 1982; 
Degremont et al., 1985; Taylor et al., 1990; Webb, 1990; Etard, 2004).  
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One explanation for the inconsistencies between all these diagnostic tests relates to the current lack 
of a definitive ‘gold standard’ reference test for urinary schistosomiasis.  Consequently, the 
diagnosis of schistosomiasis as well as the control of this disease becomes problematic.  Diagnostic 
assays with low sensitivities are unsuitable for evaluation of schistosomiasis control programmes, 
such as those aimed at morbidity reduction through mass human chemotherapy (Bosompem et al., 
2004).  Indeed, methods that allow infections to be correctly diagnosed are a prerequisite for 
effective disease control (Doenhoff et al., 2004).  One solution may therefore relate to the need for 
more sophisticated statistical models to be developed and utilized in order to obtain more reliable 
empirical estimates of sensitivities and specificities of diagnostic tests (Begg, 1987; Formann, 1994). 
 
In the present study I assessed the performance of five diagnostic tests for S. haematobium infection 
and estimated the prevalence of this infection in different age and sex groups in three villages 
northwest of Accra in Ghana.  Specifically I used five different diagnostic tests for the prevalence of 
urinary schistosomiasis infection: that of the urine antigen detection test, performed on membranes 
or in ELISA plates, the serology anti-IgG test, an ultrasound assessment by recording the shape and 
state of the urinary bladder, the dipstick for haematuria using urine reagent strips on all urine 
specimens for presence of detectable blood, and finally detection of S. haematobium eggs by 
microscopy.  Through the application of a latent class (LC) model to all of these five tests, the 
sensitivity and specificity of each test can be determined, and the overall urinary schistosomiasis 
prevalence levels within the different population groups estimated. 
 
6.2 Materials and methods 
 
6.2.1 Study sites and subjects.  Three Ghanaian villages northwest of Accra, Ayiki Doblo, 
Chento and Ntoaso were visited and consenting adults over 19 years of age formed a convenience 
sample of passers by.  However, in general, as regards to the demography in Greater Accra’s region, 
the age structure is still a youthful one, characterized by a somewhat high fertility which has begun 
to show signs of a steep downward trend (Oheneba-Sakyi & Heaton, 1993). The general public in 
the three aforementioned villages are familiar with the work of the Noguchi Memorial Institute for 
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Medical Research and its personnel. Through discussions with local authorities the public was 
alerted, and people were approached and asked to participate.  These volunteers were then 
interviewed and requested to provide specimens of urine, stool and blood for examination. 
Praziquantel (at 40mg per kg) was offered and taken following diagnosis of all infected cases of 
schistosomiasis.  At subsequent visits, bladder ultrasound scans were performed on the majority of 
participants.  All examinations were performed at the village clinics.  Participants responded to a 
questionnaire, the majority of which were reported to be peasant farmers and persons involved in 
agriculture.  Others responded as traders or vendors, but most reported regular water contact in the 
nearby river system.  Although there was municipal water available in the village of Ntoaso, many 
residents do not have access to clean running water, and through their daily activities were thereby 
potentially exposed to risks of schistosome transmission.  A total of 220 individuals consented to 
participate, had complete data on the variables examined here and were included in the analysis of 
the present study.  The age and sex structure as well as the village location of all the sampled 
individuals is given in Table 6.1, which illustrates a significantly lower proportion of individuals 
who consented to participate and had complete data were below 39 years old and from villages Ayiki 
Doblo and Chento.  
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Table 6.1 Participation by age class, sex and village 
Variable Number of 
individuals who 
consented to 
participate and 
had complete 
data   
(%)  
Number of 
individuals who 
dropped out or 
did not have 
complete data  
 
(%)  
p-value* 
Age class 
19--29 years old 
30--39 years old 
40--49 years old 
50--59 years old 
≥60 years old 
 
 51 (29.8) 
57 (42.5) 
56 (57.1) 
33 (52.4) 
23 (37.7) 
 
 120 (70.2) 
77 (57.5) 
42 (42.9) 
      30 (47.6) 
38 (62.3) 
 
<0.001 
Sex 
Female 
Male 
 
117 (40.8) 
103 (42.9) 
 
170 (59.2) 
137 (57.1) 
 
0.618 
Village location 
 
Ayiki Doblo 
Chento 
Ntoaso 
 
 
102 (49.0) 
39 (26.2) 
      79 (46.5) 
 
 
106 (51.0) 
110 (73.8) 
91 (53.5) 
 
 
<0.001 
Total n 220 307  
     *p-value for chi-square test. 
 
6.2.2 Urine-antigen detection test.  Detection of schistosome antigen in urine was 
performed after the method of Bosompem and colleagues (Bosompem et al., 1996) which has shown 
that S. haematobium antigen complexed with complement C3 can be isolated from the urine of 
infected people using a mouse monoclonal antibody.  The authors demonstrated that goat-antihuman 
C3 would also detect schistosome antigen/complement complex in the urine of infected people, but 
not in non-infected people as case controls, and subsequently developed a monoclonal antibody 
dipstick test based on these findings (Bosompem et al., 1998).  Briefly, methanol treated 
polyvinylidene difluoride (PVDF) membrane strips were incubated in test urine for 30min at room 
temperature (21-25oC), rinsed with Tris-buffered saline (TBS) (50 mM Tris and 200 mM NaCl, pH 
7.4) and then blocked for 15 min in 5% skimmed milk in TBS.  The strips were then incubated in a 
reagent mixture of S. haematobium species-specific MoAb (1:100) and goat anti-mouse-
immunoglobulins conjugated to horseradish peroxidase (1:10) in 0.1% skimmed milk in TBS for 1 h.  
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The strips were washed three times each by 10 min incubation in TBS and then incubated in 
substrate solution 0.05% (w/v) (3,3-diaminobenzidine), 0.15% (v/v) H2O2 and 5 mM Co 
(NO3)2.6H2O in TBS for 1 min. A bluish-black reaction represented positive results while negative 
results remained colourless.  
 
6.2.3 Serology anti-IgG test.  Detection of anti-schistosome IgG in serum was performed on 
serum eluted from dried blood spots on Whatman No1 filter paper.  Blood spots filled a 1 cm 
diameter circle were taken at the time of examination, desiccated and kept dry until analysis.  These 
were eluted in 1 ml PBS, diluted 1:100, and tested in ELISA plates (Immunolon-2) in triplicate.  
Analyses were repeated if there was more than 10% discrepancy.  Plates were sensitized with SWAP 
antigen (6.44 mg/ml) prepared from S. mansoni adult worms provided by Biomedical Research 
Institute, Rockville MD.  Antigen dilution was optimized against sera from known positive S. 
haematobium infections and known schistosome negative sera.  Optical densities were read from a 
Vmax kinetic microplate reader (Molecular Devices. USA).  Results were scored positive when the 
OD exceeded 2 x SD of the negative controls.  
 
6.2.4 Ultrasound examination.  A portable ultrasound apparatus, Aloka SSD-500 portable 
ultrasound with 3.5 MHz curvilinear probe (Aloka, Tokyo, Japan) was used for ultrasound 
examination, with the diagnoses made by a medically qualified person with prior training in 
ultrasound examination and interpretation.  Examinations were performed using a curvilinear probe 
and recorded photographically.  Diagnosis of pathological lesions was made in situ, and later 
confirmed by review of the ultraradiograph.  For the purpose of this study, lesions were classified as 
positive or negative.  Positive cases were registered when any two of the following situations were 
evident: epithelium enlarged more than 5 mm, evidence of polyps in the bladder wall, calcification 
of the epithelium, evidence of hydronephrosis. 
 
6.2.5 Parasitological examination.  Classic parasitological methods usually used by field 
clinicians were employed and evaluated in this study.  Microscopy was performed on the product of 
a single measure of filtration of 10 ml urine taken from a specimen passed between 10:00 and 14:00, 
the time of optimum egg passage (Weber et al., 1967).  Urine specimens were kept cool in an 
insulated ice box and processed in the laboratory within 4 hours of passing.  The presence of any S. 
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haematobium eggs was recorded as positive.  Haematuria was detected by the use of standard 
“hemastix”, with any positive reaction being designated positive for urinary schistosomiasis 
(Multistix, Bayer Diagnostics). 
 
6.2.6 Statistical analysis.  By considering the true S. haematobium infection status of a 
sample of Ghanaian adults as a latent variable with two categories: ‘infected’ and ‘non-infected’, I 
validated the five diagnostic tests.  In other words, I considered the observed data of the five 
diagnostic tests (urine antigen detection, serology anti-IgG test, ultrasound, dipstick for haematuria 
and microscopy) as indicators of an underlying, not directly observable variable (i.e. S. haematobium 
infection).  Results of the five diagnostic tests are directly observed and are known as manifest 
variables while the S. haematobium infection is the unobservable latent variable (Bartholomew & 
Knott, 1999). 
 
Given a sample of individuals with unknown infection status, for whom results from several 
diagnostic tests are available, latent class analysis can model the probability of each combination of 
tests results conditional on latent class (i.e. infection status).  The manifest binary variables (x1j, x2j, 
x3j, x4j and x5j) were defined such that xij=0 represents a negative result for test i and xij=1 represents 
a positive test result for test i on individual j.  I tested whether correlations between these manifest 
variables could be accounted for by a single latent dichotomous variable Y (i.e. the absence Y=0 or 
presence Y=1 of S. haematobium infection) and I defined η = P(Y=1) the probability of being in the 
infected latent class.  In other words, I divided the studied population into two classes (i.e. non 
infected and infected) assuming that the xij’s were mutually independent within each class (i.e. true 
infection status).  It is expected that the xij’s are correlated as they are attempting to measure the 
presence of the same infection; the model assumes that these correlations are negligibly small only 
once one has accounted for an individual’s true infection status (i.e. latent class membership).  This 
assumption results in a more parsimonious model compared to one in which residual correlations are 
estimated, and one that is often adequate for the data.  In the unlikely case that there are substantial 
residual correlations between the xij’s, additional latent classes would likely be required for an 
adequate fit to the data.    
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The likelihood function of the LC model was 
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Such a model has two types of parameters.  First, there is the unconditional probability η that a 
person is in the infected latent class.   
 
The second type of parameters are the conditional probabilities πi1 and πi0 that an individual in a 
particular latent class has a specified value of each of the manifest variables (Rindskopf  & 
Rindskopf, 1986).  In fact, πi1 represents the sensitivity and is the conditional probability 
P(xi=1|yj=1) while (1-πi0) represents the specificity and is the conditional probability P(xi=0|yj=0).  
The LC model hence produces an estimate of disease prevalence as η is the proportion of individuals 
in the population of which our sample is expected to be in infection class Y=1.  It also provides 
direct estimates of sensitivity and specificity for all the diagnostic tests (Formann & Kohlmann, 
1996).  
 
A natural way to extend the LC model (1) is to include stratification or grouping variables and 
examine group differences of measurement invariance.  In this study such group differences were 
examined for males/females, different village locations and age groups.  Likelihood ratio tests 
between less and more restrictive models were used to examine differences in infection prevalence 
and measurement invariance between groups.  A significant measurement invariance tests suggests 
that specificities and sensitivities of the diagnostic tests vary by group and should be estimated for 
each group. Such an approach is referred to in the literature as multigroup latent class analysis 
(LCA) and comparisons of this sort are useful for at least two purposes: (a) to test whether the 
distribution of the latent variable is the same in each group and (b) to test whether the manifest 
observed variables are equally reliable indicators of the latent variable in each group (Clogg & 
Goodman, 1984).  
 
Expectation-maximization (EM) algorithm was applied to produce maximum likelihood estimates 
for all parameters in the model using PROC LCA in SAS Version 9.1 (SAS Institute, Cary, NC, 
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USA). Identifiability of maximum likelihood parameter estimates was checked by using several 
different seed values.   
6.3 Results 
 
Table 6.2 represents the observed positive results expressed as percentages of S. haematobium 
infection for the five diagnostic tests.  Different diagnostic tests gave different proportions of 
positive results.  
 
Table 6.2 Positive results expressed as percentages by each of the five diagnostic tests among 220 
Ghanaian adults studied 
Diagnostic tests Positive results expressed as % with (95% CI)* 
Urine-antigen detection  68.6 (62.5-74.8) 
Serology anti-IgG 44.1 (37.5 50.7) 
Ultrasound 31.8 (25.7-38.0) 
Haematuria 21.8 (16.4-27.3) 
Microscopy 15.5 (10.7 -20.2) 
* CIs are based on normal approximation methods 
 
Table 6.3 presents the results of one latent class model as it was dictated by likelihood ratio tests.  
Specifically, this model and denoted in table as ‘LC Model 1’ is a latent class model where 
measurement invariance was found to hold among males and females.  Because of the measurement 
invariance found here, we obtain a common set of specificities and sensitivities for both males and 
females.  The best diagnostic test for the detection of the prevalence of S. haematobium infection 
among the five diagnostic tests examined here was microscopy with a specificity estimated as 98% 
and a sensitivity estimated as 93%. In addition, ‘LC Model 1’ yielded quite high specificities and 
sensitivities also for haematuria and ultrasound.  From this same model estimates of prevalence of S. 
haematobium infection by sex were also obtained.  It is estimated that the prevalence of S. 
haematobium infection was highest among males (21%) compared to females (10%). 
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Table 6.3 Accuracy of diagnostic tests performance as estimated from latent class model 1 when 
measurement invariance was imposed across males and females 
LC 
Model 
1 
 Diagnostic tests 
 S.  
haematobium 
prevalence  
(%) 
Urine-antigen 
detection 
Specificity/Sensitivity 
(%) 
Serology anti-IgG 
Specificity/Sensitivity 
(%) 
Ultrasound 
Specificity/Sensitivity 
(%) 
Haematuria 
Specificity/Sensitivity 
(%) 
Microscopy 
Specificity/Sensitivity 
(%) 
Sex        
Male   21 
Female 10 
36/98 57/48 74/65 87/73 98/93 
 
 
‘LC Model 2’ in Table 6.4 is a latent class analysis model where measurement invariance was found 
to hold among different village locations and this is again the reason why it is obtained only a set of 
specificities and sensitivities for this group of sampled subjects. Results of this model agree with 
results of LC Model 1 in Table 6.3. The best diagnostic test for the detection of the prevalence of S. 
haematobium infection was again microscopy with specificity estimated as 95 % and sensitivity as 
100%.  In addition, ‘LC Model 2’ yielded quite high specificities and sensitivities also for 
haematuria and ultrasound.  Furthermore, ‘LC Model 2’ also indicated Chento village as the one 
with the highest prevalence of S. haematobium infection (39%) among the three examined villages 
here. 
 
Table 6.4 Accuracy of diagnostic tests performance as estimated from latent class model 2 when 
measurement invariance was imposed across different village locations 
 
 
LC 
Model 
2 
 Diagnostic tests 
 S.  
haematobium 
prevalence (%) 
Urine antigen 
detection 
Specificity/Sensitivity 
(%) 
Serology anti-IgG 
Specificity/Sensitivity 
(%) 
Ultrasound 
Specificity/Sensitivity 
(%) 
Haematuria 
Specificity/Sensitivity 
(%) 
Microscopy 
Specificity/Sensitivity 
(%) 
Village 
location  
      
Ayiki 
Doblo 
7 
Chento 39 
Ntoaso 2 
 
35/100 
 
 
56/47 
 
73/70 
 
86/91 
 
95/100 
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Finally, ‘LC Model 3’ in Table 6.5 is a latent class model where measurement non-invariance 
was found for different age groups and this is the reason why different specificities and 
sensitivities were calculated for each of these groups.  Using this model, diagnostic tests which 
could be characterized as acceptable for the detection of the prevalence of S. haematobium 
infection were those of ultrasound, haematuria and microscopy in the age groups of 19 to 29 
and 40 to 49 years old; haematuria and microscopy were indicated as good diagnostic tests in 
the age group of 30 to 39 years as they both gave quite high specificities and sensitivities at the 
same time.  Finally, in the age group of >60 years old the estimates of specificity and 
sensitivity were sufficiently high (94% and 100% respectively) only for haematuria, whilst for 
the age group of 50 to 59 years old, when taking into consideration both estimates of 
specificity and sensitivity, none of the diagnostic tests examined here was indicated as 
appropriate.  From this same model estimates of prevalence of S. haematobium infection by 
age group were also obtained.  ‘LC model 3’ shows that the highest prevalence of active, i.e. 
by egg passage S. haematobium infection was determined among the youngest age group of the 
sampled individuals of this study (30%).  
 
Table 6.5 Accuracy of diagnostic tests performance as estimated from latent class model 3 when 
measurement invariance was not imposed across different age groups 
                                                     
LC 
Model 
3 
 Diagnostic tests 
 S.  
haematobium 
prevalence (%) 
Urine antigen 
detection 
Specificity/Sensitivity 
(%) 
Serology anti-IgG 
Specificity/Sensitivity 
(%) 
Ultrasound 
Specificity/Sensitivity 
(%) 
Haematuria 
Specificity/Sensitivity 
(%) 
Microscopy 
Specificity/Sensitivity 
(%) 
Age 
group 
(in 
years)  
      
19 to 29  30 36/100 43/82 89/74 88/84 93/82 
30 to 39  9 31/81 50/0 77/41 86/100 94/99 
40 to 49  14 31/100 58/13 73/75 88/75 100/100 
50 to 59  20 61/100 78/20 72/53 100/45 100/45 
>=60  11 39/100 60/71 46/0 93/100 100/0 
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6.4 Discussion 
 
Current estimates of the prevalence of schistosomiasis depend on the use of well-established, but 
imperfect, diagnostic tests (Wilson et al., 2006). Appropriate schistosomiasis diagnosis becomes 
increasingly important for several reasons. For example, clinical diagnosis might lose its value 
because of lack of specificity and mass treatment might only remain cost-effective through the use of 
appropriate diagnostic tools to only target further drug treatment to those groups of people actually 
infected (van Lieshout et al., 2000).  The purpose of the epidemiological survey reported here was to 
assess the performance of five diagnostic tests for S. haematobium infection and examine if the 
prevalence of this infection varied across different age and sex groups of sampled individuals from 
three villages northwest of Accra in Ghana where there has been reported previously medium S. 
haematobium prevalence (Bosompem et al., 2004). I have addressed this specific problem by taking 
into account the absence of a gold standard diagnostic test for S. haematobium infection and by 
fitting LC models with a frequentist approach to these data obtained from adults northwest of Accra 
in Ghana.  Although LC models have been used extensively in epidemiological literature of several 
infectious diseases (Alvord et al., 1988; Engels et al., 2000; Langhi et al., 2002; Kudel et al., 2006; 
Strauss et al., 2006; Hebert et al., 2007), they have rarely been used in parasite epidemiology and 
particularly in the area of schistosomiasis.  More precisely, to my knowledge, only two previously 
published studies, both based within Côte d’Ivoire, have used LC models through a Bayesian 
approach in order to assess performance of the Kato-Katz technique in diagnosing S. mansoni and 
hookworm co-infections as well as to estimate reduction of prevalence and intensity for hookworm 
infection in humans post-praziquantel treatment (Utzinger et al., 2002; Booth et al., 2003), while 
only one study in the Philippines has provided estimates of sensitivity and specificity of a faecal 
examination method for Schistosoma japonicum infection in mammals, using also a LC modeling 
approach within a Bayesian framework (Carabin et al., 2005).   
 
The current study therefore provides the first, to my knowledge, evaluation of the performance of 
multiple diagnostic criteria and estimation of the prevalence of S. haematobium infection in Africa 
which raises important implications to consider with reference to reliable tests for the diagnosis of 
urinary schistosomiasis.  Such findings should be also of direct relevance and application to current 
mass chemotherapeutic control programmes. Nevertheless, as the current dataset focuses on adults, I 
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would recommend additional similar studies aimed to assess the application of such LC models on 
data from school-aged children across varying schistosomiasis endemic countries within sub-
Saharan Africa since school children form the major target age group of current mass 
chemotherapeutic control in human helminthiasis (WHO, 2006).   
In this Chapter it was clearly demonstrated that in adults the microscopic detection of the parasite's 
eggs in the urine is the best currently available diagnostic tool for S. haematobium infection 
whenever this is of course performed properly (results in Tables 6.3, 6.4 and 6.5 support this 
argument) with the exception for the age group of >50 years old where very low specificities were 
estimated (Table 6.5). Standard errors of the estimates were larger for the older age groups compared 
to the young age groups due to the smaller sample sizes here (Table 6.1) and therefore such results 
should be interpreted cautiously. Based on these findings, I would thus recommend the inclusion of 
microscopic examination in the monitoring process of human mass chemotherapy programmes 
whenever financial resources allow for this option, mainly because of its relatively low operational 
cost compared to other urinary schistosomiasis diagnostic techniques and its feasibility under most 
conditions. Furthermore, as microscopic examination can quantify the intensity of the S. 
haematobium infection, it enables evaluation of important indicators in the control planning, such as 
possible risk factors, presence of severe clinical forms, degree of transmission and reinfection in the 
area, as well as intervals for necessary re-treatments.  
In addition, this study confirms that haematuria dipsticks can be sufficiently sensitive and specific 
indicators (results in Tables 6.3, 6.4 and 6.5 support this argument with the exception of results in 
Table 6.5 where for the age group of 50 to 59 years old haematuria dipsticks yielded a very low 
sensitivity (45%)) for detection of S. haematobium infection in endemic areas, and therefore I would 
also recommend their inclusion in the monitoring process of human mass chemotherapy 
programmes.  Indeed, in Chapters 4 and 5 of this PhD Thesis I have also found that semiquantitative 
reading of dipsticks correlates well with intensity of S. haematobium infection and ultrasound 
pathology.  
On the other hand, whilst the urine antigen detection test showed similar sensitivity to microscopy 
(results in Tables 6.3, 6.4 and 6.5 support this argument), it was also suggested that false-positive 
urine antigen detection tests may be more common than previously reported (Bosompem et al., 
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1998).  One potential explanation for the low specificity of this test might be that potentially cross-
reactive parasites are more prevalent in the age group studied here and polyparasitism is of course 
common in these areas. Indeed, Dunyo and colleagues (1996) found filarial infections in the towns 
or in the villages east of Accra in a similar age group and I would thus recommend further studies to 
define both the prevalence of such parasites in this same endemic area and examine any potential 
cross-reactivity between helminth species within the urine antigen detection test.  Results from the 
current study suggest that the urine-antigen detection tests I evaluated should perhaps not be used for 
the identification of high-risk groups which, due to the possibility of false positive reactions 
produced by such tests, could artificially inflate the actual numbers of people targeted for mass 
chemotherapy.  Furthermore, estimates from all LC models presented here yielded low sensitivities 
and specificities for the serology anti-IgG tests. The observation here that antibody detection lacks 
specificity is consistent with findings of other epidemiological studies which reported that antibody 
is often found without concomitant parasitological evidence of infection (Doenhoff et al., 1993; Xue 
et al., 1993). 
Furthermore, antigen detection methods are generally more expensive than antibody ones (Hamilton 
et al., 1998).  On the other hand, microscopy and haematuria dipsticks require relatively 
unsophisticated equipment and, in areas of high endemicity, personnel with only basic training.  
These two latter diagnostic tests could therefore constitute the lowest cost option when technical 
assistance is plentiful.  Thus the current findings, if combined with consideration of costs involved, 
which is a critical issue in the economically developing countries, leads me to the conclusion that 
antibody and antigen detection tests should not be used in the determination of the prevalence of 
long term urinary schistosomiasis infections. 
 
With reference to the detection of urinary schistosomiasis infection through ultrasound examination, 
the results of this study indicated that the performance of this diagnostic tool was quite acceptable in 
all age groups except in those of 30 to 39 years old and >50 years old.  An explanation for the 
variability in these results among different age groups might be that successive episodes of infection 
would result in recrudescence of urinary tract abnormalities and more severe pathology caused by 
urinary schistosomiasis would be expected to be observed in young adults because of continuing 
reinfection.  Thus, I would conclude that ultrasound examination is not a reasonable substitute for 
microscopy or dipsticks in regards to determining the prevalence of S. haematobium infection. 
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Nevertheless, I would still support the argument that the best currently available diagnostic tool for 
morbidity assessment in S. haematobium infections is the visualization of urinary tract pathology 
through ultrasound examination (Koukounari et al., 2006)  
 
Finally, with statistical analysis alone, one can never be certain about the validity of a dependence 
model as it is not known from the observed data how each of the examined diagnostic tests relates to 
the others conditional on disease status (Albert & Dodd, 2004).  Consequently, I certainly recognize 
that the results of this study depend upon the assumption of conditional independence assumed by 
the models fitted here. In addition, LC models based on current assumptions may not be appropriate 
for some similar alternative datasets as very large correlations (if these are present after accounting 
for latent class membership i.e. the true infection status) could potentially bias parameter estimates 
and result in an underestimation of the error rates of the examined tests (Vacek, 1985). Finally the 
SAS procedure for latent class analysis ‘PROC LCA’ applied here which has been recently 
developed by The Methodology Center at Penn State, does not yet supply standard errors for the 
parameter estimates; thus a limitation in this study is that the magnitude of the standard error and 
consequently of the confidence interval of the acquired predictions is not provided.  
 
To conclude, in this Chapter I assessed the prevalence of S. haematobium infection through the use 
of LC models, because accurate sensitive and specific measures for this indicator are imperative, 
particularly at later stages of successful mass chemotherapy control programmes.  I demonstrate that 
LC models proved a useful tool for validation research in the absence of a perfect gold-standard 
diagnostic technique. These models have suggested microscopy and haematuria dipsticks as 
sensitive and specific indicators of prevalence of S. haematobium infection in Ghanaian adults.  In 
addition, they have provided estimated prevalences of S. haematobium infection that fit well with 
those previously obtained by those such as Nsowah-Nuamah and colleagues (2001) in Southern 
Ghana, and Amankwa  and colleagues (1994) in upper-east region of Ghana as well as the focality of 
this infection even within small areas of the same country.  However, it must be also considered that 
in the general context of chemotherapy programmes, if monitoring and evaluation results are based 
exclusively on determining infection prevalence, the impact data obtained may be inaccurate in 
terms of validity reflecting the success of any programme.  Therefore, it is fundamental to also 
monitor the impact of such control programmes on the intensity of the infection in the treated 
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population, particularly as modern day chemotherapy programmes are aimed at reducing morbidity 
and hence intensity and further research in this area is thereby warranted.  
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Chapter 7: General discussion 
 
 
In this Chapter I discuss the motives behind this thesis, drawing together the various findings and 
emphasizing how these relate to one another.  Finally, based on the findings of this thesis I also 
attempt to identify implications for both future schistosomiasis research and control.  
Over the past 50 years, the challenge of schistosomiasis control has persisted as a complex dilemma 
for health policy makers (Gryseels, 1989), while past studies on the effects of chemotherapy on 
morbidity induced by schistosomiasis have produced somewhat controversial results leaving 
fragmentary knowledge on the impact of chemotherapy against schistosomiasis (Richter, 2003).  
Despite the long and rich history of research in the field of schistosomiasis with major scientific 
accomplishments, the majority of past studies have often been statistically underpowered to examine 
each parasite’s particular role in the causation of morbidities (King et al., 2005), resulting in 
schistosomiasis to be underappreciated as a serious health problem (Ouma et al., 2001).  However, 
in recent years international interest and political commitment for control of helminthic diseases in 
sub-Saharan Africa has grown substantially with schistosomiasis on the international health agenda 
(Utzinger et al., 2003; Stothard & Gabrielli, 2007) and major shifts in global health policy towards 
the implementation of mass chemotherapeutic control programmes at the national scale in sub-
Saharan Africa (Fenwick & Webster, 2006).  Evaluation of such mass human chemotherapy 
programmes was clearly an area that deserved more careful investigation at the time this PhD thesis 
started as it could serve the need of each national schistosomiasis control programme to define 
national policy and to prioritize areas where intervention is most needed and producing the greatest 
benefit.  
The fact that there is a lack of large-scale studies and the need for proper evaluation of mass human 
chemotherapy programmes,inspired the studies presented in Chapters 2, 3, 4 and 5 of this thesis, 
using appropriate biostatistical methods for the analysis of large cohorts sampled as part of these 
newly established national schistosomiasis control programmes in various geographical endemic 
African settings, examined where possible the independent and interactive effects of schistosomiasis 
with other parasitic diseases on different health outcomes. The aim of these studies was to elaborate 
more clearly the significant morbidity caused by schistosomiasis (Chapters 2, 3, 4 and 5) and to 
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refine the understanding of the specific benefits of mass treatment in various schistosomiasis-
endemic settings (Chapters 2 and 4).  King and Dangerfield-Cha (2008) have recently stressed the 
necessity for such studies, as most people living in the developing world are vulnerable to a great 
variety of chronic diseases throughout the course of their lives.  I also believe that the findings 
presented in these chapters have made significant contributions to the current state of knowledge 
because of the limited large scale community screening of morbidity and rare geographic 
comparisons (Balen et al., 2006). 
 
More precisely, in Chapters 2 and 4, I used uniquely detailed data arising from the Ugandan and 
Burkinabé National Schistosomiasis Control Programmes, before and one year following 
praziquantel and albendazole chemotherapy, with the aim to evaluate the potential relationship 
between S. mansoni or S. haematobium infections, anti-helminthic chemotherapy, and anaemia as 
well as to assess the extent to which schistosomiasis might be a cause of anaemia.  Within different 
schistosome species, it is possible that different biological interactions exist by age and gender while 
complexities in the ecological context and varying clinical presentations make quantifying the 
magnitude of the relationship between schistosomiasis and anaemia challenging (Friedman et al., 
2005).  Both these SCI datasets are on school-aged children (6 to 14 years old) and cover areas of 
different endemicity for S. mansoni, S. haematobium and other soil transmitted helminths; in Uganda 
S. haematobium is known not to be endemic in the areas where the surveys took place (Stothard et 
al., 2006; Kolaczinski et al., 2007), while in Burkina Faso, prevalence of S. mansoni, hookworms 
and other soil-transmitted helminthiasis was estimated to be very low.  Despite the different burden 
of parasitic diseases and schistosome species in the two countries, in both these studies heavy 
infections of intestinal or urinary schistosomiasis were demonstrated to be associated with lower Hb 
counts and consequently with potential anaemia.  It was also shown that children most benefiting 
from anthelminthic treatment in terms of increased Hb counts were those who were anaemic at 
baseline.  Therefore, both these studies imply that anaemia is a likely morbidity indicator of 
schistosomiasis and it can be reduced following chemotherapy. 
 
Additional data from older school-aged children (10-21 years old) with S. mansoni infections were 
analyzed through Bayesian hierarchical modeling from Western Kenya with the aim to examine 
further the issue of lowered Hb levels and potentially anaemia risk identified in Chapter 3.  The 
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surveyed location in western Kenya is another well known endemic schistosomiasis area (Brooker et 
al., 2000; Thiong'o et al., 2001) and different from those surveyed areas in Uganda in the sense that 
in this specific dataset there were also observed medium prevalences of T. trichiura and A. 
lumbricoides infections as well as a high prevalence of hookworm infection.  It should be noted that 
all of these aforementioned parasitic infections have the potential to cause iron deficiency by extra-
corporeal blood loss.  In addition, this Kenyan specific dataset is a richer one if compared to those 
from Uganda and Burkina Faso in the sense that it contained malaria measurements and socio-
economic status-both potential important risk factors of anaemia- and which could add important 
information into the statistical analyses.  Results from this Chapter also suggest that heavy intensity 
of S. mansoni infection, being stunted and malaria parasitaemia were significantly associated with 
lower mean Hb although only heavy intensity of S. mansoni infection was significantly associated 
with the risk of anaemia among schoolchildren over 10 years of age.  The fact that hookworm 
infection was not associated either with lower Hb or with anemia in the present study is in contrast 
with the findings of Chapter 2 where I found statistically significant associations of moderate and 
heavy intensities of hookworm infections with the examined health outcomes of interest here.  This 
is probably due in part to the low intensity of hookworm infection in this Kenyan study area, and 
highlights how different factors contribute to anaemia in different parasite transmission settings.  
 
I believe that all the above findings provide strong evidence that anaemia represents a significant 
part of chronic disease burden associated with schistosomiasis.  The mechanisms by which 
schistosome infections lead to anemia have been discussed in Chapters 2, 3 and 4, while a very 
analytical description of the pathophysiology that underlies each mechanism is provided by 
Friedman et al. (2005) and hence I will not discuss this issue further here.  Based on the current 
findings, I conclude that anaemia should continue being used as a measurable target in programmes 
to reduce morbidity due to schistosomiasis and helminthiasis as it reflects the aim of the programmes 
to reduce disease morbidity rather than transmission indicators (Bates et al., 2007).  
 
In Chapter 4, analyses were expanded to examine also associations of urinary schistosomiasis with 
undernutrition and pathologic effects on the human organism such as microhematuria pre- and post- 
treatment.  Children with more severe microhaematuria scores at baseline were demonstrated to have 
higher S. haematobium infection intensities which suggests that positive microhaematuria scores are 
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likely to be valuable markers in children for morbidity caused by S. haematobium infections.  It 
should also be noted that such morbidity was significantly decreased one year post chemotherapeutic 
treatment.  On the other hand, neither the associations between the risk of wasting or stunting at 
baseline with the intensity of S. haematobium infection were found, nor the percentages of wasted 
and stunted children one year post treatment were significantly decreased.  Nevertheless, as the study 
design included neither a random allocation nor a placebo group it is very difficult to demonstrate 
cause and effect of urinary schistosomiasis on malnutrition and generalize further these results.  This 
is clearly an area that needs and deserves more careful investigation and thus it would be interesting 
to apply and expand the biostatistical analyses presented in this thesis in other endemic countries and 
SCI datasets such as those from Tanzania and Zambia. 
From a disease-impact perspective, both Chapters 2 and 4 also served to confirm that praziquantel 
can have a substantial effect on schistosomiasis infection and associated morbidity when delivered 
as part of a large-scale control programmes.  In Burkina Faso there was observed a decrease of 
approximately 90% in the schistosomiasis prevalence at 1st follow-up compared to baseline, while in 
Uganda this was observed to be approximately 50%. One of the factors likely to have contributed to 
the great impact demonstrated in Burkina Faso is the high nationwide treatment coverage (over 90%) 
achieved in a relatively short space of time by the control programme. Another factor is that 2004 
was a very dry year and treatment was delivered in the dry season. These two important factors 
together may have helped to reduce the prevalence and, therefore, should be considered when 
implementing a national control programme in other sub-Saharan countries to maximize the 
treatment impact. It must be considered, nevertheless, as briefly mentioned above, that essential 
methodological constraints inherent in both these present study designs, in particular that of the 
necessary, due to ethical reasons, lack of the inclusion of an untreated control group, could result in 
some potential bias to the estimation of the absolute impact of the treatment, thereby allowing only 
the relative impact of the treatment in different groups of children to be calculated.  
From a research standpoint, two recent articles stress the necessity for better diagnostics in the field 
of schistosomiasis (Colley & Secor, 2007; King & Dangerfield-Cha, 2008).  In Chapters 5 and 6 I 
have attempted to validate and evaluate field applicable diagnostic tools of schistosomiasis infection. 
More precisely, in Chapter 5 I initially tested the suitability of the full WHO-recommended 
ultrasound protocol in the context of large-scale schistosomiasis control programmes using 
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hierarchical modeling with a frequentist approach for the statistical analysis of SCI baseline data on 
school-aged children (7 to 14 years old) from Mali. Findings from this chapter suggested that 
ultrasound is a suitable and valid public health tool for urinary schistosomiasis morbidity control 
programs focused on children while in the case of intestinal schistosomiasis morbidity detection in 
large scale control interventions, this same protocol is a useful tool provided that local cut-offs are 
used to define abnormal values and that results are interpreted with cautiousness.   
 
As mentioned in several sections of Chapters 2, 3, 4 and 5 I explored and took hierarchical modeling 
approaches for the analysis of all these datasets because the children were clustered within schools 
and schools were clustered within districts.  In addition, in Chapters 2 and 4 there were repeated 
measurements for each child.  Ignoring this correlation structure would have resulted in 
underestimation of variability and thus to narrower associated confidence intervals of the relevant 
regression coefficients.  The fact that I have used similar statistical modeling for the analysis of these 
data could facilitate later meta-analysis of these studies. Recent advances in hierarchical models 
have, I believe, been invaluable to the scientific field of parasite epidemiology. However, in contrast 
to the richness of this statistical methodology, I feel that these models have not yet been fully 
utilized in the analysis of schistosomiasis infection and therefore I hope that the studies presented 
here will contribute to initiate such applications for the statistical analysis of relevant data.  
 
Finally, in Chapter 6 I expanded on the theme of schistosomiasis diagnosis by comparing diagnostic 
measures of S. haematobium infection prevalence through the use of latent class (LC) models with a 
frequentist approach on data from Ghanaian adults (19-86 years old).  I used such models in order to 
estimate in the absence of a perfect gold-standard diagnostic technique, sensitivities and specificities 
for five diagnostic tests: microscopic examination of urine for detection of S. haematobium eggs, 
dipsticks for detection of haematuria, tests for circulating antigens, serology tests and ultrasound 
scans of the urinary system.  The dataset I used in Chapter 6 also has the potential to provide a good 
comparison reference to the results reported in Chapter 5 as in the northwest of Accra in Ghana it 
was estimated that the S. haematobium prevalence was low (15.5 %) among adults while in Mali the 
prevalence of S. haematobium infection was found to be high among children (59 %)-as both 
detected by microscopic examination.   
  122 
Results from LC models in Chapter 6 have suggested microscopy and haematuria dipsticks as 
sensitive and specific indicators of prevalence of S. haematobium infection in Ghanaian adults.  
These models also provided evidence that the urine-antigen detection test I examined in Chapter 6 
should perhaps not be used for the identification of high risk groups which would be probably 
unnecessarily included for treatment in human mass chemotherapy programs as they were found to 
be non-specific. Furthermore, estimates from all models presented in this Chapter yielded low 
sensitivities and specificities for the serology anti-IgG tests. These findings, if combined with cost-
analyses, the latter being a key influential factor with respect to public health in economically 
developing countries such as those examined in this PhD thesis, leads me to the conclusion that 
currently available antibody and antigen detection tests should not be used in the determination of 
the prevalence of latest stages of urinary schistosomiasis infection.  In order to make 
recommendations about their inclusion in the monitoring and evaluation process of schistosomiasis 
control, I suggest that similar studies should be repeated on children using the combination of such 
diagnostic tests together with latent class analysis. 
 
As regards to ultrasonographic examination, based on the findings of Chapters 5 and 6, I believe that 
ultrasound global scores are likely to be valuable markers in children for morbidity caused by both 
light and heavy infections with S. haematobium but that it is not a reasonable substitute for 
microscopy or dipsticks in regards to determining the prevalence of this infection.  Furthermore, 
based on findings from Chapter 6 where I found a very poor performance of ultrasound in older age 
groups and which might be explained by decreased rates of reinfection in older adults, this 
diagnostic tool might not be the most appropriate one to detect late stage morbidity caused by 
urinary schistosomiasis. I would agree with observations from colleagues in Venezuela that the 
specificity of the method must be improved, especially for the recognition of precocious pathology 
(Ruiz et al., 2002). 
 
In addition, it must be also considered that in the general context of chemotherapy-based 
programmes, if based exclusively in determining the prevalence, the evaluation of the results 
reached with the control measurements introduced in an endemic region may be inaccurate and thus 
future work emerging from Chapter’s 6 findings is compulsory.  It is fundamental to also observe the 
impacts of treatment on the intensity of the infection in the treated population particularly as modern 
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day chemotherapy programs are aimed at reducing morbidity and hence intensity. I believe that use 
of latent trait models (Uebersax & Grove, 1993; Agresti, 1999), which regard intensity and not only 
prevalence of infection as a latent variable pre and post treatment, constitutes a very interesting field 
in the research of schistosomiasis’ diagnostics because particularly in communities where 
schistosomiasis transmission levels are decreasing, appropriate diagnosis becomes increasingly 
important for the mass treatment to remain cost effective (van Lieshout et al., 2000).  
 
In conclusion, results from this PhD thesis established several schistosomiasis morbidity indicators 
while it was validated that mass human chemotherapeutic control for schistosomiasis in sub-Saharan 
African countries has significant impact at reducing the intensity of schistosomiasis and associated 
morbidity.  As King and Dangerfield-Cha (2008) recently propose such drug-based anti-schistosome 
control programmes will need to continue for long intervals, i.e. time-spans of more than a single 
generation, in order to eliminate the true burden of schistosomiasis in endemic countries.  
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Abstract. The potential relationship between Schistosoma mansoni and anemia was examined using data obtained
by the Schistosomiasis Control Initiative (SCI) before (baseline) and 1 year after (follow-up) a chemotherapeutic
treatment program in Uganda. Changes in hemoglobin (Hb) levels in 2,788 children in relation to their schistosomiasis
and/or hookworm infection intensity category and baseline anemia status were analyzed. At baseline, significant pre-
dictors of childhood anemia were intensities of S. mansoni and hookworm infection. At follow-up, moderate or heavy
hookworm as well as heavy S. mansoni infections were important. Children heavily infected with S. mansoni or hook-
worm had significantly lower Hb counts at baseline compared with those not infected. Among anemic children at the
baseline survey, a significant increase in Hb counts of 0.834 g/dL after treatment was found. Our results suggest that
anemia is associated with schistosomiasis and hookworm in Ugandan children and that such anemia shows a significant
improvement after chemotherapy.
INTRODUCTION
Anemia is a common problem throughout the world and of
enormous public health concern in developing countries, but
its etiology is very complex, making the effect of any one
factor difficult to assess. Malaria plays a key causative role for
anemia among young African children, although HIV infec-
tion, hemoglobinopathies, intestinal helminths, in particular
that of hookworm infection, poor nutritional status, and mi-
cronutrient deficiencies are also likely to make important ad-
ditional contributions.1 Schistosomiasis is a parasitic disease
of profound medical and veterinary importance, second only
to malaria in terms of parasite-induced human morbidity and
mortality, with some 600 million people exposed and 200 mil-
lion infected at any time throughout the tropical world.2 The
relative role of schistosomiasis as a causative agent for ane-
mia, however, particularly compared with that known for
hookworm infection, remains controversial.3–7 Preston and
Dargie,8 for instance, provided convincing evidence that
schistosomiasis causes anemia in experimental animals; how-
ever, although Foy and Nelson9 did acknowledge that anemia
was generally associated with heavy schistosome infections,
they doubted that early or light infections were of importance.
There is, nevertheless, a general consensus for the need for
further epidemiologic research into the potential role of schis-
tosomiasis as a causative agent for anemia.9,10
Since 2003, the Schistosomiasis Control Initiative (SCI) has
assisted six sub-Saharan African countries with the objective
to develop sustainable national schistosomiasis morbidity
control programs and reach at least 75% of school-aged chil-
dren and other high-risk group through mass deworming us-
ing praziquantel for schistosomiasis and albendazole for in-
testinal helminths. Such control programs thereby provide a
unique opportunity to assess the potential role of schistoso-
miasis and/or other intestinal helminths as causative agents of
anemia morbidity, together with the potential ameliorative
impact of chemotherapy on a large scale. This may be par-
ticularly pertinent in terms of identifying and evaluating mor-
bidity associated with S. mansoni (intestinal schistosomiasis),
which is frequently very difficult to assess and quantify pre-
cisely except in the most severe or late chronic cases.11–14
Moreover, because demonstration of successful morbidity
control is feasible only if there are reliable morbidity markers
capable of showing reversion within the time frame of disease
surveillance, it is vital to identify S. mansoni morbidity indi-
cators for sustainable disease control and for evaluating the
success of intervention.15,16
Using uniquely detailed data arising from the Ugandan Na-
tional Schistosomiasis Control Program, before and 1 year
after praziquantel and albendazole chemotherapy, we aimed
to evaluate the potential relationship between S. mansoni in-
fection, anti-helminthic chemotherapy, and anemia and to as-
sess the extent to which schistosomiasis is a cause of anemia.
MATERIALS AND METHODS
Study sites, sampling, and cohort design. Parasitological
and morbidity data were collected on a cohort of 4,351 Ugan-
dan children, 6–14 years old, randomly sampled from 37
schools situated in eight districts just before and one year
after implementation (2003 and 2004, respectively), as part of
ongoing monitoring and evaluations of the SCI program in
Uganda. The eight districts were selected to represent the
Albert Nile (Nebbi, Arua, and Moyo), Lake Victoria (Bugiri,
Busia, and Mayuge) and Lake Albert basins (Masindi and
Hoima). Further details on these districts and their inhabi-
tants are provided elsewhere.17,18 Schools were chosen on the
basis of existing S. mansoni data for schoolchildren from
Uganda (SCI-National Survey of Bilharziasis) and parasito-
logical stratification with different categories of infection
prevalence, classified as low (< 10%), medium (11–50%), and
high prevalence (> 50%) within each district, which also al-
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lowed pooling to reach sample sizes technically detailed in
Brooker and others.19 Fixed cohort structure was recruited at
each school to allow comparisons to be made across schools
and districts. Required sample sizes were calculated using the
EpiSchisto software tool (http://www.schoolsandhealth.org/
epidynamics.htm) using an expected reduction in mean inten-
sity of 60% (S. mansoni) after chemotherapy to achieve 80%
statistical power and a significance level of 5%. The value of
60% was chosen as a conservative estimate of the expected
reduction over a 2-year period (two annual treatments). An
overall drop-out rate of 40% over the course of the monitor-
ing period was also allowed.
As it was not logistically possible to survey all schools
within the same month, surveys were staggered. Children
were identified at follow-up using a named roll call as well as
retrieval of SCI individual treatment cards with unique code
identifier given to the children the previous year as well as
hardcopy of a group cohort photograph to ensure that chil-
dren remember to which group they were reassigned. Before
the 1-year follow-up visit a pre-survey team re-registered the
children and also sensitized the children to ensure that as
many children as possible in the cohorts were at school the
day of survey. All children enrolled into this study were in-
terviewed and examined by appropriately trained Ministry of
Health field workers. Administration of praziquantel and al-
bendazole was according to WHO guidelines (praziquantel 40
mg/kg and single 400 mg albendazole tablet). Ethical clear-
ance was obtained from the Ugandan National Council of
Science and Technology and Imperial College London. For
ethical reasons, it was not appropriate to include any un-
treated control groups in the study design.
Parasitological and anemia morbidity data. A single stool
sample was collected from each individual and 41.7 mg was
processed to make duplicate Kato-Katz slides for microscopic
determination of schistosome and/or hookworm infection
and, where applicable, egg per gram counts. For comparative
reasons between the two successive years of study, where the
second measurement of the Kato-Katz smear was missing, S
mansoni prevalence and individual intensities were calculated
using a single thick Kato-Katz smear, although we are aware
that we miss a certain proportion of infections for assessment
of individuals’ infection status, by this way. Anemia was de-
fined (according to WHO guidelines), as a dichotomous vari-
able taking the value 1 for children from 5 to 11 years old with
Hb < 11.5 g/dL and for children between 12 and 14 years old
with Hb < 12.0 g/dL. Further details for other indicators in-
cluded and methodology followed in the SCI questionnaires
are given elsewhere.19 All Kato-Katz smears were read within
1 hour of preparation so that hookworm eggs could be easily
seen.
S. haematobium is known not to be endemic in these areas
of Uganda.20 However, for absolute confirmation, urine from
all children sampled was also tested for micro-hematuria us-
ing hemastix dipsticks and all urine sampled from children
from the 11-year-old cohort was pooled for concentration of
schistosome eggs using a Pitchford and Visser funnel and no
S. haematobium egg was observed. We are therefore fully
confident that S. haematobium was absent within this cohort.
The prevalence of Trichuris trichura and Ascaris lumbricoides
is unevenly distributed in the country with prevalence great-
est in southwestern Uganda and such infections were also
examined from the feces of all children sampled.21
Nutritional assessment data (i.e., weight and height) and
blood samples for hemoglobin levels were obtained from each
individual by the finger prick method, because this provides a
sufficient sample for accurate Hb measurement using a
Hemocue photometer.22
Statistical analyses. Because of clustered data with a natu-
ral hierarchical structure, we chose to use linear hierarchical
models to model changes in Hb levels from baseline to follow-
up and hierarchical logistic regression models to model the
risk of being anemic. Additionally, because schistosomiasis
occurs focally, heterogeneity in the degree of endemicity
among schools has to be accounted for.23 In such circum-
stances, ordinary least squares regression can overestimate
the precision associated with an analysis yielding spuriously
statistically significant results (i.e., a type 1 error). Hierarchi-
cal models permit combination of exposures to group and
individual factors that is important in epidemiologic analyses
of infectious disease data.24,25
The hierarchical logistic regression models were fitted to
data coming from children with complete records at each
time-point of interest. Because of variable cohort recovery
success, attributable to frequent population movements
within Uganda, the remainder of the statistical analyses were
restricted to children with complete records from both time-
points of interest, and no replacements were used for missing
subjects. Summary reportings, figures, and analyses are based
on data from all available subjects. A comparison between
the baseline characteristics of children successfully followed-
up and those that dropped out in the second year of the study
was performed through 2 tests with regard to all the param-
eters examined in this study. Frequency tables were obtained
using SAS V8 (SAS Institute, Cary, NC). A forward selection
procedure was used for the evaluation of the remaining vari-
ables in the final models.
An association of anemia with parasitic infections (schisto-
some and hookworm) was studied after simultaneously ad-
justing for potential confounders in the statistical models
used. Indices of the anthropometric status of the studied chil-
dren based on the 1978 CDC/WHO growth reference curves
were computed using the Nutstat program within Epi Info V
3.3. Body mass index is considered an indicator of acute un-
der-nutrition (thinness or wasting) and is generally associated
with failure to gain weight or a loss of weight.26–28 The Z-
score cut-off point recommended by WHO, CDC, and others
to classify low anthropometric levels is 2 SD units below the
reference median for this specific index. Cut-off of −2 body
mass index Z-scores (BMIZ) were calculated to classify un-
derweight children and finally this categorical variable was
incorporated in all models as a potential predictor. Initially
we examined the impact of parasitic infections, sex, and nu-
tritional status as defined from Z-scores at baseline and fol-
low-up using two-level multivariate logistic regression models
with level 1 (the children) and level 2 (the schools). We also
tested three-level multivariate logistic regression models with
level 3 (the districts), but it was proved that the districts were
rather homogeneous in the risk of being anemic, and there-
fore this random effect was not finally included in the models.
Nutritional status was included in the baseline hierarchical
logistic regression model as generally malnutrition in children
is the consequence of a range of factors that are often related
to poor food quality, insufficient food intake, and severe and
repeated infectious diseases, or frequently some combina-
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tions of the three. The same variable (BMI Z-score at base-
line) was included in the hierarchical logistic regression model
referring to 1-year post-praziquantel and albendazole treat-
ment, because in this study, the duration of this period did not
produce a nutritional impact. Finally, in both hierarchical lo-
gistic regression models the BMI Z-score at baseline was not
significant, and therefore it was omitted from these models.
Age was included in both hierarchical logistic regression mod-
els (baseline and follow-up) as a categorical variable.
Two separate hierarchical linear modeling analyses were
carried out to determine any change in the children’s Hb
levels in relation to their schistosomiasis and/or hookworm
infection intensity category, controlling at the same time for
age and sex and anemia status (as defined above). Children’s
Hb levels at baseline and 1-year post-treatment were modeled
through three-level hierarchical models where level 1 (two
periods of interest), level 2 (the children), and level 3 (the
schools). The validity of the distributional assumptions of this
model was examined using plots of level 1, level 2, and level
3 residuals against their normal scores. To take into account
the paired data structure, a dummy variable corresponding to
the second year of study was included as a covariate in the
model. Through this model we aimed to quantify the adjusted
overall change of Hb from baseline to follow-up and to quan-
tify average Hb counts of different groups of children at base-
line.
Changes in Hb levels in relation to their baseline schisto-
somiasis and/or hookworm infection intensity category and
anemia status from baseline to 1-year follow-up were mod-
eled through two-level hierarchical models with level 1 (the
children) and level 2 (the schools). Through this approach we
aimed to compare the average change in Hb counts over the
two examined periods between different groups of children.
Baseline anemia status was also included in the explanatory
part of the model to be able to examine rises in Hb levels in
anemic and not anemic subjects as earlier recommended.10
We made an effort to control for the fact that by adjusting for
baseline anemia the effect of moderate or heavy infection for
S. mansoni or hookworm may be underestimated if the type
of anemia in the uninfected group is predominantly mild and
self-limiting. We therefore also tested the two-way interaction
terms of intensity of S. mansoni and of hookworm infections
with anemia status, and because none were significant, these
were omitted from the model. To test the statistical signifi-
cance of the fixed effects, Wald tests were used, whereas like-
lihood ratio tests were performed for the random effects. All
of the hierarchical models presented are random intercepts
models with multiple independent variables and were ob-
tained using Mlwin (Multilevel Models Project, Institute of
Education, London, UK).
RESULTS
Because of drop-outs during the second year of the study,
baseline and follow-up data concerning the Hb counts were
available from 2,788 children, 6–14 years old, from 36 of the
37 schools initially visited at baseline, over the period 2003
and 2004 inclusive. In school Tonya in the Hoima district, Hb
counts were measured neither at baseline nor at follow-up so
this specific school was not included in this analysis. Table 1
presents the health indicators of children surveyed during this
period. Over the 12 months between examinations, overall
prevalence significantly decreased for both S. mansoni and
hookworm infections as well as for anemia. For both years of
the study the prevalences of severe anemia were negligible
and therefore these cases were not examined further here.
Similarly, overall point prevalences, at both time-points, for
T. trichura and A. lumbricoides were very low. The arithmetic
mean intensities for all subjects (negatives and positives) for
S. mansoni and hookworm infections decreased significantly
1-year post-praziquantel and albendazole treatment. A sig-
nificant increase in hemoglobin concentration was also ob-
served during the study period.
Table 2 shows that there were significant differences be-
tween the children that were successfully followed up and the
drop-outs with reference to their age, sex, home district, and
schistosomiasis infection. Children of 6 and 11 years old or
above as well as children living in Arua and Mayuge proved
most difficult to recruit into the cohort in the second year of
the study. The largest recovery cohort failure was observed in
children heavily infected with S. mansoni at baseline.
The results of the hierarchical multivariate logistic regres-
sion model for the probability of a child being anemic at
baseline are presented in Table 3. This model included inten-
sities of S. mansoni and hookworm infections and the analysis
controlled for age and sex, allowing also for assessment of the
extent of between-school variation in anemia prevalence. At
follow-up, there were very few children who were heavily
infected with hookworm and therefore the convergence of the
TABLE 1
Health characteristics of children in 2003–2004 successfully followed up for 1 year
2003 2004
Parasitology (n  2,682)*
Percent infected with S. mansoni 43.91 (42.01–45.81)‡ 28.78 (27.06–30.52)
Percent infected with hookworm 52.13 (50.21–54.04) 24.04 (22.40–25.67)
Percent infected with T. trichura 2.34 (1.75–2.91) 2.29 (1.72–2.87)
Percent infected with A. lumbricoides 2.41 (1.82–3.00) 1.45 (1.00–1.91
Mean S. mansoni intensity (epg) 239.28 (215.82–262.73) 75.66 (64.58–86.74)
Mean hookworm intensity (epg) 307.19 (253.80–360.58) 79.36 (66.48–92.25)
Hematology (n  2,788)
Mean haemoglobin (g/dL) 11.43 (11.37–11.48) 11.67 (11.61–11.72)
Percent anemic 49.96 (48.11–51.82) 45.80 (43.95–47.65)
Percent severely anemic† 0.29 (0.09–0.49) 0.18 (0.02–0.34)
* Sample sizes are provided into parentheses for each examined outcome.
† Severe anemia: Hb < 7 g/dL.
‡ Values in parens are 95% CIs.
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fitting algorithm in some of the models led us to merge the
heavy and moderate hookworm intensities into one category.
Moreover, there were very few children that were 9 and 10
years old (only two children were 9 and none were 10 years
old) within the cohort with these ages who caused problems
to some of the models fits and again we decided to exclude
them from all analyses. This was performed in all models
presented in this study so that they can be comparable. Also
for a similar reason, we do not specifically examine co-
infections of schistosomiasis and hookworm, because overall,
TABLE 2
Comparison of children successfully followd-up and drop-outs
Variable Categories Drop-outs Followed up P**
Intensity of schistosomiasis infection Uninfected 786 (50.29%) 1512 (54.23%)†† 0.034
Lightly infected* 245 (1.67%) 426 (15.28%)
Moderately infected† 171 (10.94%) 314 (11.26%)
Heavily infected‡ 295 (18.87%) 440 (15.78%)
Missing 66 (4.22%) 96 (3.44%)
Intensity of hookworm infection Uninfected 736 (47.09%) 1289 (46.23%) 0.527
Lightly infected§ 724 (46.32%) 1330 (47.70%)
Moderately/heavily infected¶ 37 (2.37%) 72 (2.58%)
Missing 66 (4.22%) 97 (3.48%)
Age  11 years old 422 (27.00%) 707 (25.36%) < 0.001
8 years old 360 (23.03%) 739 (26.51%)
7 years old 352 (22.52%) 683 (24.50%)
6 years old 401 (25.66%) 654 (23.46%)
Missing 28 (1.79%) 5 (0.18%)
Sex Male 723 (46.26%) 1406 (50.43%) < 0.001
Female 702 (44.92%) 1380 (49.50%)
Missing 138 (8.83%) 2 (0.07%)
Anemia Not anemic 754 (48.24%) 1395 (50.04%) 0.260
Anemic 809 (51.76%) 1393 (49.96%)
Missing – –
District Nebbi 148 (9.47%) 414 (14.85%) < 0.001
Arua 74 (4.73%) 44 (1.58%)
Bugiri 218 (13.95%) 380 (13.63%)
Busia 188 (12.03%) 440 (15.78%)
Hoima 233 (14.91%) 322 (11.55%)
Masindi 212 (13.56%) 366 (13.13%)
Mayuge 261 (16.70%) 332 (11.91%)
Moyo 229 (14.65%) 490 (17.58%)
Missing – –
* Lightly infected with S. mansoni: 1–99 epg.
† Moderately infected with S. mansoni: 100–399 epg.
‡ Heavily infected with S. mansoni:  400 epg.
§ Lightly infected with hookworm: 1–1999 epg.
¶ Moderately/heavily infected with hookworm:  2000 epg.
** P value for 2 test.
†† Column percentages are given in the parentheses.
TABLE 3
Adjusted odds ratios from hierarchical multivariate logistic regression model for baseline prevalence of anemia (n 2,682)
Variable Categories Adjusted odds ratio (95% CI) P
Fixed effects
Intensity of schistosomiasis infection at baseline Uninfected 1
Lightly infected* 0.958 (0.753–1.219) 0.727
Moderately infected† 1.274 (0.962–1.686) 0.091
Heavily infected‡ 1.309 (0.993–1.725) 0.056
Intensity of hookworm infection at baseline Uninfected 1
Lightly infected§ 1.142 (0.965–1.352) 0.123
Moderately/heavily infected¶ 2.219 (1.312–3.752) 0.003
Age at baseline  11 years old 1
8 years old 1.464 (1.175–1.823) < 0.001
7 years old 1.824 (1.453–2.290) < 0.001
6 years old 2.212 (1.755–2.788) < 0.001
Sex Male 1
Female 0.908 (0.774–1.064) 0.230
Random effects 2 SE
School-level variance 0.291 0.083
* Lightly infected with S. mansoni at baseline: 1–99 epg.
† Moderately infected with S. mansoni at baseline: 100–399 epg.
‡ Heavily infected with S. mansoni at baseline:  400 epg.
§ Lightly infected with hookworm at baseline: 1–1999 epg.
¶ Moderately/heavily infected with hookworm: at baseline  2,000 epg.
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there were too few co-infected children in our cohort to sup-
port model fitting.
Table 3 shows that children moderately or heavily infected
with S. mansoni were marginally significantly more likely to
be anemic than those uninfected with S. mansoni. Children
moderately or heavily infected with hookworm were signifi-
cantly more likely to be anemic than those uninfected with
hookworm. The school-level variance at the bottom of the
same table shows that schools differed significantly in the
baseline prevalence of anemia observed. We also tested
whether the effects of the intensities of schistosomiasis and
hookworm infections varied by age, sex, or state of weight.
For this reason we incorporated the relevant two-way inter-
action terms in the model, and because none of these were
significant, these estimates are not presented here.
Results from the hierarchical logistic regression model for
the probability of a child being anemic at 1-year follow-up are
presented in Table 4. Children heavily infected with S. man-
soni at follow-up were significantly more likely than unin-
fected children to be anemic. Age, sex, and moderate or
heavy hookworm infections were also significant predictors.
Finally, schools varied in the prevalence of anemia observed
at follow-up.
Table 5 contains the estimates of the three-level hierarchi-
cal model for Hb counts before and after praziquantel and
albendazole treatment. Normal plots of the different levels
residuals appeared fairly linear, which suggested that the as-
sumption of normality and the selection of a linear hierarchi-
cal model were reasonable. An overall increase of 0.061 g/dL
in the Hb level after chemotherapeutic treatment was not
significant (P  0.115). Children heavily infected with S.
mansoni had significantly lower Hb counts (0.322 g/dL; P <
0.001) compared with uninfected children at baseline. Chil-
dren with moderate or heavy hookworm infection at baseline
had significantly lower Hb counts (0.595 g/dL; P < 0.001) than
those not infected after controlling for S. mansoni intensity,
age, sex, and anemia status. The random effects variance com-
ponents indicate that much of the variation is between chil-
dren within a school, but there was also statistically significant
variation between schools. The total variance is 1.758, the
sum of the three variance components [Var(v0k), Var(u0jk),
and Var(0ijk)]. Of the total variability in Hb counts, 0.122/
1.758 6.94% was situated at the school level, whereas 0.551/
1.758  31.34% arose between children within a school.
Figure 1 shows 36 level 3 residuals plotted one for each
school with the schools ordered according to the rank of their
posterior mean. It indicates that most of them have approxi-
mately average Hb counts that cannot be distinguished sta-
tistically. The school with the lowest intercept residual (at the
bottom left) and mean Hb count was Kibiro school in Hoima
district. At baseline the S. mansoni and hookworm point
prevalences in this school were 94.87% and 10.26%, whereas
at follow-up these decreased to 87.18% and 2.56%, respec-
tively. The school with the highest intercept and mean Hb
count was Arua Public in the Arua district. The raw data for
this school showed that S. mansoni and hookworm prevalence
at baseline were 22.86% and 25.71% and decreased to
14.29% and 2.86%, respectively, at follow-up.
Finally, Table 6 contains the estimates of the two-level hi-
erarchical model for the change of Hb counts between the 2
years of the study. It indicates that most risk groups had a
relatively slowed reduction or actual increase in Hb counts
after praziquantel and albendazole chemotherapy compared
with the reference group (baseline uninfected, non-anemic,
 11 years old). More precisely, children heavily infected with
S. mansoni at baseline had a smaller decrease by 0.229 g/dL in
their Hb counts in comparison with the uninfected with S.
mansoni. Among children found to be anemic at the baseline
survey, Hb counts increased significantly by 0.834 g/dL (i.e.,
1.240–0.406 g/dL) after treatment.
DISCUSSION
Friedman and others29 recommended that future research
aimed to quantify a relationship between schistosomiasis and
anemia should include an adequate follow-up period and in-
clude individuals with a range of infection intensities. To our
knowledge, our study represents the first longitudinal exami-
nation into the occurrence of anemia in a cohort of children
TABLE 4
Adjusted odds ratios from hierarchical multivariate logistic regression model for follow-up prevalence of anemia (n 2,696)
Variable Categories Adjusted odds ratio (95% CI) P
Fixed effects
Intensity of schistosomiasis infection at follow-up Uninfected 1
Lightly infected* 1.158 (0.905–1.483) 0.244
Moderately infected† 1.203 (08.66–1.672) 0.272
Heavily infected‡ 1.567 (1.038–2.365) 0.032
Intensity of hookworm infection at follow-up Uninfected 1
Lightly infected§ 1.037 (0.842–1.276) 0.732
Moderately/heavily infected¶ 4.289 (1.468–12.530) 0.008
Age at follow-up  12 years old 1
9 years old 0.697 (0.560–0.868) 0.001
8 years old 0.760 (0.607–0.950) 0.015
7 years old 1.184 (0.941–1.489) 0.147
Sex Male 1
Female 0.837 (0.713–0.983) 0.029
Random effects 2 SE
School-level variance 0.367 0.100
* Lightly infected with S. mansoni at follow-up: 1–99 epg.
† Moderately infected with S. mansoni at follow-up: 100–399 epg.
‡ Heavily infected with S. mansoni at follow-up:  400 epg.
§ Lightly infected with hookworm at follow-up: 1–1999 epg.
¶ Moderately/heavily infected with hookworm at follow-up:  2,000 epg.
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infected with S. mansoni and hookworm in Uganda using a
uniquely detailed large dataset arising from the National Con-
trol Schistosomiasis Program within the country. We exam-
ined the relationship of S. mansoni and hookworm infection
to anemia and Hb levels and evaluated the effectiveness of
practical interventions to control or reduce the severity of
such anemia.
Helminth infections at a young age may induce, among
other factors, pro-inflammatory mediators that are detrimen-
tal to protein metabolism, appetite, and erythropoiesis and
the WHO therefore recommends the use of anti-schistosome
treatment.1 In Uganda, it has been proven that drug distribu-
tion in schools is excellent and community-directed treatment
is a feasible health approach for mass drug distribution in
poor remote communities.30 Our study provides further con-
vincing evidence to show that young children may benefit
from deworming in terms of increased Hb and consequently
reduced anemia levels. In particular, while our data clearly
show there was association between anemia and both schis-
tosomiasis and hookworm infection at baseline, by the follow-
up data, the probability of anemia was only associated with
heavy S. mansoni and moderate or heavy hookworm infec-
tions (Tables 3 and 4).
However, whereas the first hierarchical model of Hb counts
(Table 5) showed that treatment arrests the drop in Hb, it
suggests that without iron replacement, Hb levels probably
will not rise. Additionally, the second hierarchical model
(Table 6) revealed a drop in Hb counts in the comparison
group of baseline uninfected, non-anemic,  11-year-old chil-
dren. One could speculate that this could reflect, for example,
an increased malaria infection rate at follow-up and/or a bad
harvest during the second year of this study, perhaps ex-
plained from the fact that there were > 1.6 million internally
displaced persons in Uganda’s north and east where malnu-
trition is one of the most pressing health concerns as a result
of fighting between government forces and rebels from the
Lord’s Resistance Army.31 It is likely that inadequate dietary
iron was another factor contributing to this observed decline.
These results confirm the findings of Taylor and others32 in
South Africa where through a randomized controlled trial
provided two different anthelmintic treatment regimens twice
at 6-month intervals combined with iron supplementation for
1 year in groups of 428 primary school pupils. These authors
observed a significant decrease in Hb levels of pupils receiv-
ing triple dose of albendazole and praziquantel only and a
significant increase in Hb levels of pupils receiving three
doses of these drugs and iron supplementation. Such com-
bined results thereby strengthen the argument of Stoltzfus
TABLE 5
Estimates from three-level hierarchical model for hemoglobin counts before and after chemotherapeutic treatment (n 2,682)
Fixed effects Parameter Coefficient (SE) Wald test statistics (P)
Intercept 00 11.854 (0.083) < 0.001
Baseline intensity of schistosomiasis infection (reference category uninfected) 01 −0.073 (0.055) 0.183
Moderate† 02 −0.153 (0.068) 0.024
Heavy‡ 03 −0.322 (0.072) < 0.001
Baseline intensity of hookworm infection (reference category uninfected)
Light§ 04 −0.046 (0.041) 0.262
Moderate/heavy¶ 05 −0.595 (0.139) < 0.001
Sex (reference category male)
Female 06 0.097 (0.042) 0.115
Baseline age (reference category  11 years old)
8 years old 07 −0.319 (0.052) < 0.001
7 years old 08 −0.509 (0.053) < 0.001
6 years old 09 −0.615 (0.069) < 0.001
Effect of follow-up (relative to baseline)—linear coefficient of time 10 0.061 (0.039) 0.115
Random effects
Level-3 (i.e., between schools) variance

2  Var(0k) 0.122 (0.032)
Level-2 (i.e., between children within a school) variance
u
2  Var(u0 jk) 0.551 (0.038)
Level-1 (i.e., measurement occasions within a child) variance

2  Var(0ijk) 1.085 (0.034)
Deviance 15,398.82
* Lightly infected with S. mansoni at baseline: 1–99 epg.
† Moderately infected with S. mansoni at baseline: 100–399 epg.
‡ Heavily infected with S. mansoni at baseline:  400 epg.
§ Lightly infected with hookworm at baseline: 1–1999 epg.
¶ Moderately/heavily infected with hookworm at baseline:  2,000 epg.
FIGURE 1. Caterpillar plot: 36 level 3 residuals from model pre-
sented in Table 5 (bars represent 95% CIs and the triangles level 3
residuals).
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and others33 that deworming programs should be combined
with increased iron intake through supplementation, fortifi-
cation, or improved diet to reduce the incidence of anemia
substantially.
Moreover, data from Beasley and others34 in rural Tanga,
Tanzania, and Friis and others35 in western Kenya suggest
that children most benefited from anthelmintic treatment in
terms of increased Hb levels were those who were anemic at
baseline. From our second hierarchical model of Hb counts
(Table 6), we also found a significant increase in the change of
Hb counts and a stronger effect for anemic children compared
with non-anemic. This same model also showed a slower re-
duction in Hb counts for heavily infected children with S.
mansoni and moderately or heavily infected children with
hookworm compared with uninfected after treatment, which
suggests that the effect of anthelmintic treatment on Hb was
mediated by reductions in intensities of S.mansoni and hook-
worm infections.
Ethical reasons as well as the operational reality of the
national control program did not permit the inclusion of a
control (i.e., untreated) group here. Consequently, the study
design did not allow estimation of the absolute impact of
treatment only the relative impact in different groups. There-
fore, to provide substantial support for the plausibility of the
impact of the intervention, the epidemiologic findings from
the models presented in this study should be further validated
with quantitative predictions arising from mathematical mod-
els and this work is underway. The high percentage of drop
outs in the group of heavily infected children with S. mansoni
(Table 1) because of frequent population movements within
Uganda, might also add some bias to the epidemiologic find-
ings of this study. Moreover, although malaria is a well-known
cause of anemia and Plasmodium falciparum is almost ho-
loendemic in our study population,36 this factor as well as
dietary iron intake were not examined, but we highly recom-
mend that this information should be included in future
evaluation follow-ups.29 Indeed the variance components of
the linear hierarchical models (Tables 5 and 6) have shown
that there remains substantial variability that is not explained
by the models, and this might well be caused by malaria and
iron deficiency not being taken into account here. In addition
to these, variables referring to mosquito control at the school/
village level were not available, and future studies may ben-
efit from their incorporation. The hierarchical model did,
however, show that Kibiro school in Hoima district, with sig-
nificantly lower mean Hb count compared with the overall
mean Hb count, had also very high S. mansoni prevalence,
possibly because of its proximity to Lake Albert, the major
source of transmission. On the other hand, the school with
significantly higher mean Hb count compared with the overall
mean Hb count was situated in the northern part of the coun-
try, where S. mansoni and hookworm prevalences were mod-
erately low. These results agree with previous work on the
distribution of S. mansoni in Uganda, which indicates that
highest schistosomiasis prevalences are found close to the east-
ern shores of Lakes Albert and Victoria, whereas areas of low
or zero prevalence are found in the northeast of the country.37
To conclude, our results, from a large scale national control
program suggest that S. mansoni and hookworm infections
may be related to anemia in specific districts of Uganda and
chemotherapy with praziquantel and albendazole may reduce
anemia. Anemia is therefore likely to represent a valuable
marker for morbidity caused by heavy infection with S. man-
soni, provided that other likely causes, such as hookworm,
dietary iron intake, and malaria, are taken into consideration.
Received November 11, 2005. Accepted for publication February 15,
2006.
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Abstract
Anaemia is multi-factorial in origin and disentangling its aetiology remains problematic, with surprisingly few studies investigating
the relative contribution of diﬀerent parasitic infections to anaemia amongst schoolchildren. We report cross-sectional data on haemo-
globin, malaria parasitaemia, helminth infection and undernutrition among 1523 schoolchildren enrolled in classes 5 and 6 (aged 10–21
years) in 30 primary schools in western Kenya. Bayesian hierarchical modelling was used to investigate putative relationships. Children
infected with Plasmodium falciparum or with a heavy Schistosoma mansoni infection, stunted children and girls were found to have lower
haemoglobin concentrations. Children heavily infected with S. mansoni were also more likely to be anaemic compared with uninfected
children. This study further highlights the importance of malaria and intestinal schistosomiasis as contributors to reduced haemoglobin
levels among schoolchildren and helps guide the implementation of integrated school health programmes in areas of diﬀering parasite
transmission.
 2008 Australian Society for Parasitology Inc. Published by Elsevier Ltd. All rights reserved.
Keywords: Anaemia; Haemoglobin concentration; Malaria; Helminth infections; Bayesian hierarchical models; School children; Kenya
1. Introduction
Anaemia remains one of the most intractable public
health problems in Africa, contributing to a quarter of
Africa’s nutrition-related Disability Adjusted Life Years
(DALYs) lost (World Health Organization, 2002). Several
studies have highlighted the contribution of parasitic dis-
eases to childhood anaemia. Recent meta-analyses of
malaria intervention trials among African children, for
example, provide compelling evidence that both symptom-
atic and asymptomatic malaria contributes to anaemia
(Geerligs et al., 2003; Korenromp et al., 2004). The eﬀect
of hookworm infection is also well documented, with risk
of anaemia correlated with intensity of infection (Stephen-
son, 1993; Olsen et al., 1998; Brooker et al., 1999); in con-
trast, the contributory role of schistosomiasis remains
unclear (Desai et al., 2005b; Friedman et al., 2005a). How-
ever, there are surprisingly few published studies describing
the relative contribution of these diﬀerent parasitic infec-
tions in populations of school-aged children (Olsen et al.,
0020-7519/$34.00  2008 Australian Society for Parasitology Inc. Published by Elsevier Ltd. All rights reserved.
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1998; Tatala et al., 1998; Friis et al., 2003; Leenstra et al.,
2003; Leenstra et al., 2004; Desai et al., 2005a; Friedman
et al., 2005b). Investigation of this issue is particularly rel-
evant for the design of integrated control strategies aimed
at reducing anaemia, including anthelmintic treatment pro-
grammes, micronutrient supplementation and malaria con-
trol measures, through school health programmes. In
particular, the same suite of school-based interventions will
not be relevant everywhere, and the selection of interven-
tion options will need to be guided by an informed under-
standing of the epidemiology of parasite-related anaemia
(Crawley, 2004), as well as of the geography of infection
(Brooker et al., 2007).
The aim of the present study was to examine the rela-
tionships of haemoglobin (Hb) concentration and anaemia
with common parasitic infections, including malaria, hook-
worm, Ascaris lumbricoides, Trichuris trichiura and Schisto-
soma mansoni in school children in western Kenya through
Bayesian hierarchical modelling. Adjustment for nutri-
tional and socioeconomic status (SES) has also been taken
into account here as they might inﬂuence anaemia risk
(Ong’echa et al., 2006). By employing a Bayesian approach
for the statistical modelling of the Hb counts and of anae-
mia prevalence, our model speciﬁcation via Markov chain
Monte Carlo (MCMC) algorithms oﬀers ﬂexibility in ﬁt-
ting complex models and enables estimates for the whole
distribution of the unknown parameters, including point
and interval estimates, to be derived. This approach is in
contrast to the frequentist approach which often only gives
estimates and crude standard errors based on asymptotic
results.
2. Materials and methods
2.1. Study area
The study was conducted between February and March
2005 in 30 primary schools in Bondo district in western
Kenya. Malaria transmission is intense and perennial
(Beier et al., 1994), with two seasonal peaks, March–May
and November–December, following the long and short
rainy seasons, respectively. Previous studies in western
Kenya have reported a high prevalence of hookworm
and T. trichiura infections and a medium prevalence of S.
mansoni and A. lumbricoides infections (Brooker et al.,
2000; Thiong’o et al., 2001).
2.2. Study design
This study used cross-sectional, baseline data from a
stratiﬁed, cluster-randomised placebo-controlled trial of
the impact of antimalarial intermittent preventive treat-
ment (IPT) among schoolchildren. The trial design and
protocol are described elsewhere (Clarke et al., 2008).
Brieﬂy, sample size was estimated on the basis of the
expected impact of IPT on anaemia, using the methods
for cluster-randomised trial design proposed by Hayes
and Bennett (1999). The 30 study schools were randomly
selected from primary schools in Usigu and Maranda Divi-
sions with P150 pupils with >15 pupils per class and
located more than 5 km from the shores of Lake Victoria,
so as to minimise the eﬀect of S. mansoni which is generally
only prevalent along the shoreline (Brooker et al., 2001;
Handzel et al., 2003). No stratiﬁcation by intestinal nema-
tode was undertaken because of their relatively homoge-
neous distribution (Handzel et al., 2003) but schools were
stratiﬁed according to past school examination perfor-
mance. We present data from the baseline survey on a
sub-sample of children enrolled in classes 5 and 6 (age
range 10–21 years) for whom complete data on anaemia,
helminth infection, malaria parasitaemia, nutritional status
and SES were available.
2.3. Procedures
Finger-prick blood samples were obtained from all chil-
dren to assess Hb levels and malaria parasitaemia. Haemo-
globin was measured in the ﬁeld using a portable
photometer (Haemocue, Angelholm, Sweden). Malaria
parasite prevalence and parasite densities were estimated
in Giemsa-stained thick blood ﬁlms, assuming an average
white blood cell count of 8,000 per ll, with species identi-
ﬁcation carried out on Giemsa-stained thin ﬁlms. A slide
was declared negative after examination of 100 high-pow-
ered ﬁelds. Stool samples provided by each child were
examined microscopically using the semi-quantitative
Kato-Katz technique and intensity of infection was
expressed as eggs/gram of faeces. Height was measured
to the nearest 0.1 cm using a Leicester portable ﬁxed base
stadiometer (Chasmors, UK) and weight was measured
to the nearest 0.1 kg using an electronic balance. A simple
questionnaire was administered to pupils to obtain data on
key socio-economic variables including: structure of the
house, type of overall light, ownership of bicycle, use of
bednet as well as education of the child’s guardian.
Ethical clearance for the study was obtained from the
ethics committee of the Kenyatta National Hospital,
Kenya and from the London School of Hygiene and Trop-
ical Medicine, UK. Permissions were obtained from the
Ministry of Education, and the district education and
health authorities, and headteachers. Prior to the start of
the study, a series of meetings were held in participating
schools to explain the nature and purpose of the trial and
to obtain individual informed parental consent from the
parents or legal guardians of children enrolled in study
schools.
2.4. Statistical analysis
An index of SES was constructed from asset and educa-
tion variables using principal component analysis (Filmer
and Pritchett, 2001). Data were available for 1453 (92%)
of the 1577 children in 30 schools. Analysis was done using
the PROC PRINCOMP command in SAS version 9.1
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(SAS Institute Inc., Cary, NC). For the index of SES, the
ﬁrst principal component explained 28% of the variance
in the asset and education variables with the greatest
weight given to the presence of a permanent house struc-
ture (0.43), and the lowest weight to the presence of a tra-
ditional house structure (0.39), respectively. Weights for
each variable were derived from the ﬁrst principal compo-
nent and applied to each child to derive a SES index. We
then assigned these children to a group on the basis of their
value on the index. Following the approach of Filmer and
Pritchett, we classiﬁed children into a 0–39 percentile, 40–
79 percentile and upper 20 percentile, which we refer to
as ‘most poor’, ‘poor’ and ‘least poor’, respectively.
Anthropometric indices were calculated on the basis of
the 2000 Centres for Disease Control and Prevention
(CDC) Growth Charts, and analysed as binary variables.
Children were classiﬁed as stunted if z-scores of height-
for-age were less than 2 S.D. below the CDC median. Body
mass index, which is weight (kg)/height (cm)2, was also cal-
culated and a cut-oﬀ of 2 Body Mass Index Z-scores
(BMIZ) were calculated to classify underweight children.
Data management and bivariate relationships between
mean Hb concentration and key predictors examined were
obtained using SAS V 9.1 (SAS Institute Inc., Cary, NC,
USA).
2.4.1. Bayesian modelling
Bayesian hierarchical modelling was used to assess asso-
ciations between anaemia, Hb and parasitic infection,
including children and schools as random eﬀects drawn
from some common prior distribution with unknown
parameters. Children within each school as well as the
results from diﬀerent schools were treated as ‘exchange-
able’ in the sense that their joint probability densities
should be invariant to permutations of the indexes (Gel-
man et al., 2004).
In Bayesian analysis, the proposed model of the
observed data is combined with the prior distribution of
all the unknown model parameters to give the posterior
distributions for all unknowns. MCMC methods (Gilks
et al., 1996) are used to sample from the posterior distribu-
tions of the unknown parameters. Analysis was conducted
using WinBUGS which employs the Gibbs sampler to form
the posterior distribution for each unknown parameter by
drawing samples from their full conditional distributions
(Spiegelhalter et al., 2003) to ﬁt models. An advantage of
the Bayesian hierarchical approach is that prior informa-
tion can be incorporated in the model in probabilistic form.
However, in the absence of any prior knowledge about the
model parameters, the choice of non-informative improper
priors is dictated by pragmatic conditions (Diggle et al.,
2002). Model convergence was evaluated on the basis of
inspection of sample traces, which all showed a reasonable
degree of convergence to a stationary distribution.
We ﬁtted Bayesian normal hierarchical models on Hb
because there is a two-level data structure applied to
cross-sectional data. Individual subjects were classiﬁed at
the lower level for older children with data on helminth
infection and age range 10–21 years old was classiﬁed by
cluster at the higher level. We assume that individual i
(=1,. . .,n) – where n = 1523 can belong in any of j
(=1,. . .,n2) – where n2 = 30 schools. Hb at a child level
may be aﬀected by those childrens’ characteristics (age,
sex, intensities of helminth infections, nutritional and
socio-economic status) but may also vary according to
which school these children are enrolled in. Speciﬁcally
for Hb, we used a random intercepts normal model which
can be written as:
Hbij  normalðlij; sÞ;
with lij ¼ X ijbþ uj and s  gammað0:001; 0:001Þ;
uj  normalð0; sujÞ and suj  gammað0:001; 0:001Þ:
Where lij is given by the sum of the product of Xij with
b – this constitutes the ﬁxed part of the model, and uj con-
stitutes the random part of the model. More precisely, Xij is
a vector of individual-level characteristics, b is a vector of k
estimated parameter coeﬃcients and uj is the error term at
the school-level which represents each school’s diﬀerence
from the overall population mean as its mean is set to 0.
s represents the precision (1/variance) of the normal
distribution of the response Hb whereas suj represents the
precision (1/variance) of the normal distribution of the
uj’s. For both variance components, we follow the usual
practice of specifying a gamma prior distribution to the
corresponding precision parameters which is proper and
close to being uniform on log (s).
For the vector of the k estimated parameter coeﬃcients
we assumed:
pðbkÞ / 1
Where p(bk) symbolizes the prior distribution of the k esti-
mated parameters and is proportional to 1.
In order to examine the prevalence of anaemia with
associated covariate vectors, we chose the single outcome
of the probability that a child is anaemic as estimated by
a hierarchical Bayesian logistic regression model. We
labeled the survey responses anaemiaij as 1 for children i
being anaemic (if Hb < 11.0 g/dL) in school j and 0 other-
wise, and model them independently with Pr(anae-
miaij = 1) = logit
1((Xb)ij). We present an analysis based
on a prior distribution for b that is independent and locally
uniform in the k parameters; that is p(b1, . . ., bk) / 1. Spe-
ciﬁcally for the risk of being anaemic, we used a random
intercepts logit link model which can be written as:
anaemiaij  binomialðpij; nijÞ;
with logitðpijÞ ¼ X ijbþ uj and s  gammað0:001; 0:001Þ;
uj  normalð0; sujÞ and suj  gammað0:001; 0:001Þ
Where nij is the total number of events (this is equal to 1523
children). The rest of the notation remains identical to the
normal hierarchical Bayesian models which were employed
for the analysis of the Hb levels. In these aforementioned
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regression models we used the same predictors of anaemia
prevalence as those in the models of Hb counts.
To compare model complexities and goodness of ﬁt we
also monitored the recently proposed deviance information
criterion (DIC) of (Spiegelhalter et al., 2002).
3. Results
Data on Hb, malaria parasitaemia and helminth infec-
tion were available for 1523 children (aged 10–21 years)
in the 30 schools (Table 1). Overall 13.5%, (95% Conﬁ-
dence Interval (CI): 11.8–15.2) of these children were
anaemic at the time of survey and the mean Hb concen-
tration was estimated to be 12.43 g/dL, (95% CI: 12.35–
12.50).
A total of 34.7% of children were infected with Plasmo-
dium falciparum with a further 0.3% having mixed infec-
tions with P. falciparum and Plasmodium malariae. Up
to 76.9% of children were infected with at least one para-
sitic helminth infection. Hookworm was the most preva-
lent helminth infection (47.3%); 14.1% were infected
with S. mansoni, 23.7% with A. lumbricoides and 12.9%
with T. trichiura. The prevalences of P. falciparum, hook-
worm and S. mansoni were, respectively, 35.8%, 41.2%
Table 1
Mean Hb concentration and prevalence of anaemia according to infection status and other characteristics in 1523 schoolchildren aged 10–21 years
(univariate analysis)
Variable Children No (%) Mean Hb level, g/dL (95% CI) Anaemia prevalence (%) (95% CI)
Sex
Male 786 (51.6) 12.51 (12.40–12.61) 13.2 (10.9–15.6)
Female 737 (48.4) 12.34 (12.23–12.45) 13.7 (11.2–16.2)
Age
10–12 years old 573 (39.0) 12.29 (12.17–12.41) 13.1 (10.3–15.9)
13–15 years old 896 (61.099) 12.52 (12.42–12.62) 13.8 (11.6–16.1)
> = 16 years old 54 (3.7) 12.44 (12.08–12.80) 11.1 (2.7–19.5)
Classiﬁcation of SES (n = 1404b)
Least poor 281 (20.01) 12.42 (12.24–12.61) 12.81 (8.90–16.72)
Poor 560 (39.89) 12.45 (12.34–12.58) 13.93 (11.06–16.79)
Most poor 563 (40.10) 12.40 (12.28–12.53) 13.14 (10.35–15.93)
Classiﬁcation of BMIZ
Not underweight 1430 (93.9) 12.44 (12.36–12.52) 13.2 (11.4–14.9)
Underweight 93 (6.1) 12.22 (11.92–12.52) 18.3 (10.4–26.1)
Classiﬁcation of HAZ
Not stunted 1323 (86.9) 12.48 (12.40–12.56) 12.8 (11.0–14.6)
Stunted 200 (13.1) 12.10 (11.88–12.31) 18.0 (12.7–23.3)
Intensity of hookworm infectionc
Not infected 803 (52.7) 12.42 (12.31–12.53) 14.0 (11.6–16.3)
Lightly infected 691 (45.4) 12.45 (12.35–12.56) 12.9 (10.4–15.4)
Moderately infected 15 (1.0) 12.21 (11.60–12.83) 13.3 (0.0–30.5)
Heavily infected 14 (0.9) 11.87 (11.34–12.40) 14.3 (0.0–32.6)
Intensity of S. mansoni infectionc
Not infected 1309 (86.0) 12.44 (12.36–12.53) 13.2 (11.4–15.1)
Lightly infected 91 (6.0) 12.41 (12.11–12.71) 11.0 (4.6–17.4)
Moderately infected 76 (5.0) 12.54 (12.21–12.87) 13.2 (5.6–20.8)
Heavily infected 47 (3.0) 11.79 (11.28 to 12.30) 25.5 (13.1–38.0)
Intensity of T.trichiura infectionc
Not infected 1326 (87.1) 12.41 (12.33–12.50) 13.4 (11.6–15.3)
Lightly infected 188 (12.3) 12.47 (12.26–12.69) 14.4 (9.4–19.4)
Moderately infected 8 (0.5) 13.26 (12.30–14.23) 0.0 NAa
Heavily infected 1 (0.1) 12.80 NAa 0.0 NAa
Intensity of A. lumbricoides infectionc
Not infected 1162 (76.3) 12.46 (12.37–12.55) 13.6 (11.6–15.6)
Lightly infected 236 (15.5) 12.34 (12.16–12.52) 13.1 (8.8–17.5)
Moderately infected 125 (8.2) 12.27 (12.04–12.50) 12.8 (6.9–18.7)
Heavily infected 0 (0.0) 0.0 NAa 0.0 NAa
Malaria spp. infection
Not infected 989 (69.9) 12.49 (12.40–12.58) 12.8 (10.8–14.9)
Infected 534 (35.1) 12.31 (12.18–12.44) 14.6 (11.6–17.6)
BMIZ, Body Mass Index Z-score; HAZ, Height for Age Z-score; CI, conﬁdence interval.
a NA, not available.
b Socio-economic status (SES) data were missing for 119 children.
c Intensity of helminth infection was classiﬁed in light, moderate and heavy according to WHO recommended thresholds: Schistosoma mansoni infection,
1–99, 100–399 andP400 eggs per gram of faeces (epg); hookworm, 1–1999, 2000–3999 andP4000 epg; Trichuris trichiura, 1–999, 1000–9999 andP10,000
epg; and Ascaris lumbricoides, 1–4999, 5000–49,999 and P50,000 epg.
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and 12.4% in the 10–12 years old age group, 34.4%, 51.2%
and 14.7% in the 13–15 years old age group and 25.9%,
46.3% and 20.4% in the older age group (i.e. > = 16 years
old).
3.1. Bayesian hierarchical normal model of haemoglobin
Table 2 contains the posterior means and 95% credible
intervals of the ﬁnal two-level Bayesian normal hierarchical
model for the Hb of children with complete data on all
covariates. According to this model, the posterior mean
for the overall mean Hb was estimated to be 12.52 g/dL
(95% credible interval: 12.28–12.76). On average, girls
had lower mean Hb compared with boys by 0.18 g/dL.
Older children tended to have higher mean Hb than chil-
dren aged 10–12 years. Stunted children compared with
non-stunted children had lower mean Hb by 0.34 g/dL.
From the 95% credible intervals of all the parasitic infec-
tions, only children heavily infected with S. mansoni had
signiﬁcantly lower mean Hb by an average of 0.51 g/dL,
(95% credible interval: 0.94 to 0.10) and children
infected with malaria had signiﬁcantly lower mean Hb by
an average of 0.16 g/dL, (95% credible interval: 0.32 to
0.01) compared with uninfected children, respectively.
Although there was no evidence of a signiﬁcant eﬀect of
the intensities of single hookworm, T. trichiura or A. lumb-
ricoides infection, we still allowed adjustment for these and
therefore they were ﬁnally included in the model. The two-
way interaction terms of intensities of helminth infections
mentioned before, were also included and tested in the
models in order to check for the eﬀect of helminth co-infec-
tions on the mean Hb. As none of these terms, as well as
the SES, were found to be signiﬁcantly associated with
Hb levels and/or anaemia, they were omitted from the ﬁnal
model. The random eﬀects variance components indicate
that most of the variance is between children within a
school: of the total variability in Hb, 9.9% (0.225/2.256)
occurred at the school level while 90.0% (2.031/2.256)
occurred between children within a school. This is also
illustrated by Fig. 1 which presents a box plot of the
level-2 residuals among older children for each school,
and indicates that most schools had similar Hb levels that
Table 2
Estimated posterior mean diﬀerences in mean Hb concentration for the eﬀects of selected explanatory variables from a ﬁnal Bayesian hierarchical model
(n = 1523)
Variable Mean 95% credible intervala
Fixed part of the model
Intercept 12.520 (12.280–12.760)
Sex (Reference category: ‘Male’) Female 0.183 (0.330 to 0.036)b
Age (Reference category: ‘10–12 years old’)
13–15 years old 0.222 (0.064–0.377)b
> = 16 years old 0.417 (0.012–0.832)b
Classiﬁcation of BMIZ (Reference category:’ Not wasted’) Wasted 0.244 (0.544 to 0.062)
Classiﬁcation of HAZ (Reference category:’ Not stunted’) Stunted 0.347 (0.564 to 0.128)b
Intensity of hookworm infection (Reference category: ‘Not Infected’)
Lightly infected 0.050 (0.102 to 0.197)
Moderately infected 0.310 (1.048 to 0.419)
Heavily infected 0.516 (1.277 to 0.233)
Intensity of Schistosoma mansoni infection (Reference category: ‘Not Infected’)
Lightly infected 0.113 (0.417 to 0.189)
Moderately infected 0.068 (0.268 to 0.414)
Heavily infected 0.513 (0.942 to 0.097)b
Intensity of Trichuris trichiura infection (Reference category: ‘Not Infected’)
Lightly infected 0.105 (0.121 to 0.336)
Moderately infected 0.834 (0.195 to 1.857)
Heavily infected 0.110 (2.649 to 2.890)
Intensity of Ascaris lumbricoides infection (Reference category: ‘Not Infected’)
Lightly infected 0.164 (0.372 to 0.047)
Moderately infected 0.206 (0.480 to 0.073)
Malaria spp infection (Reference category: ‘Not Infected’) Infected 0.159 (0.315 to 0.009)b
Random part of the model
Level-2 (i.e. between schools) variance 0.225 (0.114–0.413)
Level-1 (i.e. between children within a school) variance 2.031 (1.889–2.186)
BMIZ, Body Mass Index Z-score; HAZ, Height for Age Z-score.
a 95% Credible intervals (CIs) are diﬀerent from classical 95% conﬁdence intervals in various ways, some of which are: (i) in their interpretation: we say
there is a 95% probability that the true parameter lies in a 95% credible interval where this is certainly not the interpretation of a 95% conﬁdence interval.
In a long series of 95% conﬁdence intervals, 95% of those should contain the true parameter value – unlike the Bayesian interpretation we cannot give a
probability for whether a particular conﬁdence interval contains the true value; and (ii) credible intervals will generally be narrower due to the additional
information provided by the prior (Spiegelhalter et al., 2004).
b These are signiﬁcant diﬀerences compared with the reference category in the sense that the probability is at least 95% that these parameters lie within
the credible interval, which is signiﬁcant.
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could not be distinguished statistically, thereby conﬁrming
the suitability of assumptions for the chosen ﬁnal model.
Interestingly, mean Hb was substantially higher in one
school (#21) relative to other schools.
3.2. Bayesian logistic regression model of anaemia
Table 3 presents the hierarchical logistic regression
model of anaemia risk and shows that only children with
[1] [2]
[3]
[4]
[5]
[6]
[7]
[8]
[9] [10]
[11]
[12]
[13]
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[19]
[20]
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[22]
[23]
[24]
[25]
[26]
[27]
[28]
[29]
[30]
Box Plot of uj
-2.0
-1.0
0.0
1.0
2.0
Fig. 1. Box plot of school-level residuals from a Bayesian hierarchical model for Hb counts among older children. Each box plot represents a school-level
residual uj in our study. Numbers above each box plot are label identiﬁers for each school. This is a plot in which the posterior distributions of all ujs are
summarised side by side. Boxes represent inter-quartile ranges and the solid black line at the (approximate) centre of each box is the mean of each speciﬁc
uj; the arms of each box extend to cover the central 95 percent of the distribution–their ends correspond, therefore, to the 2.5% and 97.5% quantiles.
The horizontal straight line in the middle of the graph represents the overall mean of the ujs which is set to 0.
Table 3
Estimated posterior odds ratios for prevalence of anaemia (Hb < 110 g/L) for the eﬀects of selected explanatory variables from ﬁnal Bayesian hierarchical
logistic regression model (n = 1523)
Variable Odds ratio 95% credible interval
Fixed part of the model
Main eﬀects
Sex (Reference category: ‘Male’)
Female 1.073 (0.787 to 1.405)
Age (Reference category: ‘ > =10–12 years old’)
13–15 years old 1.095 (0.804–1.462)
> = 16 years old 0.688 (0.218–1.547)
Intensity of hookworm infection (Reference category: ‘Not Infected’)
Lightly infected 0.895 (0.645–1.208)
Moderately infected 1.156 (0.121–3.708)
Heavily infected 1.165 (0.132–3.861)
Intensity of Schistosoma mansoni infection (Reference category: ‘Not Infected’)
Lightly infected 0.825 (0.360–1.442)
Moderately infected 1.004 (0.426–1.969)
Heavily infected 2.292 (1.070–4.258)a
Intensity of Ascaris lumbricoides infection (Reference category: ‘Not Infected’)
Lightly infected 1.060 (0.680–1.584)
Moderately infected 1.057 (0.582–1.748)
Malaria spp infection (Reference category: ‘Not Infected’) infected 1.136 (0.821–1.540)
Random part of the model
Level-2 (i.e. between schools) variance 0.288 (0.088–0.630)
a This is a signiﬁcant odds ratio of heavily infected children with S. mansoni compared with uninfected children in the same sense as denoted in Table 2.
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heavy S. mansoni intensities were more likely to be anae-
mic, deﬁned as Hb < 11.0 g/dL, compared with uninfected
children (Odds ratio: OR = 2.3, 95% credible interval: 1.1–
4.3; Table 3). There was no evidence that other predictors
were signiﬁcantly associated with the risk of anaemia.
4. Discussion
Malaria, undernutrition and helminth infections have a
large impact on the survival and quality of lives of school-
aged children living in Africa. Understanding the direct
and indirect consequences of these factors on lower Hb lev-
els and anaemia is important, as ﬁndings may help guide
the suite of school-based interventions in endemic areas
where polyparasitism is the norm (Raso et al., 2004; Pullan
and Brooker, 2008). Our analysis found evidence that
malaria parasitaemia, heavy intensity of S. mansoni infec-
tion and being stunted were signiﬁcantly associated with
lower mean Hb, although only heavy intensity of S. man-
soni infection was signiﬁcantly associated with the risk of
anaemia among schoolchildren over 10 years of age. Such
results underscore current eﬀorts to control helminths
and malaria as part of integrated school health pro-
grammes (Bundy et al., 2006; Brooker et al., 2008).
Although our cross-sectional design hampers the inter-
pretation of our ﬁnding, especially the direction of causal-
ity, the use of hierarchical Bayesian modelling allows the
incorporation of both individual- and school-level factors,
the omission of one or the other leading to biased estimates
(Congdon, 2001). Furthermore, our results are consistent
with previous studies which report similar associations
(Stoltzfus et al., 1997b; Olsen et al., 1998; Leenstra et al.,
2004; Desai et al., 2005a). However, the diﬀerence in Hb
between children infected with malaria and those unin-
fected, though signiﬁcant, was small. The anaemia of
malaria is multifactorial, involving a complexity of
mechanims including increased destruction of red blood
cells (RBCs) through rupturing, phagocytosis and hyper-
splenism, and decreased RBC production through inﬂam-
mation and dyserythropiesis (Menendez et al., 2000). The
single time point of our cross-sectional design means that
we were unable to capture information on clinical attacks
of malaria and therefore separate haemolysis due to clinical
malaria and the role of asymptomatic low grade infections
on RBC concentrations and Hb. Neither can this design
examine the eﬀect of recently cleared infections on the pro-
cess of haematological recovery and current Hb. However,
clearer evidence of the contribution of malaria to anaemia
in school-aged children is provided by the results of our
intervention trial which showed that school-based intermit-
tent preventive treatment with sulfadoxine-pyrimethamine
and amodiaquine signiﬁcantly reduced the prevalence of
anaemia among the wider age range of schoolchildren
included in the main trial (Clarke et al., 2008).
A surprising ﬁnding was the strong association between
heavy intensity of S. mansoni infection, anaemia and Hb.
Potential mechanisms through which S. mansoni may con-
tribute to anaemia include: (i) blood loss caused by the rup-
ture of blood vessels surrounding the intestine by the spined
schistosome eggs; (ii) splenic sequestration; (iii) autoim-
mune hemolysis; and (iv) anaemia of inﬂammation which
is typically characterised by decreased RBC production
induced by pro-inﬂammatory cytokines (Friedman et al.,
2005a; Tolentino and Friedman, 2007). In addition it is pos-
sible that the importance of S. mansoni infection is likely to
be greater than estimated here since only schools located
more than 5 km from the lake shore were sampled to purpo-
sively minimise confounding by S. mansoni in the interven-
tion trial. By contrast, hookworm infection, a major
attributable factor for anemia in schoolchildren in other
areas of East Africa (Stoltzfus et al., 1997a; Lwambo
et al., 2000), was not associated either with lower Hb or with
anemia in the present study. This ﬁnding, which is consis-
tent with previous studies in western Kenya (Olsen et al.,
1998; Handzel et al., 2003), is probably due in part to the
low intensity of hookworm infection in our study area,
and highlights how diﬀerent factors contribute to anaemia
in diﬀerent parasite transmission settings. We did not ﬁnd
any evidence of an increased risk of anaemia in children
co-infected with multiple helminth species and/or malaria.
The results of our Bayesian linear hierarchical approach
indicate that a high degree of variation remains to be
explained and that there are other factors beyond what
was measured in this study which still need to be consid-
ered. One advantage of a hierarchical approach over con-
ventional statistical approaches is the partitioning of the
unexplained variance into variability between clusters and
individual level variation within clusters, which shows that
most of the residual variation within our study population
was attributable to individual level variation occurring
between children. More precisely, although dietary iron
insuﬃciency is very likely to impact on Hb and anaemia
(Olivares et al., 1999), no information was available on iron
status of the children included in the study. Nutritional
variables which were measured such as stunting and wast-
ing, representing chronic and severe acute undernutrition,
respectively, may not adequately capture moderate, current
undernutrition which may also explain variation in mean
Hb levels. Reported age is also often uncertain and may
be inaccurate. This may have implications for the reliability
of the derived HAZ and BMIZ scores. A further source of
variation not measured in this study is the eﬀect of menar-
che in adolescent girls (Leenstra et al., 2004). When inter-
action terms of age and sex were ﬁtted to the model these
were not found to be signiﬁcant, however as described
above, reported age may be both unreliable and too crude
a proxy for individual variation in the timing of onset of
menarche. Similarly, the SES index used here may not fully
capture socio-economic variability within the population as
it was based on a small number of assets and relied on
reporting by schoolchildren. A ﬁnal source of individual
variation which was not taken into account in this study
was genetic traits such as sickle-cell and other haemoglo-
binopathies (Tolentino and Friedman, 2007).
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In conclusion, this study demonstrated that lower mean
Hb levels were signiﬁcantly associated with malaria,
chronic undernutrition and heavy intensity of S. mansoni,
and that anaemia was associated with heavy intensity of
S. mansoni. Such results have important implications for
the control of anaemia among African schoolchildren
and can help guide the design of appropriate interventions.
Integrated school health programmes which include dewor-
ming, micronutrients and potentially malaria control, will
help alleviate the anaemia burden faced by the school-aged
children of Africa. Further research is required to identify
the optimal packages and to identify areas where diﬀerent
packages of interventions may be required.
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(See the editorial commentary by King, on pages 653–5.)
Background. In sub-Saharan Africa, 112 million people are infected with Schistosoma haematobium, with the
most intense infections in children 5–15 years old.
Methods. We describe a longitudinal epidemiological study that evaluates the relationship between S. hae-
matobium infection and associated morbidity in children before and after the large-scale administration of pra-
ziquantel for schistosomiasis and albendazole for soil-transmitted helminths.
Results. At baseline, higher intensities of S. haematobium infection were observed in children with anemia
and/or severe microhematuria, but there was no apparent association between the risk of undernutrition and
intensity of S. haematobium infection. Significant reductions in the prevalence and intensity of S. haematobium
infection 1 year after treatment were, however, observed. Children who benefited the most from anthelmintic
treatment in terms of increased hemoglobin concentrations were those who had anemia at baseline and those with
highly positive microhematuria scores at baseline.
Conclusions. This study suggests that even a single round of mass chemotherapy can have a substantial impact
on S. haematobium infection and its associated morbidity in children.
Improving the health of school-aged children, partic-
ularly in developing countries, has emerged as a policy
priority in international health [1, 2]. Over the past 2
decades, significant progress has been made in im-
proving child survival, resulting in more children reach-
ing primary school age. However, human infections
with 1 of the 5 parasitic helminths of the family Schis-
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tosomatidae still represent a significant segment of the
global burden of illness, with ∼200 million people in-
fected and with the highest intensities in children 5–
15 years old [3]. Schistosomiasis causes granuloma for-
mation and both reversible and irreversible damage to
the urinary and intestinal tracts [4]. Furthermore, new
estimates of schistosomiasis-related disability have in-
dicated the need to reassess priorities for treating this
chronic infection in areas where it is endemic [5].
Praziquantel has been established in several con-
trolled trials as a safe and effective drug for the treat-
ment of infection with all human schistosome species
[6–9]. The dramatic reduction in its price since 1990—
by 190%, from US$4 to treat a person to approximate-
ly US$0.30—has led to the resolution of many of the
challenges surrounding large-scale chemotherapy cam-
paigns [10]; recently, through the Schistosomiasis Con-
trol Initiative (SCI), 120 million treatments were ad-
ministered in 2005–2006 in 6 sub-Saharan African
countries [11, 12]. One of the primary objectives of
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Table 1. Baseline characteristics of Burkinabe´ schoolchildren who were followed up for 1 year
or dropped out.
Characteristic
Followed up
for 1 year Dropped out P
Demographic
Age, mean, years 9.8 (n p 1131) 11.3 (n p 686) !.001
Male sex, % 55.0 (n p 1131) 62.0 (n p 686) .004
Parasitologic
Infected with Schistosoma haematobium, % 53.9 (n p 1124) 54.1 (n p 690) .953
Infected with S. mansoni, % 6.2 (n p 536) 5.8 (n p 432) .810
Infected with hookworm, % 6.3 (n p 556) 4.3 (n p 418) .174
S. haematobium intensity, mean (SD), eggs/10 mL 83.6 (229.2) 94.2 (234.6) .728
S. mansoni intensity, mean (SD), epg 8.0 (73.9) 11.3 (76.1) .869
Hookworm intensity, mean (SD), epg 12.5 (90.7) 3.3 (21.0) .158
Hematologic
Anemia, % 65.8 (n p 1130) 66.4 (n p 687) .390
Hemoglobin concentration, mean (SD), g/dL 11.0 (1.4) 11.1 (1.4) .036
Nutritional status
Wasted, % 32.8 (n p 1131) 100.0 (n p 686) !.001
Stunted, % 13.3 (n p 1131) 100.0 (n p 686) !.001
Hemastix test (n p 1124) (n p 692) .460
Negative, % 50.4 53.5
Trace, % 12.9 10.7
+, % 6.8 5.6
++, % 9.3 8.9
+++, % 20.6 21.4
NOTE. Anemia was defined (according to World Health Organization guidelines) as a hemoglobin concentration
!11.5 g/dL for children 5–11 years old and !12.0 g/dL for children 12–14 years old. Wasting denotes reduced body
weight for height, defined as a body-mass-index z score less than 2. Stunted denotes reduced body length in
relation to a reference standard, defined as a height-for-age z score less than 2. +, weakly positive; ++, moderately
positive; +++, highly positive; epg, eggs per gram of feces.
these SCI-supported control programs is to achieve, and hence
also to demonstrate, a quantifiable reduction in schistosome-
associated morbidity as a consequence of chemotherapeutic
intervention.
The aim of the present study was to evaluate the relationship
between Schistosoma haematobium infection and associated mor-
bidity in children before and after the large-scale administration
of praziquantel and albendazole (against soil-transmitted hel-
minths) by the national Burkinabe´ helminth control program.
A secondary aim was to identify those individuals whom one
may predict to show the greatest improvements in nutritional
status and hemoglobin (Hb) concentrations after chemotherapy.
SUBJECTS AND METHODS
Control program, study sites, sampling, and cohort design.
Both Schistosoma mansoni and S. haematobium are endemic
throughout Burkina Faso [13]. The SCI-supported schistoso-
miasis control program was implemented during 2004 and had
treated 3,322,564 school-aged children in the 13 regions of the
country through October 2006. Further details about the na-
tional Burkinabe´ helminth control program have been de-
scribed elsewhere [14].
For the present study, parasitological and morbidity data
were collected from a cohort of 1727 Burkinabe´ children 6–14
years old, randomly sampled from 16 schools before and 1 year
after chemotherapy (2004 and 2005, respectively). The schools
included in these surveys were randomly selected from all
schools in 4 Regional Health Directorates known a priori to
be places where schistosomiasis is highly endemic. Details con-
cerning sample-size calculations and cohort design have been
described elsewhere [15, 16].
Parasitological and morbidity measures. All children en-
rolled in the study were interviewed by appropriately trained
personnel at the Ministry of Health, Burkina Faso. Ethical clear-
ance was obtained from the Ministry of Health and Imperial
College London.
Stool examination. A single stool sample was collected
from each child, and 41.7 mg was processed to make duplicate
Kato-Katz slides for microscopic determination of intestinal
helminth infection. Individual egg output was expressed as eggs
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Table 2. Health characteristics of children successfully followed up for 1 year (2004–
2005), at baseline and after treatment.
Characteristic 2004 2005
Parasitologic
Infected with Schistosoma haematobium, %
(n p 1124) 53.91 (51.00–56.83) 5.78 (4.42–7.15)
Infected with S. mansoni, % (n p 536) 6.16 (4.12–8.19) 0.19 (0.00–0.55)
Infected with hookworm, % (n p 555) 6.31 (4.28–8.33) 1.62 (0.57–2.67)
S. haematobium intensity, mean, eggs/10 mL 83.55 (70.14–96.96) 0.94 (0.35–1.53)
S. mansoni intensity, mean, epg 8.04 (1.77–14.31) 0.02 (0.00–0.07)
Hookworm intensity, mean, epg 12.47 (4.92–20.03) 0.78 (0.22–1.34)
Hematologic (n p 1131)
Hemoglobin concentration, mean, g/dL 10.97 (10.88–11.05) 11.25 (11.18–11.32)
Anemia 65.75 (62.99–68.52) 61.59 (58.76–64.43)
Microhematuria as diagnosed by Hemastix test
(n p 1124)
Negative, % 50.44 (47.52–53.37) 89.50 (87.71–91.29)
Trace, % 12.90 (10.94–14.86) 4.89 (3.63–6.15)
+, % 6.76 (5.29–8.23) 2.31 (1.43–3.19)
++, % 9.34 (7.64–11.04) 1.07 (0.47–1.67)
+++, % 20.55 (18.19–22.91) 2.22 (1.36–3.09)
Nutritional status (n p 1131)
Thinness or wasting, % 32.80 (30.07–35.54) 35.10 (32.32–37.88)
Shortness or stunting, % 13.26 (11.29–15.24) 11.85 (9.96–13.73)
NOTE. Data are means or proportions (95% confidence interval) of children with characteristic, unless
otherwise indicated. Sample sizes are provided in parentheses for each examined outcome in the left-hand
column. Anemia was defined (according to World Health Organization guidelines) as a hemoglobin concen-
tration !11.5 g/dL for children 5–11 years old and !12.0 g/dL for children 12–14 years old. Wasting denotes
reduced body weight for height, defined as a body-mass-index z score less than2. Stunted denotes reduced
body length in relation to a reference standard, defined as a height-for-age z score less than 2. +, weakly
positive; ++, moderately positive; +++, highly positive; epg, eggs per gram of feces.
per gram of feces, calculated as the arithmetic mean of the 2
individual slide counts whenever these were available.
Urine examination. One urine specimen was collected
from each child to determine the prevalence and intensity of
S. haematobium infection by the filtration method. The inten-
sity of S. haematobium infection was expressed as the number
of eggs per 10 mL of urine. To determine the presence and
severity of microhematuria, all urine specimens were tested for
presence of detectable blood using urine reagent strips (Bayer
Hemastix). The results were recorded semiquantitatively: neg-
ative, trace hemolyzed, weakly positive (+), moderately positive
(++), and highly positive (+++).
Nutritional assessment. Heights and weights were mea-
sured to determine height-for-age z scores (HAZ) and body-
mass-index z scores (BMIZ). All measures were obtained using
height poles and electronic balances in the morning, and chil-
dren were barefoot, wearing only light indoor clothing. A low
BMIZ is the index of choice for the assessment of recent un-
dernutrition resulting in thinness or wasting, whereas a low
HAZ represents long-term growth and nutritional status re-
sulting in shortness or stunting [17, 18]. z scores for each
nutritional index were calculated from Centre for Disease Con-
trol (National Center for Health Statistics; year 2000) reference
values using EpiInfo (version 2000; US Centers for Disease
Control and Prevention) [19].
Anemia assessment. Blood samples for Hb concentrations
were obtained from each individual by the fingerprick method
using a photometer (Hemocue) [20]. Anemia was defined ac-
cording to World Health Organization (WHO) guidelines [21].
Statistical analyses. Differences between dropouts and
children successfully followed up were tested by univariate anal-
ysis using a Wilcoxon 2-sample test for means and a x2 test or
Fisher’s exact test if there was a small value for proportions.
SAS software was used (version 8; SAS Institute).
Hierarchical models are often applicable to modeling data
from complex surveys of a population, with a hierarchical struc-
ture used to explain relations between individual and suprain-
dividual determinants. A 2-level linear hierarchical model
assuming normally distributed errors was fitted to the loga-
rithmically transformed baseline S. haematobium egg counts
, using Gibbs sampling for all parameters [22] to(ln [x+ 1])
quantify any associations with anemia, measures of nutritional
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Table 3. Estimates from 2-level hierarchical model for Schistosoma haematobium egg counts
among 1130 Burkinabe´ schoolchildren at baseline and after treatment (2004–2005).
Model Coefficient (95% CI) P
Fixed effects
Effect of year 1 follow-up relative to baseline 52% (57% to 47%) !.001
Male sex (reference category: female) 11% (2% to 21%) .020
Baseline age (reference category: 14 years)
13 years 9% (19% to 45%) .572
12 years 45% (11% to 90%) .007
11 years 25% (4% to 63%) .095
10 years 32% (2% to 72%) .035
9 years 24% (4% to 61%) .106
8 years 22% (6% to 59%) .143
7 years 2% (24% to 37%) .906
6 years 19% (27% to 92%) .488
Baseline anemia (reference category: not anemic) 11% (1% to 21%) .026
Baseline hematuria (reference category: negative)
Trace 242% (191% to 302%) !.001
+ 462% (357% to 592%) !.001
++ 1470% (1176% to 1833%) !.001
+++ 4107% (3493% to 4827%) !.001
Baseline thinness or wasting (reference category:
not wasted) 4% (6% to 14%) .463
Baseline shortness or stunting (reference category:
not stunted) 13% (26% to 2%) .089
Variance components (SE)
Random effects
Level 2 variance (between schools) 0.008 (0.004)
Level 1 variance (measurement occasions within a child) 0.190 (0.006)
NOTE. Anemia was defined (according to World Health Organization guidelines) as a hemoglobin concentration
!11.5 g/dL for children 5–11 years old and !12.0 g/dL for children 12–14 years old. Wasting denotes reduced body
weight for height, defined as a body-mass-index z score less than 2. Stunting denotes reduced body length in
relation to a reference standard, defined as a height-for-age z score less than2. +, weakly positive; ++, moderately
positive; +++, highly positive; CI, confidence interval.
status, and microhematuria while adjusting at the same time
for demographic factors such as age and sex. In this way, we
tested whether children with pathology potentially induced by
S. haematobium infection had higher S. haematobium egg
counts before treatment. We used a similar model to quantify
changes in S. haematobium egg counts from baseline to 1 year
of follow-up. Mlwin software (version 2.01; Multilevel Models
Project, Institute of Education, University of London) was used.
Box plots of the S. haematobium egg counts at baseline were
used for validation and comparison of the significant findings
from the model described above.
Changes in Hb concentration and in HAZ and BMIZ scores
over time were evaluated using 2-level linear hierarchical mod-
els of raw change scores between baseline and the 1-year follow-
up time point. With this approach, we aimed to compare the
average change in each of the studied outcomes over the studied
period between different groups of children. All of the models
presented were also adjusted for age and sex. was con-P ! .05
sidered to be significant.
An additional 3-level hierarchical linear modeling analysis
was performed to determine any change in the children’s Hb
concentrations. With this model, we aimed to quantify the
adjusted overall change in Hb concentration from baseline to
follow-up and to quantify average Hb concentrations of dif-
ferent groups of children at baseline as well as to examine
whether the intensity of S. haematobium infection was asso-
ciated with lower Hb concentrations. Logistic random-inter-
cepts regression models were fitted to examine whether the
intensity of S. haematobium infection was associated with an
increased risk of thinness and shortness at baseline while ad-
justing for potential confounders.
RESULTS
A total of 1727 children from 16 schools were recruited at
baseline. Of these, 1131 (65%) were successfully retraced at the
1-year follow-up time point, and 321 new children were re-
cruited into the cohort during the second year of the study
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Figure 1. Box plots for the logarithmically transformed (base e) Schistosoma haematobium egg counts of positive subjects only ( Burkinabe´np 613
schoolchildren, 2004). A, Box plot for log S. haematobium egg counts with respect to different microhematuria test scores at baseline. B, Box plots
for log S. haematobium egg counts with respect to anemia status at baseline. Data are smallest observations, lower quartiles (Q1), medians, upper
quartiles (Q3), and largest observations. +, weakly positive; ++, moderately positive; +++, highly positive.
(data not shown). There were significant differences between
the children who were successfully followed up and the drop-
outs, according to their demographic characteristics and nu-
tritional status as defined by baseline thinness and shortness
as well as by baseline Hb concentrations (table 1). The children
who dropped out were of an older mean age than those suc-
cessfully followed up, and boys proved more difficult to recruit
into the cohort during the second year of the study. All children
who dropped out were wasted and stunted at baseline and had
slightly higher mean Hb concentrations. No other baseline
characteristic measured varied significantly between children
followed up and those who dropped out.
Table 2 presents the health indicators of children surveyed
at baseline and successfully followed up 1 year after treatment.
During the 12 months between examinations, the overall
prevalences of S. haematobium, S. mansoni, and hookworm
infections decreased significantly ( ). For both years ex-P ! .001
amined, Ascaris lumbricoides infection was absent, and the prev-
alence of Trichuris trichura infection was estimated to be 1.1%
at baseline and totally absent 1 year later. Because prevalences
and coinfections with S. haematobium were so low for the
intestinal helminth species at both time points, such data were
not analyzed further here.
A significant increase in mean Hb concentration ( )P ! .001
and a significant decrease in the prevalence of anemia (Pp
) were also observed between 2004 and 2005. Finally, the.021
unadjusted observed changes in both recent and chronic un-
dernutrition from baseline to follow-up were not significant
( and , respectively).Pp .135 Pp .093
Table 3 presents the results of the model of the change in S.
haematobium egg counts for 1 year after treatment as well as
differences in S. haematobium egg counts between different
groups of children at baseline. This model indicated that, com-
pared with baseline counts, there was on average an overall
significant decrease in S. haematobium egg counts by 52% 1
year after treatment ( ). At baseline, only children 10P ! .001
and 12 years old had significantly higher S. haematobium egg
counts, compared with those who were 14 years old (Pp
and , respectively) after controlling for sex, nu-.035 Pp .007
tritional and anemia status, and microhematuria test scores.
Children with +++, ++, +, and trace microhematuria scores
had on average significantly higher S. haematobium egg counts
than those of children with negative scores at baseline, by
4107%, 1470%, 462%, and 242%, respectively. Additionally,
children with anemia at baseline had significantly higher S.
haematobium egg counts (by 11%) than children without ane-
mia ( ). Boys also had significantly higher S. haema-Pp .026
tobium egg counts (by 11%) than girls at baseline ( ).Pp .020
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Table 4. Estimates from 2-level hierarchical model for the change of body-mass-index z score (BMIZ) and height-for-age z score
(HAZ) ( ).np 1130
Model
Coefficient (95% CI)
for change in BMIZ P
Coefficient (95% CI)
for change in HAZ P
Fixed effects
Intercept 0.519 (1.003 to 0.035) .053 0.143 (0.073 to 0.359) .214
Baseline intensity of Schistosoma haematobium
infection (reference category: uninfected)
Lightly infected 0.060 (0.133 to 0.253) .543 0.032 (0.059 to 0.124) .490
Heavily infected 0.218 (0.030 to 0.465) .085 0.078 (0.040 to 0.196) .193
Male sex (reference category: female) 0.011 (0.100 to 0.122) .850 0.066 (0.119 to 0.013) .015
Baseline age (reference category: 14 years old)
13 years 0.120 (0.649 to 0.410) .658 0.134 (0.388 to 0.119) .300
12 years 0.375 (0.816 to 0.067) .097 0.236 (0.447 to 0.025) .029
11 years 0.396 (0.835 to 0.043) .077 0.177 (0.386 to 0.033) .099
10 years 0.483 (0.915 to 0.051) .029 0.008 (0.215 to 0.198) .936
9 years 0.347 (0.778 to 0.084) .115 0.000 (0.206 to 0.206)) .999
8 years 0.448 (0.879 to 0.017) .042 0.051 (0.155 to 0.257) .625
7 years 0.642 (1.083 to 0.201) .004 0.033 (0.244 to 0.178) .757
6 years 0.483 (1.051 to 0.085) .096 0.428 (0.157 to 0.699) .002
Baseline anemia (reference category: not anemic) 0.005 (0.114 to 0.123) .939 0.041 (0.098 to 0.015) .153
Baseline hematuria (reference category: negative)
Trace 0.166 (0.389 to 0.057) .144 0.063 (0.169 to 0.043) .243
+ 0.147 (0.416 to 0.123) .286 0.014 (0.142 to 0.114) .829
++ 0.054 (0.208 to 0.317) .685 0.027 (0.152 to 0.097) .669
+++ 0.110 (0.356 to 0.136) .383 0.058 (0.174 to 0.059) .334
Baseline BMIZ 0.588 (0.628 to 0.548) !.001 0.054 (0.035 to 0.073) !.001
Baseline HAZ 0.184 (0.135 to 0.232) !.001 0.138 (0.161 to 0.115) !.001
Variance components (SE)
Random effects
Level 2 variance (between schools) 0.155 (0.065) 0.009 (0.004)
Level 1 variance (between children within a school) 0.846 (0.036) 0.194 (0.008)
NOTE. Anemia was defined (according to World Health Organization guidelines) as a hemoglobin concentration !11.5 g/dL for children 5–11 years old and
!12.0 g/dL for children 12–14 years old. +, weakly positive; ++, moderately positive; +++, highly positive; CI, confidence interval.
Figure 1A shows that children with the most severe micro-
hematuria scores harbored higher intensities of S. haematobium
infection than children who were negative for microhematuria
at baseline. Children with anemia at baseline also harbored
slightly higher intensities of S. haematobium infection than
those without anemia (figure 1B).
Results from the 2-level logistic regression model for the
probability of being wasted did not suggest associations with
any baseline characteristics examined other than age. In par-
ticular, there was a trend toward younger children being less
likely to be wasted, although none of the other odds ratios
(ORs), except for those for 10-year-old children, were signifi-
cantly different from the ORs for 14-year-old children (Pp
). Furthermore, the 2-level logistic regression model of the.022
probability of being stunted at baseline suggested a trend toward
younger children being less likely to be stunted; the OR for 6–
12-year-old children was significantly different from that for
14-year-olds. In addition, children with anemia were almost
1.5 times more likely than those without anemia to be stunted
at baseline ( ; data not shown).Pp .034
Table 4 contains estimates from the two 2-level linear mul-
tilevel models for changes in HAZ and BMIZ during the period
studied. The effect for the 14-year-old comparison group was
a decrease in BMIZ of 0.519 units, which was of borderline
significance ( ). This suggests that there was no dra-Pp .053
matic change over the period studied in this group. However,
children who were 7, 8, and 10 years old at baseline had a
greater decrease in BMIZ, compared with 14-year-olds. The
coefficients of the continuous variables that refer to the baseline
HAZ and BMIZ scores indicated that BMIZ increased for
wasted children, whereas, BMIZ decreased for stunted children
more than that of children with no nutritional problems. These
results can be obtained if one multiplies the coefficients of HAZ
and BMIZ by 2 (i.e., the cutoff score that defines wasting
and stunting, respectively).
The effect for the 14-year-old comparison group was a non-
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Table 5. Estimates from 3-level hierarchical models for hemoglobin concentration before and after treatment, taking into account
adjustment and nonadjustment for microhematuria scores ( ).np 1124
Model
Coefficient (95% CI)
with adjustment for
microhematuria P
Coefficient (95% CI)
without adjustment for
microhematuria P
Fixed effects
Intercept 11.473 (11.067 to 11.879) !.001 11.480 (11.074 to 11.886) !.001
Effect of year 1 follow-up relative to baseline 0.092 (0.031 to 0.215) .146 0.093 (0.030 to 0.216) .139
Baseline intensity of Schistosoma haematobium
infection (reference category: uninfected)
Lightly infected 0.107 (0.311 to 0.097) .303 0.079 (0.238 to 0.080) .332
Heavily infected 0.084 (0.354 to 0.186) .542 0.220 (0.410 to 0.030) .024
Male sex (reference category: female) 0.035 (0.158 to 0.088) .577 0.039 (0.162 to 0.084) .538
Baseline age (reference category: 14 years old)
13 years 0.026 (0.383 to 0.331) .888 0.037 (0.396 to 0.322) .838
12 years 0.136 (0.489 to 0.217) .452 0.138 (0.493 to 0.217) .445
11 years 0.334 (0.683 to 0.015) .061 0.353 (0.704 to 0.002) .048
10 years 0.468 (0.813 to 0.123) .008 0.471 (0.818 to 0.124) .008
9 years 0.296 (0.643 to 0.051) .095 0.290 (0.639 to 0.059) .103
8 years 0.425 (0.780 to 0.070) .019 0.415 (0.772 to 0.058) .022
7 years 0.817 (1.205 to 0.429) !.001 0.816 (1.206 to 0.426) !.001
6 years 0.693 (1.297 to 0.089) .024 0.685 (1.289 to 0.081) .026
Baseline hematuria (reference category: negative)
Trace 0.108 (0.115 to 0.331) .344
+ 0.135 (0.149 to 0.419) .352
++ 0.229 (0.063 to 0.521) .124
+++ 0.318 (0.577 to 0.059) .016
Baseline thinness or wasting (reference category:
not wasted) 0.042 (0.162 to 0.078) .488 0.042 (0.162 to 0.078) .491
Baseline shortness or stunting (reference category:
not stunted) 0.149 (0.351 to 0.053) .148 0.155 (0.359 to 0.049) .135
Variance components (SE)
from the model with
adjustment for microhematuria
Variance components (SE)
from the model without
adjustment for microhematuria
Random effects
Level 3 variance (between schools) 0.136 (0.056) 0.140 (0.057)
Level 2 variance (between children within a school) 0.514 (0.051) 0.519 (0.051)
Level 1 variance (measurement occasions within a child) 1.106 (0.047) 1.116 (0.047)
NOTE. Wasting denotes reduced body weight for height, defined as a body-mass-index z score less than 2. Stunting denotes reduced body length in
relation to a reference standard, defined as a height-for-age z score less than 2. +, weakly positive; ++, moderately positive; +++, highly positive; CI, confidence
interval.
significant ( ) increase in HAZ of 0.143 units. Com-Pp .214
pared with 14-year-olds, 6-year-olds had a significantly greater
increase, whereas the 12-year-olds had a decrease in HAZ (sig-
nificantly different from that of 14-year-olds). Boys had a sig-
nificantly smaller increase in HAZ than girls. Likelihood ratio
tests indicated a better fit in both models mentioned above
when we included HAZ and BMIZ as explanatory continuous
variables and not the relevant categorical ones that would de-
note wasting and stunting if HAZ or BMIZ was, respectively,
less than 2 SD.
Table 5 contains the estimates of two 3-level hierarchical
models for Hb concentrations before and after chemothera-
peutic treatment, taking into account adjustment and nonad-
justment for microhematuria scores. From the former model
it was estimated that an overall increase of 0.092 g/dL in Hb
concentration after treatment was not significant ( ).Pp .146
Children with +++ microhematuria scores had significantly
lower Hb concentrations (0.318 g/dL; ) than micro-Pp .016
hematuria-negative children at baseline. Children who were 6,
7, 8, and 10 years old at baseline had significantly lower Hb
concentrations ( , , , and ,Pp .024 P ! .001 Pp .019 Pp .008
respectively) than those who were 14 years old, after controlling
for intensity of S. haematobium infection, sex, hematuria, wast-
ing, and thinness. From the alternative model, which did not
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Table 6. Estimates from a 2-level hierarchical model for changes in hemoglobin concentration
( ).np 1130
Model Coefficient (95% CI) P
Fixed effects
Intercept 0.128 (0.888 to 0.633) .747
Baseline intensity of Schistosoma haematobium infection
(reference category: uninfected)
Lightly infected 0.081 (0.350 to 0.187) .553
Heavily infected 0.258 (0.602 to 0.086) .141
Male sex (reference category: female) 0.050 (0.105 to 0.205) .529
Baseline age (reference category: 14 years old)
13 years 0.625 (1.364 to 0.114) .097
12 years 0.605 (1.222 to 0.013) .055
11 years 0.435 (1.049 to 0.179) .165
10 years 0.464 (1.067 to 0.140) .132
9 years 0.719 (1.321 to 0.117) .019
8 years 0.284 (0.886 to 0.318) .355
7 years 0.139 (0.753 to 0.475) .657
6 years 0.788 (1.575 to 0.002) .050
Baseline anemia (reference category: not anemic) 1.488 (1.323 to 1.653) !.001
Baseline hematuria (reference category: negative)
Trace 0.106 (0.204 to 0.415) .504
+ 0.029 (0.404 to 0.345) .878
++ 0.010 (0.354 to 0.375) .955
+++ 0.361 (0.019 to 0.702) .039
Baseline thinness or wasting (reference category:
not wasted) 0.057 (0.226 to 0.112) .506
Baseline shortness or stunting (reference category:
not stunted) 0.004 (0.225 to 0.234) .971
Variance components (SE)
Random effects
Level 2 variance (between schools) 0.123 (0.062)
Level 1 variance (between children within a school) 1.647 (0.070)
NOTE. Anemia was defined (according to World Health Organization guidelines) as a hemoglobin concentration
!11.5 g/dL for children 5–11 years old and !12.0 g/dL for children 12–14 years old. Wasting denotes reduced body
weight for height, defined as a body-mass-index z score less than 2. Stunting denotes reduced body length in
relation to a reference standard, defined as a height-for-age z score less than2. +, weakly positive; ++, moderately
positive; +++, highly positive; CI, confidence interval.
adjust for microhematuria scores, estimates of the parameters
mentioned previously remained approximately the same, but
the effect of S. haematobium infection intensity became sig-
nificant, such that children who were heavily infected with S.
haematobium at baseline had significantly lower Hb concen-
trations (0.220 g/dL; ) than uninfected children. ThisPp .024
suggests that because the variable of microhematuria scores is
related to both Hb concentration and the intensity of S. hae-
matobium infection, 2 different causal effects of S. haematobium
infection on Hb concentrations are indicated. Two-way inter-
action terms were also tested, but because they were not sig-
nificant, they were omitted from the models presented. Also,
variances in all 3 levels of the second model were higher than
the corresponding ones in the first model, which implies that
the microhematuria scores explain some of the variability in
the studied outcome across all 3 levels of the models presented.
Finally, table 6 contains estimates from the 2-level linear
multilevel model for the change in Hb concentration over the
course of the period studied. This model suggested that the
change varied significantly as a function of the following base-
line characteristics: anemic status, +++ microhematuria score,
and age. The effect for the comparison group (baseline unin-
fected, male, 14 years old, not anemic, negative microhematuria
score, not wasted, and not stunted) was a decrease in Hb con-
centration of 0.128 g/dL, which was not significant ( ).Pp .747
Significant increases in Hb concentration during the period
studied were observed among children with anemia at baseline
(increase by 1.360 g/dL [that is, 1.488–0.128 g/dL]; )P ! .001
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and among children with +++ microhematuria scores at base-
line (increase by 0.233 g/dL [that is, 0.361–0.128 g/dL]; Pp
). Marginally significant decreases in Hb concentration dur-.039
ing the same period were observed in children who were 12
years old at baseline; these children had a greater decrease, by
0.733 g/dL (that is, 0.605–0.128 g/dL; ), in Hb con-Pp .055
centration than 14-year-old children. In addition, 9-year-old
children had a significantly greater decrease in Hb concentra-
tion, by 0.847 g/dL (that is, 0.719–0.128 g/dL; ).Pp .019
DISCUSSION
Among the different schistosomes infecting humans, S. hae-
matobium is responsible for the largest number of infections.
It has been estimated that, in sub-Saharan Africa, 112 million
people are infected with S. haematobium, compared with 54
million infected with S. mansoni [23]. However, S. haemato-
bium remains largely unstudied, particularly in comparison to
S. mansoni, primarily because of the more demanding condi-
tions for its laboratory maintenance. This is also reflected in
the paucity of research examining the potential effectiveness of
praziquantel against S. haematobium under various experi-
mental and clinical circumstances [24]. To our knowledge, the
present study represents the first longitudinal study in Africa
that reports on the relationship between S. haematobium in-
fection and its associated morbidity as a whole, by use of a
uniquely detailed large data set from 16 randomly selected
schools across the entire national territory of Burkina Faso.
Moreover, these data have the potential to provide important
evidence characterizing urinary schistosomiasis-associated mor-
bidity, particularly in a population such as that of Burkinabe´,
where the prevalence of hookworms and other soil-transmitted
helminthiasis is estimated to be very low. Although previous
studies have tended to focus on the impact of large-scale control
programs on intense transmission of S. haematobium infection
with regard to Hb concentrations and anemia only (Tohon Z,
Boubacar Mainassara H, Elhaj Mahamane A, et al., submitted)
[25], to parasitological measures only [26, 27], or to S. hae-
matobium morbidity indicators before and after treatment [28],
the present study examined all these issues together and also
adjusted for potential differences in demographic characteristics
as well as potential confounders.
We have demonstrated that children with anemia or children
with more severe microhematuria scores at baseline had higher
S. haematobium infection intensities (table 3 and figure 1),
which suggests that heavy intensities of S. haematobium infec-
tion can be associated with anemia and hematuria. We also
provide evidence that heavy infections of urinary schistoso-
miasis are associated with lower Hb concentrations and, as a
consequence, with potential anemia, given that the models in
table 5 indicate that S. haematobium infection might be asso-
ciated with anemia in 2 different ways. More precisely, he-
maturia—which, as demonstrated previously (Tohon Z, Bou-
bacar Mainassara H, Elhaj Mahamane A, et al., submitted) [29],
is associated with S. haematobium infection—can be an im-
portant cause of blood and iron loss, which also may lead to
anemia. Our data suggest significant reductions in the preva-
lence and, more importantly, intensity of infection of S. hae-
matobium as well as in the percentages of children with positive
microhematuria scores 1 year after treatment (tables 2 and 3).
The children who most benefited from anthelmintic treat-
ment in terms of increased Hb concentration were those with
anemia at baseline and those who had +++ microhematuria
scores at baseline (table 6), which confirms similar findings
presented elsewhere [30, 31]. The mechanisms by which treat-
ment for S. haematobium infection allows Hb concentrations
to increase in children with anemia may be the decrease in
blood in urine that results from a reduction in the intensity of
S. haematobium infection [32].
Growth and nutritional status have been proposed to rep-
resent the most sensitive indicators of health in children [33].
Furthermore, one of the factors emphasized in the World De-
velopment Report 1993 is the relationship between parasitic
infections and malnutrition [2]. We examined whether greater
S. haematobium egg counts were associated with increased risks
of wasting or stunting at baseline, adjusting for demographic
characteristics and other potential predictors such as micro-
hematuria and anemia status. The results of this study did not
suggest any significant association between the risk of under-
nutrition and intensity of S. haematobium infection, with only
age being revealed as a significant factor. Younger children
tended to be less likely to be wasted or stunted than 14-year-
old children, which could imply prior malnutrition in these
older children, as has been reported elsewhere [1]. In the afore-
mentioned study, the authors also reported that, in Zanzibari
boys, the association between microhematuria and poor growth
was only marginally significant [1], which is in line with our
findings that, in the Burkinabe´ children, changes in the BMIZ
scores depended only on age, whereas changes in the HAZ
scores depended on age and sex (table 4). A more plausible
explanation for the lack of statistical association between the
intensity of S. haematobium infection and stunting may relate
to dropout bias toward stunted children (table 1); this means
that it is difficult to make a definitive conclusion regarding the
relationship between urinary schistosomiasis and stunting in
our study population [34].
Nevertheless, it must be considered that essential method-
ological constraints inherent in the present study design—in
particular the lack of a control group, which was necessary for
ethical reasons, could result in some potential bias toward the
estimation of the absolute impact of the treatment, thereby
allowing only the relative impact of the treatment in different
groups of children to be calculated. However, even though these
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data were obtained from a large-scale control program and stud-
ies such as ours are generally difficult to execute in terms of
design, methodology, and sampling, we believe that the results
will be of substantial value in estimating the total benefit that
control of schistosomiasis can provide to communities [35].
This study shows that praziquantel can have a substantial
impact on S. haematobium infection and associated disease
when delivered as part of a large-scale control program in a
country such as Burkina Faso, which was the first country in
the WHO African Region to achieve nationwide coverage with
anthelminthic drugs against 3 major neglected tropical diseases:
lymphatic filariasis, schistosomiasis, and soil-transmitted hel-
minthiasis [36]. Our findings suggest a dramatic reduction in
the prevalence and intensity of S. haematobium infection, an
improvement in Hb concentration in certain groups of chil-
dren, and reductions in schistosome-related morbidity in a co-
hort of Burkinabe´ schoolchildren, which demonstrate that mass
chemotherapy can offer a practical strategy for the control of
S. haematobium infection and its associated morbidity.
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Abstract. We assessed morbidity indicators for both Schistosoma haematobium and Schistosoma mansoni infections
and evaluated the appropriateness of the World Health Organization (WHO) guidelines for ultrasound in schistoso-
miasis in the context of large-scale control interventions. Abdominal and urinary tract ultrasonography was performed
on 2,247 and 2,822 school children, respectively, from 29 randomly selected schools in Mali before the implementation
of mass anthelminthic drug administration. Using two-level logistic regression models, we examined associations of
potential factors with the risk of having a positive ultrasound global score (morbidity indicative of S. haematobium
infection), abnormal image pattern scores, dilatation of the portal vein, and/or enlarged liver (morbidity indicative of S.
mansoni infection). The WHO protocol was found useful for detection of S. haematobium pathology but overestimated
the risk of portal vein dilatation and left liver lobe enlargement associated with S. mansoni infection. We conclude that
ultrasonography should be included in large-scale control interventions, where logistics allow, but cautiously.
INTRODUCTION
Schistosomiasis remains one of the most prevalent parasitic
diseases in developing countries and has significant economic
and public health consequences.1 Recently, it has been esti-
mated that the urinary type of schistosomiasis, resulting from
infection with Schistosoma haematobium, causes hematuria in
70 million people and major bladder wall pathologic effects in
18 million people in sub-Saharan Africa.2 Schistosoma man-
soni, one of the etiologic agents of the intestinal type of schis-
tosomiasis, is responsible for bloody diarrhea in an estimated
4.4 million people, and an estimated 8.5 million people have
hepatomegaly due to the infection. The death rate due to S.
mansoni-related hematemesis may be up to 130,000 per year
in sub-Saharan Africa.2 King and others have argued convinc-
ingly that additional subtle morbidities (i.e. symptoms such as
anemia, chronic pain, diarrhea, exercise intolerance, growth
stunting, and nutritional and cognitive impairment, which
have so far been difficult to quantify and are based on ob-
served association rather than established causality) should
be added to these estimates of disease burden.3
Since 1984 the World Health Organization (WHO) Expert
Committee on the Control of Schistosomiasis has recom-
mended a strategy for morbidity control that is now feasible
because of the availability of effective, affordable, and safe
single-dose drugs.4 As a consequence, since 2003, the Schis-
tosomiasis Control Initiative (SCI) has assisted six sub-
Saharan African countries to develop and implement schisto-
somiasis morbidity control programs through the provision of
health education and mass treatment, using praziquantel for
schistosomiasis and co-administering, where appropriate, al-
bendazole for soil-transmitted helminthiasis. The primary ob-
jective of these SCI-supported control programs is to achieve
and demonstrate a quantifiable reduction in schistosome-
associated morbidity as a consequence of such chemothera-
peutic intervention. Inherent within such an objective, it is
therefore imperative to both define and characterize pre-
treatment baseline morbidity levels within the risk popula-
tions so that any subsequent changes in morbidity caused by
the intervention can be accurately determined.5 Furthermore,
identification of sensitive and specific indicators of schisto-
some-associated morbidity that may be practically imple-
mented within such large scale-control programs, as distinct
from the individual clinical or research-based setting, should
also prove invaluable in assisting identification of target
populations for ongoing and future intervention.6 Campagne
and others also emphasized the need to validate indirect mor-
bidity indicators to know the development of their predictive
value during different stages of a schistosomiasis control pro-
gram.7
Ultrasonography is currently the diagnostic tool of choice
for detecting pathologic conditions associated with schistoso-
miasis, such as dilatation of the renal pelvis, bladder wall
lesions, liver fibrosis and enlargement, and dilatation of the
portal vein.8,9 For detection of infection with S. haematobium,
ultrasonography is an established method for detecting urinary
tract pathologic effects not only in the hospital setting,10–13
but also in field-based studies,14 with the advantage of being
non-invasive, relatively simple to perform, well accepted by
communities, and providing a direct image of the pathologic
changes.15 Additionally, ultrasonography provides sensitive
and precise measurements of S. mansoni-associated patholog-
ic changes16,17 In the attempt to objectively define and cat-
egorize the pathologic changes associated with schistosomia-
sis and to standardize the different scoring systems used in the
past in different disease-endemic areas,18,19 successive ultra-
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sound consensus meetings were held in Niamey, Niger in 1996
and Belo Horizonte, Brazil in 1997. These meetings led to the
revision of standardized scoring protocols and the develop-
ment of the WHO-recommended ultrasonography protocol
(Niamey-Belo Horizonte protocol).19 Nevertheless, the prog-
nostic features of individual ultrasonography findings in dif-
ferent disease-endemic situations,17 as well as whether ultra-
sonography can be incorporated into a mass chemotherapy
program to monitor morbidity, are still to be confirmed.
The aim of this study was to assess indicators of ultraso-
nography-detectable morbidity caused by infection with both
S. haematobium and S. mansoni in the context of large-scale
control interventions targeting school age children in Mali
before large-scale administration of praziquantel by the Na-
tional Schistosomiasis Control Program with support from
SCI. In Mali, both S. haematobium and S. mansoni pose se-
rious public health problems.20 Fishing, market gardening,
and rice cultivation all expose the population to the risk of
occupational transmission, and children are regularly exposed
through bathing and playing in ponds, streams, and rivers.
Schistosoma haematobium transmission is more widespread,
occurring along river and streams, as well as around ponds
and in irrigation schemes.21,22 The geographic distribution of
S. mansoni infections is more restricted, mainly occurring in
irrigation schemes, such as Office du Niger, Bandiagara, Sé-
lingue, and Baguinéda-Koulikoro.22,23
The results obtained here should contribute to evaluate the
appropriateness and the role of the full WHO protocol in the
context of large-scale schistosomiasis control programs. We
also aimed to determine whether the numeric WHO cut-off
values, originally derived from a healthy Senegalese popula-
tion in an area not endemic for S. mansoni, contain bias in the
estimation of the risk of dilatation of portal vein and enlarge-
ment of left liver lobe in a Malian setting. This will be
achieved here by comparison with local height-indexing of
portal vein diameter (PVD) scores and longitudinal paraster-
nal line scores (PSL), respectively, obtained from children
who had normal image patterns as assessed by ultrasonogra-
phy using the recommendations of King and others.17
MATERIALS AND METHODS
Preparation of the survey and selection of schools. The Ma-
lian Ministry of Health, through its National Institute of Re-
search in Public Health (Institut National de Recherche en
Santé Publique [INRSP]) and its Disease Prevention and
Control Division (Direction Nationale de la Santé), was
charged with planning and implementing data collection with
assistance from the SCI. Baseline data collection was initiated
in the Ségou region in late March 2004 and was completed in
Bamako in June 2004. Ultrasonagraphic examination based
on the WHO protocol was performed on children 7–14 years
of age (2,841 for S. haematobium and 2,820 for S. mansoni)
from 29 schools. These schools were randomly selected from
all schools in three areas highly endemic for schistosomiasis:
Bamako, Ségou, and Baguinéda-Koulikoro (Figure 1). All
children enrolled in the study were interviewed by appropri-
ately trained Ministry of Health staff. Ethical clearance was
obtained from the Ministry of Health, Mali and Imperial Col-
lege, London.
Sampling design. In schools from areas known to be en-
demic for only S. haematobium, the estimated sample size was
calculated to be 180 persons per sampling unit (usually a
school) with 80% power to detect a 70% reduction in S. hae-
matobium mean intensity over a two-year period (two annual
treatments). The expected reductions of 70% in S. haemato-
bium and 60% in S. mansoni mean intensities over two annual
treatments were calculated using the EpiSchisto software tool
(http://www.schoolsandhealth.org/epidynamics.htm). The fig-
ure of 180 was selected based on prevalence/intensity data
from schools in various African countries with similar age
ranges (Table 1). Since the relationship between prevalence
and intensity varied between countries, a different k value (an
inverse measure of worm aggregation in the host population
that was estimated by maximum likelihood estimation using
the negative binomial relationship between prevalence and
intensity) was estimated separately for each country. Conse-
quently, a different sample size was calculated for each coun-
try in Table 1 and the value of 180 was selected because it was
the maximum of all values. Calculations were made for the
sample size of the entire school so that results were compa-
rable between countries. A simple approach of a paired
sample t-test with level of type I error  0.05 for testing the
difference between pre-treatment mean intensity and post-
treatment mean intensity was followed. Finally, we allowed
for an overall dropout rate of 40% over the course of the
monitoring period.
Where both S. haematobium and S. mansoni infections
were known a priori to be prevalent, the same methodology
as for only S. haematobium was followed, although the num-
ber of surveyed children was increased to 300 per school with
80% power because EpiSchisto simulations showed an ex-
pected reduction in mean S. mansoni intensity of 60%. Since
the difference of the two means became larger compared with
that of S. haematobium infection, the magnitude of the non-
centrality parameter increased the required sample size
needed to achieve suitable statistical power. No schools were
included in the present study in which only S. mansoni infec-
tion was prevalent.
Whenever it was difficult to recruit the required number of
children in any one school (usually because of the small size
of the school), we combined data from two or more adjacent
schools provided that they appeared to be ecologically similar
(e.g., with the same relative proximity to the nearest supposed
focus of transmission). For ethical reasons, it was not appro-
priate to include any untreated control groups. Further tech-
nical details concerning the sample size calculations can be
found elsewhere.24
Parasitologic examination. From each child, two urine
specimens were collected on two consecutive days to deter-
mine the intensity of S. haematobium infection using filtration
method. 10 mL of urine were passed through a Whatman
(Brentford, United Kingdom) filter paper (Ø 25 mm) using
a Millipore (Billerica, MA) Swinnex filter support. Filters
were stained with 3% ninhydrin and microscopically exam-
ined for eggs. The intensity of S. haematobium infection was
expressed as number of eggs per 10 mL of urine and the mean
intensity of infection was the arithmetic mean of egg counts in
the two urine samples. To determine the presence and extent
of microhematuria (invisible hematuria), all urine specimens
were tested for detectable blood with urine reagent strips
(Hemastix; Bayer, Tarrytown, NY). The results were re-
corded semi-quantitatively as −, +, ++, and +++. Additionally,
two fecal specimens (each 41.7 mg) were screened for S. man-
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soni by the Kato-Katz technique.25–27 Individual egg output
was expressed as eggs per gram of faces (epg), which was
calculated as the arithmetic mean of the two individual slide
counts.
Ultrasound examinations. Utrasonographic assessments
were performed with a portable ultrasonography device
(SSD-500; Aloka, Tokyo, Japan). A convex 3.5-Mhz trans-
ducer was used to detect pathologic changes associated with
both S. haematobium and S. mansoni infection. All examina-
tions were performed by the same clinician (A.D.K.), who
was blind to schistosome infections status of the individual
children. Ultrasonographic examinations were performed ac-
cording to current WHO guidelines.19
Pathologic changes caused by S. haematobium were as-
sessed by recording the shape of the urinary bladder, defining
any lesions detected on the bladder wall, and measuring the
degree of dilation of the ureters and renal pelvis. The exact
coding of each of these characteristics was made according to
the recommendations of Richter and others.19 Further cat-
egorization of pathologic changes was performed by calculat-
ing the global score, which serves as an index of severity of
morbidity and lesions. Children were provided with water and
asked to drink abundantly before having an ultrasonographic
examination, which took place only when the bladder was
filled. In case of detection of dilatation of the renal pelvis,
which is suggestive of hydronephrosis, the child was re-
examined after urination to rule out the possibility that such
dilatation was caused by bladder and urethral repletion.
To characterize morbidity caused by S. mansoni, the size of
the left liver lobe was measured in PSL. Measurements of
PVD were also performed. Liver patterns were graded from
A to F, in order of the severity of the pathologic changes they
indicate. B0, B1, and B2 are most often grouped together, as
are C1 and C2. It should be noted, however, that the SCI
protocol did not include periportal thickening measurements
TABLE 1
Sample data used in the study
Infection Data used
S. mansoni Uganda SCI survey, 11,844 children 5–12 years
of age from 135 schools
S. mansoni Uganda SCI baseline survey, 3,689 children 6–12
years of age from 32 sentinel schools in 7
districts
S. mansoni Busia region, Kenya, 603 children 6–12 years of
age from 25 schools
S. haematobium Tanga region, Tanzania, 1,396 children 8–13
years of age from 41 schools
S. haematobium Volta region, Ghana, 1,216 children 6–12 years
of age from 57 schools
FIGURE 1. Location of sampled schools in Mali. Schools in Bamako and Koulikoro are in the upper box and schools in Ségou are in the lower
box.
KOUKOUNARI AND OTHERS1044
because of concerns about both the reproducibility of mea-
surements16 and the time-consuming component of the ex-
amination. Therefore, interpretation of the final score for
morbidity caused by S. mansoni infection was based on as-
sessment of image patterns and portal hypertension only.
Presence of ascites and portosystemic collaterals was also re-
corded. Detection of pathologic changes not caused by schis-
tosomiasis was also recorded but is not discussed in the
present paper. Persons in need of health care were directed to
the nearest medical facility.
Ultrasonography protocol definitions. The WHO protocol
states that measurements of organ size and vein diameter
should be height-adjusted, using standard reference measure-
ments for healthy members of the same population group.19
King and others found that the numeric WHO cut-off values
derived from a healthy Senegalese population in an area not
endemic for S. mansoni seriously overestimated the risk of
portal vein enlargement in Kenyan and Egyptian patients in-
fected with S. mansoni.17 We have also investigated this issue
in a Malian setting because the Niamey workshop members
anticipated the refinement of the guidelines through contin-
ued use and evaluation, by using alternative height-indexing
of PVD scores obtained from all children that had normal
image patterns as assessed by ultrasonography (n  2,719).
With reference to the PSL measurement, the liver was con-
sidered enlarged, or much enlarged if the height-adjusted
value exceeded two or four SD in relation to the normogram
produced for a Senegalese population, respectively.28 In ad-
dition, we also calculated local cut-off scores for liver left lobe
enlargement and verified if the overestimation also applied to
this parameter.
At the end of all examinations, each child enrolled in the
survey was treated with the WHO-recommended dose of
praziquantel (40 mg/kg) for schistosomiasis and with albenda-
zole (400 mg) for intestinal helminths. Side effects were moni-
tored, and adverse reactions after drug administration were
infrequent; when present, these were minimal and transient,
and no severe adverse experiences were observed.
Statistical analysis. Data from children with incomplete
parasitologic or ultrasonographic records were excluded from
our analysis and no replacements were made for missing sub-
jects under the assumption that data were missing at ran-
dom.29 Descriptive statistics for subject characteristics and
outcomes were calculated using SAS version 8 (SAS Institute
Inc., Cary, NC).
To examine S. haematobium morbidity, we modeled the
probability of a child having a positive individual global score
using hierarchical multi-variable logistic regression. Potential
predictors included S. haematobium infection intensity cat-
egory (light [< 50 schistosome eggs per 10 mL of urine] or
heavy [ 50 eggs/10 mL),24 microhematuria, sex, school-level
S. haematobium infection prevalence (classified as low [<
10%], medium [11–49%], and high [ 50%]), and age. The
model structure was a two-level random intercept logistic re-
gression model with level-1 defined as the individual child and
level-2 as the school allowing for assessment of the extent of
between-school variation in individual global scores. The
model had the form
logij1 − ij = xija + wjb + uj + eij
where ij is the probability that child i in school j has a posi-
tive individual global score, xij and wj are vectors of indi-
vidual- and school-level characteristics respectively, a and b
are vectors of estimated parameter coefficients, uj (∼Nor-
mal(0, 2)) is an error term at the school level, and eij (∼Nor-
mal(0, 2)) is an error term at individual level.
To study the morbidity of S. mansoni, we used three hier-
archical multi-variable logistic regression models where we
aimed to model 1) the probability of having abnormal image
pattern scores, 2) the probability of having dilatation or
marked dilatation as assessed by the PVD based on the Ma-
lian cut-off scores, and 3) the probability of having enlarged
liver as assessed by the PSL measurements based on the Ma-
lian cut-off scores. Potential predictors included S. mansoni
infection intensity category (light [1–99 epg of feces, moder-
ate [100–399 epg], or heavy ( 400 epg]),30 sex, school-level S.
mansoni prevalence (included in the relevant models as a
categorical variable and classified as that of S. haematobium),
and age. The structure and form of the model used to assess
each of these S. mansoni morbidity indicators, were identical
to those used for evaluation of S. haematobium.
All four models were constructed using the Mlwin software
(version 2.01; Multilevel Models Project, Institute of Educa-
tion, University of London, London, United Kingdom). The
method of estimation was the second-order, penalized, quasi-
likelihood procedure,31 and first-order marginal quasi-
likelihood estimates were used to provide the starting values
for the estimation procedure, the stability of the algorithm,
and convergence criteria.32 The model structure was selected
because of the hierarchical nature of the dataset, i.e., children
were clustered in schools and observations from children
within the same school were therefore not independent. Mul-
tilevel models account for this dependence by partitioning the
total variance in the data into variation between and variation
within the higher-level units.33 Although partitioning of vari-
ance is straightforward in models with a continuous depen-
dent variable and with a normally-distributed error at each
level of the hierarchy, their extension to models with binary
responses is more problematic. For the school effect in each
model we calculated the median odds ratio (MOR) to quan-
tify the variation between schools.34,35 The MOR is always 
1 and directly comparable with fixed-effects odds ratios. More
precisely, if the MOR  1, there is no variation between
clusters (no second-level variation). If there is considerable
between cluster variation, the MOR will be large.
This quantification of the heterogeneity of the schools is
not simply of technical value; the apportioned variances are
of substantive interest in much of biomedical research be-
cause they give important insights to the level at which the
action lies36 and for epidemiologic reasons (in this case quan-
tification of the importance of the schools for understanding
individual health).35 The percentage of total variation in the
ultrasonographic global scores as well as in the liver image
patterns, the PVD and the PSL, which are explained by each
of the corresponding models presented, was estimated using
an R2 measure developed by Snidjers and Boskers.37
RESULTS
Schistosoma haematobium was prevalent in all 29 schools
surveyed, and S. mansoni was prevalent in 25 of these schools.
Schistosoma haematobium. Ultrasonographic examina-
tion was performed on 2,841 children. Of these, parasitologic
data were obtained from 2,822 children. In 136 (4.8%) of
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2,822, there was no second examination of urine and preva-
lence and mean intensity calculations were based on one
urine filtration result for these children. Overall, S. haemato-
bium prevalence of infection was 59% and the arithmetic
mean intensity was 43.0 eggs/10 mL of urine. At school level,
prevalence of infection ranged from 10.8% to 100.0% and
arithmetic mean intensity ranged from 0.7 to 202.5 eggs/10
mL of urine. Girls accounted for 53% of children in the sur-
vey and approximately equal numbers of children were re-
cruited in each year group from 7 to 14 years of age. Bladder
wall thickening and irregularities, bladder masses, and
pseudo-polyps, were found in 6.0% of the children. The
prevalence of upper urinary tract (kidney) pathology was es-
timated to be 3.7%. The prevalence of positive global scores
was estimated to be 10.1%, and this prevalence at the school-
level ranged from 1.0% to 61.4%.
The odds ratios (ORs) from two-level logistic regression
analysis for the probability of having a positive ultrasono-
graphic global score are shown in Table 2. Children with ei-
ther light or heavy S. haematobium infection intensities were
more likely to have a positive ultrasonographic global score
than uninfected children (light: OR  2.6, P  0.013 and
heavy: OR  5.7, P < 0.001). Children with +, ++, and +++
microhematuria scores were significantly more likely to have
positive schistosomiasis ultrasonographic global scores than
microhematuria-negative children (OR 2.4, P 0.003; OR
 3.0, P < 0.001; and OR 5.0, P < 0.001, respectively). Boys
showed significantly higher ultrasonographic morbidity global
scores than girls (OR  2.0, P < 0.001). Age was not a sta-
tistically significant indicator of S. haematobium morbidity,
although there was a trend for older children to be more
likely to have a positive schistosomiasis ultrasonographic
global score. Schools with high S. haematobium prevalence
were significantly more likely to have positive global scores
than those with medium S. haematobium prevalence (OR 
1.7, P < 0.001). Since there were no schools with a low preva-
lence of S. haematobium included in the survey, this category
does not appear in Table 2. This table also shows that a rela-
tively high MOR (2.2) is associated with between-school
variation. Of the total variation in the global ultrasonographic
score, 9.4% remained unexplained at the school level and
48.0% remained unexplained at the child level.
Schistosoma mansoni. Both ultrasonographic and parasito-
logic data were obtained from 2,247 (79.7%) of 2,820 chil-
dren. Overall prevalence of infection was 27% and the overall
arithmetic mean intensity was 119.5 epg. Calculations were
based on two fecal smear examinations from all but four chil-
dren, for whom the second measurement was missing. School-
level prevalence of infection ranged from 0.0% to 96.0% and
arithmetic mean intensity ranged from 0.0 to 814.9 epg.
A total of 2,820 children were examined by ultrasonogra-
phy for S. mansoni-related pathologic changes. Of these chil-
dren, 96% had normal livers, as assessed by liver image pat-
terns. Of the children that had abnormal liver image patterns,
84% had grade B patterns and 16% had grade C patterns.
Figure 2 shows that using the current WHO cut-off value,
85% of the children had a 0 PVD score. In contrast, 96% of
the children had a 0 PVD when the cut-off value derived from
the data from the Malian children with normal liver image
patterns was used. The difference between these two propor-
TABLE 2
Odds ratios (ORs) with 95% confidence interval (CI) estimates and percentage of variation explained for two-level logistic model of prevalence
of positive global score as measured by ultrasound using data set of children with complete parasitologic and ultrasound data on Schistosoma
haematobium infection (n  2,822)
Fixed effects
Variables Categories OR 95% CI P
Age 7 years old 1
8 years old 1.206 0.636–2.284 0.565
9 years old 0.928 0.480–1.792 0.825
10 years old 1.380 0.750–2.538 0.300
11 years old 1.567 0.853–2.877 0.148
12 years old 1.252 0.671–2.336 0.480
13 years old 1.267 0.682–2.355 0.454
14 years old 1.665 0.888–3.124 0.112
S. haematobium intensity infection Not infected 1
Lightly infected 2.578 1.219–5.451 0.013
Heavily infected 5.709 2.521–12.927  0.001
Sex Female 1
Male 2.018 1.483–2.745 < 0.001
Results of Hemastix text Negative 1
Trace hemolyzed 1.578 0.772–3.227 0.212
+ 2.442 1.343–4.441 0.003
++ 3.010 1.722–5.262 < 0.001
+++ 4.973 3.035–8.149 < 0.001
S. haematobium school-level infection prevalence Medium 1
High 4.051 1.824–8.995 < 0.001
Random effects
School Median OR
2.147
Variation %
Total variance explained 42.640
Total variance unexplained
At school level 9.380
At child level 47.980
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tions was statistically significant (P < 0.001). Statistically sig-
nificant differences were also found between the proportions
of children allocated positive PVD scores of four and six using
the two different cut-off values (both P < 0.001).
In 99.9% of the children, no collateral vessels were de-
tected and no free fluid was detected in abdomen. Figure 3
shows that 50% of the children in the ultrasonographic cohort
had left lobe hepatomegaly as assessed by PSL using the cur-
rent WHO cut-off value. A total of 41% of the children had
an enlarged liver and 8% had a greatly enlarged liver. Con-
versely, 99% did not have an enlarged liver when the cut-off
value derived from the data from the Malian children with
normal liver image patterns was used. Statistically significant
differences were found between all proportions of children
allocated null or positive PSL scores of one and two using the
two different cut-off values (P < 0.001).
Table 3 shows the ORs from two-level logistic regression
analysis for the probability of having abnormal image pattern
scores as assessed from ultrasonography for S. mansoni infec-
tion. Children with light, moderate, or heavy S. mansoni in-
fection intensities were more likely to have an abnormal liver
image pattern than uninfected children (light: OR 2.6, P
0.023; moderate: OR  1.3, P  0.62; and heavy: OR  3.1,
P  0.036). There was a trend for older children to be less
FIGURE 3. Percentages of children with longitudinal parasternal scores based on different cut-off values.
FIGURE 2. Percentages of children with portal veins scores based on different cut-off values.
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likely to have an abnormal liver image pattern, but these
differences were only significant for 11-, 12-, 13-, and 14-year-
old children relative to 7-year-old children (OR  0.3, P 
0.027; OR  0.3, P  0.036; and OR  0.2, P  0.016,
respectively). When we attempted to include the school-level
categorical variable that was representing S. mansoni infec-
tion prevalence, classified as low, medium, and high, the al-
gorithm did not converge; therefore, we were unable to in-
clude this variable in the final model. The same applies to the
modeling of the probability of having dilatation or marked
dilatation; therefore, this variable was also excluded from the
model (Table 4).
Table 3 shows that a high MOR (13.4) was associated with
between-school variation. Of the total variation in the liver
image pattern, 67.0% remained unexplained at the school
level and 30.0% remained unexplained at the child level.
Table 4 shows the ORs from two-level logistic regression
analysis for the probability of having dilatation or marked
TABLE 3
Odds ratios (ORs) with 95% confidence interval (CI) estimates and percentage of variation explained for two-level logistic model of prevalence
of abnormal liver image patterns as measured by ultrasound using data set of children with complete parasitologic and ultrasound data on
Schistosoma mansoni infection (n  2,247)
Fixed effects
Variables Categories OR 95% CI P
Age 7 years old 1
8 years old 0.550 0.209–1.450 0.226
9 years old 0.412 0.152–1.120 0.082
10 years old 0.523 0.202–1.353 0.182
11 years old 0.305 0.107–0.875 0.027
12 years old 0.323 0.112–0.926 0.036
13 years old 0.516 0.189–1.404 0.196
14 years old 0.224 0.066–0.755 0.016
S. mansoni intensity infection Not infected 1
Lightly infected 2.622 1.144–6.008 0.023
Moderately infected 1.336 0.423–4.223 0.621
Heavily infected 3.099 1.080–8.895 0.036
Sex Female 1
Male 1.520 0.873–2.648 0.138
Random effects
School Median OR
13.444
Variation %
Total variance explained 3.388
Total variance unexplained
At school level 66.981
At child level 29.631
TABLE 4
Odds ratios (ORs) with 95% confidence interval (CI) estimates and percentage of variation explained for two-level logistic model of prevalence
of having dilatation or marked dilatation as assessed by the ultrasound PVD score based on the Malian cut-off scores by using data set of
children with complete parasitologic and ultrasound data on Schistosoma mansoni infection (n  2,247)
Fixed effects
Variables Categories OR 95% CI P
Age 7 years old 1
8 years old 1.567 0.444–5.525 0.484
9 years old 3.640 1.159–11.435 0.027
10 years old 3.245 1.035–10.172 0.043
11 years old 2.835 0.887–9.064 0.079
12 years old 1.980 0.586–6.687 0.271
13 years old 3.647 1.134–11.730 0.030
14 years old 4.655 1.462–14.826 0.009
S. mansoni intensity infection Not infected 1
Lightly infected 1.402 0.619–3.175 0.418
Moderately infected 1.408 0.547–3.621 0.478
Heavily infected 0.774 0.303–1.979 0.593
Sex Female 1
Male 2.250 1.373–3.687 0.001
Random effects
School Median OR
4.364
Variation %
Total variance explained 6.480
Total variance unexplained
At school level 39.360
At child level 54.159
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dilatation as assessed by ultrasongraphy for S. mansoni infec-
tion PVD height-adjusted measurements based on the Malian
cut-off value. The ORs of having dilatation or marked dila-
tation as assessed by ultrasonographic PVD measurements
for children with light, moderate, or heavy S. mansoni infec-
tion intensities were not significantly different from those of
uninfected children (P  0.418, 0.478, and 0.593, respec-
tively). There was a trend for older children to be more likely
to have an increased PVD, but these differences were only
significant for 9-, 10-, 13-, and 14-year-old children compared
with 7-year-old children (OR  3.7, P  0.027; OR  3.3, P
 0.043; OR  3.7, P  0.030; and OR  4.7, P  0.009,
respectively). The MOR to have an increased PVD was 4.364,
which has a high OR and is associated with between-school
variation. Of the total variation in the PVD, 39.0% remained
unexplained at the school level and 54.2% remained unex-
plained at the child level.
Relative to modeling of the probability of having an en-
larged liver as assessed by PSL measurements based on the
Malian cut-off scores, the algorithm did not converge. There-
fore, we were unable to provide any estimates and establish
any associations for this measure.
DISCUSSION
Ultrasonography has become an invaluable extension of
the clinical investigation of patients with schistosomiasis and
has provided direct evidence of the pathologic changes asso-
ciated with this infection.38 This evidence has been well vali-
dated in the individual patient clinical setting39–42 and the
relatively small-scale research setting.43–46 However, the
overall aim of this study was to test the suitability of the full
WHO-recommended ultrasonography protocol in the context
of large-scale schistosomiasis control programs. There is a
requirement to elucidate whether ultrasonography could, and
indeed should, be incorporated into a mass chemotherapy
program to monitor morbidity associated with S. haemato-
bium infection and, perhaps in particular, morbidity associ-
ated with the often more difficult to characterize S. mansoni
infections in all but the most severe cases.47,48
The current study complements and expands previous ul-
trasonography-based studies within Africa on a number of
issues. First, although previously published surveys17,49–54
have used ultrasongraphy to measure schistosomiasis-
associated morbidity both in children and in adults, which is
indicative of long-term chronic infections, we assessed ultra-
sonography in monitoring schistosomiasis morbidity in con-
trol programs focused on children. Although we recognize
that measuring only children might be a limitation, if one
considers the overall aim of this study, our results still con-
tribute to assessing the suitability of ultrasonography for
more recent infections and targeting age groups for future
disease control programs. This study should also provide a
unique opportunity to clarify the relationship of early lesions
to later ones through a subsequent comparison of the baseline
findings presented here, particularly where there are identi-
fiable cohorts, over extended periods of time. Moreover, in
terms of cohort size, we followed a larger number of persons
than previous research or clinical-based studies. Finally, our
study has methodologic advantages, particularly since we ac-
count for the interdependence of observations by partitioning
the total variance into different components of variation due
to various cluster levels in the data.
Children are probably the most important age group for
ultrasound-detectable morbidity caused by S. haematobium,
and the results obtained from Mali confirm that the current
WHO protocol (Niamey-Belo Horizonte protocol) is a suit-
able and valid public health tool because its scoring criteria
performed acceptably well in defining ultrasound pathology
caused by urinary schistosomiasis. Sophisticated statistical
models yielded significant associations between global ultra-
sonography scores from the WHO protocol and several other
morbidity predictors. A significant association between the
degree of morbidity as defined by ultrasonography global
scores and S. haematobium infection intensity and microhe-
maturia was demonstrated. Boys had a higher prevalence of
morbidity than girls and this has also been observed in studies
of Heurtier and others55 and Keita and others.56 Our results
also indicated that there was considerable variation between
schools in the prevalence of positive global scores, thus show-
ing the focal clustering of morbidity caused by urinary schis-
tosomiasis in areas of overall intense transmission. We con-
clude that ultrasonography global scores and microhematuria
scores are likely to be valuable markers in children for mor-
bidity caused by both light and heavy infections with S. hae-
matobium. We therefore recommend the inclusion of ultra-
sonographic examinations in the routine monitoring and
evaluation activities of control programs against urinary schis-
tosomiasis whenever resources are available, as in the case of
middle-income countries (i.e., North and South Africa and
potentially some Middle Eastern countries such as Iraq). In
sub-Saharan Africa, such a recommendation should be
weighted against additional costs that a subsequent decision
would bring (equipment, personnel, training) and the avail-
able national or external funds of the control programs.
With regards to intestinal schistosomiasis, the significant
associations observed between liver image patterns with S.
mansoni intensity of infection confirms that these patterns are
likely to be valuable markers for morbidity caused by light or
heavy infections with S. mansoni, as suggested by King and
others.17 However, although our findings suggest that current
scoring criteria perform well in defining disease caused by S.
haematobium infection, they also show, in accordance with
those of King and others,17 that the current WHO cut-off
values can lead to serious overestimation of the risk of PVD
in patients infected with S. mansoni. In addition, our data
show that the risk of left liver lobe enlargement may be over-
estimated by WHO cut-offs values. We therefore agree that
cut-off norms should be recalculated at least in each disease-
endemic country from a subset of local persons with pattern
A prior to the implementation of the WHO protocol, which
also fulfills the recommendations included in the Niamey-
Belo Horizonte protocol guidelines. Further studies to con-
firm appropriate cut-off scores for these measurements are
therefore required.
Nevertheless, the observation that much of the variability
in the liver image pattern remained unexplained, as well as
the high MOR, suggest that other variables might be needed
to explain the between-school heterogeneity. Another expla-
nation for this high MOR and unexplained variation might be
that among children with abnormal liver image patterns, 84%
were found to have grade B (coding for the earliest pathologic
changes in the liver), which may not be schistosomiasis spe-
cific. This same fact might also explains the unexpected find-
ing that older children have less likelihood of abnormal pat-
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terns than younger ones compared with other studies of schis-
tosomiasis morbidity. Therefore, liver image patterns of grade
B may have represented a confounding factor in our analysis.
Further studies are therefore needed to fully elucidate the
relationship between liver fibrosis and schistosomiasis, with
particular reference to the degree of association between pat-
tern B and S. mansoni infection and to the role played by
other factors in determining such fibrosis. Likewise, in the
case of hepatomegaly, we were unable to distinguish clear
associations, which may have been due to the fact that these
observed morbidities were likely to have been multifactorial,
with S. mansoni infection being only one of a number of
potential causes.57 There are often many factors (genetic and
possibly most importantly malaria, which is transmitted
throughout the year in Mali58) other than S. mansoni that can
cause liver enlargement, and their role and interaction with S.
mansoni infection also requires further clarification.
Although these data are on children and as such were ex-
pected to be less likely to demonstrate ultrasonagraphy-
detected morbidity caused by S. mansoni infection because of
the amount of time of exposure associated with the time
taken for fibrosis to build up, in contrast, they show morbidity
for this type of infection, suggesting that in these communities
children may become infected early in life.59 We expect that
in adults the dynamics of exposure, treatment, and host im-
munity would show even more ultrasonography-detectable S.
mansoni morbidity than observed in this study. It might also
be important to include the periportal thickening measure-
ment in the ultrasonography examinations when the adult
population is examined to evaluate the performance of the
protocol. We predict that in adults infected with S. mansoni,
the comparison between Malian and WHO cut-off values (de-
rived in a similar way as previously described) would show
significant differences in the estimations of risk of PVD and
left liver lobe enlargement because King and others17 also
observed the same pattern irrespective of age.
For S. haematobium, as in high transmission areas like
those under study, successive episodes of infection would re-
sult in recrudescence of urinary tract abnormalities detected
by ultrasonography,60 and we would expect to observe more
severe pathology caused by urinary schistosomiasis in young
adults because of continuing reinfection. However, ultraso-
nography may not be the most appropriate tool to detect and
define late-stage morbidity caused by S. haematobium infec-
tion in older adults because of decreased rates of reinfection
in this age group, which leads to decreased development of
new inflammatory bladder wall lesions pathognomonic of uri-
nary schistosomiasis. Thus, it would be interesting to conduct
a survey on adults from the same communities of children
described in this report and investigate up to which age group
ultrasonography is a suitable tool to monitor morbidity
caused by urinary schistosomiasis in a field setting.
Thus, for both intestinal and urinary schistosomiasis, it will
be necessary to obtain longitudinal data to fully elucidate the
natural history of morbidity related to infection, with the aim
of formulating recommendations for treatment and re-
treatment based on natural history and evolution of morbidity
after large-scale administration of anthelminthic drugs. Such
work is currently being conducted by INRSP, SCI, and the
National Schistosomiasis Control Program and hopefully will
help plan and evaluate sustainable morbidity control.
Conversely, if only parasitologic measurements were incor-
porated into monitoring of schistosomiasis morbidity of a
mass chemotherapy program, the following three issues
should be taken into consideration.15 1) Diagnosis of infected
persons might be missed because of substantial day-to-day
variation of egg output in S. mansoni infections and then in S.
haematobium infections. Some persons might not shed eggs at
the time of the stool or the urine examination or eggs could be
missed. 2) Signs of disease could still be present even in the
true absence of egg excretion. Eggs could be trapped in le-
sions, especially in long-standing infections. Just after treat-
ment, eggs could also be absent, but lesions would still be
present. In this case, ultrasonography would still provide de-
tection of irreversible lesions long after treatment. 3) Con-
founding causes other than schistosomiasis of observed
pathologic signs could be excluded by ultrasonography. The
epidemiologic importance of confounding causes of uropathy
in areas where S. haematobium is endemic appears to be
small, but information for areas where S. mansoni is endemic
is still lacking.
In conclusion, the results of this study suggest that the cur-
rent WHO protocol (Niamey-Belo Horizonte protocol) is a
suitable and valid public health tool for urinary schistosomia-
sis for morbidity control programs focused on children. In
detection of morbidity of intestinal schistosomiasis in large-
scale control interventions, this same protocol is a useful tool
provided local cut-off values are used to define abnormal
values and that results are interpreted with caution.
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Abstract.  Substantial uncertainties surround the sensitivities and specificities of 
diagnostic techniques for urinary schistosomiasis. We used Latent Class (LC) modeling 
to address this problem.  In this study 220 adults in three villages northwest of Accra in 
Ghana were examined using five Schistosoma haematobium diagnostic measures: 
microscopic examination of urine for detection of S. haematobium eggs, dipsticks for 
detection of haematuria, tests for circulating antigens, serological antibody tests and 
ultrasound scans of the urinary system.  Testing of the LC model indicated non-
invariance of the performance of the diagnostic tests across different age groups while 
measurement invariance held for males and females and for the three villages.  We 
therefore recommend the use of LC models for comparison between and the 
identification of, the most accurate schistosomiasis diagnostic tests. Furthermore, 
microscopy and haematuria dipsticks were indicated through these models as the most 
appropriate techniques for detection of S. haematobium infection. 
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INTRODUCTION 
In spite of the prolific generation of new knowledge in the area of urinary 
schistosomiasis, such as that of global burden, treatment and associated morbidity 1-4, 
there remains the unsolved practical issue associated with the basic diagnosis of this 
important parasitic disease.  This relates to both the direct (i.e. microscopical examination 
of filters of urine for detection of S. haematobium eggs) as well as with the indirect (i.e. 
detection of haematuria, detection of schistosome-specific antibodies, detection of 
circulating egg antigens and ultrasound scans of the urinary system) diagnostic methods 
of this schistosome infection.  There are several reasons for the limitations in the 
diagnosis of urinary schistosomiasis infections, such as, for example daily variation in 
egg excretion levels and/or duration of infection influencing the potential accuracy of 
determining the correct current infection status.5  Haematuria (blood in urine) alone has 
been proposed as a valid indication of current infection in S. haematobium endemic 
populations.6  Microhaematuria can be detected by reagent strips (dipsticks) which 
recognize blood and protein.  However, for the distinction of an active from a previous 
infection, particularly after treatment, in many populations and individuals, the 
circulating schistosome antigen has been proposed as the most reliable test.7,8  In 
addition, although the serological diagnosis of schistosomiasis is generally accurate9, it 
can also produce false negatives, particularly in patients with longstanding infections 
while elevated antibody levels can be still detectable many years after treatment.10  
Ultrasound is currently the diagnostic tool of choice for detecting pathological conditions 
associated with urinary schistosomiasis, such as dilatation of the renal pelvis and bladder 
wall lesions, although its usefulness has been questioned, particularly in low transmission 
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areas, because of its lack of specificity.11  In addition, large variations of sensitivity and 
specificity estimates have been observed among different endemic zones, age groups and 
sexes for all the aforementioned diagnostic methods of urinary schistosomiasis in several 
studies. 12-16  
 
One explanation for the inconsistencies between all these diagnostic tests relates to the 
current lack of a definitive ‘gold standard’ reference test for urinary schistosomiasis.  
Consequently, the diagnosis of schistosomiasis as well as the control of this disease 
becomes problematic.  Diagnostic assays with low sensitivities are unsuitable for 
evaluation of schistosomiasis control programmes, such as those aimed at morbidity 
reduction through mass human chemotherapy.17  Indeed, methods that allow infections to 
be correctly diagnosed are a prerequisite for effective disease control.18  One solution 
may therefore relate to the need for more sophisticated statistical models to be developed 
and utilized in order to obtain more reliable empirical estimates of sensitivities and 
specificities of diagnostic tests.19, 20 
 
In the present study we assessed the performance of five diagnostic tests for S. 
haematobium infection and estimated the prevalence of this infection in different age and 
sex groups in three villages of northwest of Accra in Ghana.  Specifically we used five 
different diagnostic tests for the prevalence of urinary schistosomiasis infection: that of 
the urine antigen detection test, performed on membranes or in ELISA plates, the 
serology anti-IgG test, an ultrasound assessment by recording the shape and state of the 
urinary bladder, the dipstick for haematuria using urine reagent strips on all urine 
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specimens for presence of detectable blood, and finally detection of S. haematobium eggs 
by microscopy.  Through the application of a latent class model to all of these five tests, 
the sensitivity and specificity of each test can be determined, and the overall urinary 
schistosomiasis prevalence levels within the different population groups estimated. 
 
MATERIALS AND METHODS 
Study sites and subjects.  Three Ghanaian villages northwest of Accra, Ayiki Doblo, 
Chento and Ntoaso were visited and consenting adults over 19 years of age formed a 
convenience sample of passers by.  However, in general, as regards to the demography in 
Greater Accra’s region, the age structure is still a youthful one, characterized by a 
somewhat high fertility which has begun to show signs of a steep downward trend.21 The 
general public in the three aforementioned villages are familiar with the work of the 
Noguchi Memorial Institute for Medical Research and its personnel. Through discussions 
with local authorities the public was alerted, and people were approached and asked to 
participate.  These volunteers were then interviewed and requested to provide specimens 
of urine, stool and blood for examination. Praziquantel (at 40mg per kg) was offered and 
taken following diagnosis of all infected cases of schistosomiasis.  At subsequent visits, 
bladder ultrasound scans were performed on the majority of participants.  All 
examinations were performed at the village clinics.  Participants responded to a 
questionnaire, the majority of which were reported to be peasant farmers and persons 
involved in agriculture.  Others responded as traders or vendors, but most reported 
regular water contact in the nearby river system.  Although there was municipal water 
available in the village of Ntoaso, many residents do not have access to clean running 
water, and through their daily activities were thereby potentially exposed to risks of 
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schistosome transmission.  A total of 220 individuals consented to participate, had 
complete data on the variables examined here and were included in the analysis of the 
present study.  The age and sex structure as well as the village location of all the sampled 
individuals is given in Table 1, which illustrates a lower proportion of individuals who 
consented to participate and had complete data were below 39 years old and from villages 
Ayiki Doblo and Chento.  
 
Urine-antigen detection test.  Detection of schistosome antigen in urine was performed 
after the method of Bosompem and colleagues22 which has shown that S. haematobium 
antigen complexed with complement C3 can be isolated from the urine of infected people 
using a mouse monoclonal antibody.  The authors demonstrated that goat-antihuman C3 
would also detect schistosome antigen/complement complex in the urine of infected 
people, but not in non-infected people as case controls, and subsequently developed a 
monoclonal antibody dipstick test based on these findings.23  Briefly, methanol treated 
polyvinylidene difluoride (PVDF) membrane strips were incubated in test urine for 
30min at room temperature (21-25oC), rinsed with Tris-buffered saline (TBS) (50mM 
Tris and 200 mM NaCl, pH7.4) and then blocked for 15 min in 5% skimmed milk in 
TBS.  The strips were then incubated in a reagent mixture of S. haematobium species-
specific MoAb (1:100) and goat anti-mouse-immunoglobulins conjugated to horseradish 
peroxidase (1:10) in 0.1% skimmed milk in TBS for 1 h.  The strips were washed three 
times each by 10 min incubation in TBS and then incubated in substrate solution 0.05% 
(w/v) (3,3-diaminobenzidine), 0.15% (v/v) H2O2 and 5 mM Co (NO3)2.6H2O in TBS 
for 1 min. A bluish-black reaction represented positive results while negative results 
remained colourless.  
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Serology anti-IgG test.  Detection of anti-schistosome IgG in serum was performed on 
serum eluted from dried blood spots on Whatman No1 filter paper.  Blood spots filled a 1 
cm diameter circle were taken at the time of examination, desiccated and kept dry until 
analysis.  These were eluted in 1 ml PBS, diluted 1:100, and tested in ELISA plates 
(Immunolon-2) in triplicate.  Analyses were repeated if there was more than 10% 
discrepancy.  Plates were sensitized with SWAP antigen (6.44 mg/ml) prepared from S. 
mansoni adult worms provided by Biomedical Research Institute, Rockville MD.  
Antigen dilution was optimized against sera from known positive S. haematobium 
infections and known schistosome negative sera.  Optical densities were read from a 
Vmax kinetic microplate reader (Molecular Devices. USA).  Results were scored positive 
when the OD exceeded 2 x SD of the negative controls.  
 
Ultrasound examination.  A portable ultrasound apparatus, Aloka SSD-500 portable 
ultrasound with 3.5 MHz curvilinear probe (Aloka, Tokyo, Japan) was used for 
ultrasound examination, with the diagnoses made by a medically qualified person with 
prior training in ultrasound examination and interpretation.  Examinations were 
performed using a curvilinear probe and recorded photographically.  Diagnosis of 
pathological lesions was made in situ, and later confirmed by review of the 
ultraradiograph.  For the purpose of this study, lesions were classified as positive or 
negative.  Positive cases were registered when any two of the following situations were 
evident: epithelium enlarged more than 5 mm, evidence of polyps in the bladder wall, 
calcification of the epithelium, evidence of hydronephrosis. 
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Parasitological examination.  Classic parasitological methods usually used by field 
clinicians were employed and evaluated in this study.  Microscopy was performed on the 
product of a single measure of filtration of 10 ml urine taken from a specimen passed 
between 10:00 and 14:00, the time of optimum egg passage.24  Urine specimens were 
kept cool in an insulated ice box and processed in the laboratory within 4 hours of 
passing.  The presence of any S. haematobium eggs was recorded as positive.  
Haematuria was detected by the use of standard “hemastix”, with any positive reaction 
being designated positive for urinary schistosomiasis (Multistix, Bayer Diagnostics). 
 
Statistical analysis.  By considering the true S. haematobium infection status of a sample 
of Ghanaian adults as a latent variable with two categories: ‘infected’ and ‘non-infected’, 
we validated the five diagnostic tests.  In other words, we considered the observed data of 
the five diagnostic tests (urine antigen detection, serology anti-IgG test, ultrasound, 
dipstick for haematuria and microscopy) as indicators of an underlying, not directly 
observable variable (i.e. S. haematobium infection).  Results of the five diagnostic tests 
are directly observed and are known as manifest variables while the S. haematobium 
infection is the unobservable latent variable.25 
 
Given a sample of individuals with unknown infection status, for whom results from 
several diagnostic tests are available, latent class analysis can model the probability of 
each combination of tests results conditional on latent class (i.e. infection status).  The 
manifest binary variables (x1j, x2j, x3j, x4j and x5j) were defined such that xij=0 represents a 
negative result for test i and xij=1 represents a positive test result for test i on individual j.  
We tested whether correlations between these manifest variables could be accounted for 
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by a single latent dichotomous variable Y (i.e. the absence Y=0 or presence Y=1 of S. 
haematobium infection) and we defined η = P(Y=1) the probability of being in the 
infected latent class.  In other words, we divided the studied population into two classes 
(i.e. non infected and infected) assuming that the xij’s were mutually independent within 
each class (i.e. true infection status).  It is expected that the xij’s are correlated as they are 
attempting to measure the presence of the same infection; the model assumes that these 
correlations are negligibly small only once one has accounted for an individual’s true 
infection status (i.e. latent class membership).  This assumption results in a more 
parsimonious model compared to one in which residual correlations are estimated, and 
one that is often adequate for the data.  In the unlikely case that there are substantial 
residual correlations between the xij’s, additional latent classes would likely be required 
for an adequate fit to the data.    
 
The likelihood function of the latent class (LC) model was 
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Such a model has two types of parameters.  First, there is the unconditional probability η 
that a person is in the infected latent class.   
 
The second type of parameters are the conditional probabilities πi1 and πi0 that an 
individual in a particular latent class has a specified value of each of the manifest 
variables.26  In fact, πi1 represents the sensitivity and is the conditional probability 
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P(xi=1|yj=1) while (1-πi0) represents the specificity and is the conditional probability 
P(xi=0|yj=0).  The LC model hence produces an estimate of disease prevalence as η is the 
proportion of individuals in the population of which our sample is expected to be in 
infection class Y=1.  It also provides direct estimates of sensitivity and specificity for all 
the diagnostic tests.27  
 
A natural way to extend the LC model (1) is to include stratification or grouping variables 
and examine group differences of measurement invariance.  In this study such group 
differences are examined for males/females, different village locations and age groups.  
Likelihood ratio tests between less and more restrictive models were used to examine 
differences in infection prevalence and measurement invariance between groups.  A 
significant measurement invariance tests suggests that specificities and sensitivities of the 
diagnostic tests vary by group and should be estimated for each group. Such an approach 
is referred to in the literature as multigroup latent class analysis (LCA) and comparisons 
of this sort are useful for at least two purposes: (a) to test whether the distribution of the 
latent variable is the same in each group and (b) to test whether the manifest observed 
variables are equally reliable indicators of the latent variable in each group.28  
 
Expectation-maximization (EM) algorithm was applied to produce maximum likelihood 
estimates for all parameters in the model using PROC LCA in SAS Version 9.1 (SAS 
Institute, Cary, NC). Identifiability of maximum likelihood parameter estimates was 
checked by using several different seed values.   
 
RESULTS 
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Table 2 represents the observed positive results expressed as percentages of S. 
haematobium infection for the five diagnostic tests.  Different diagnostic tests gave 
different proportions of positive results.  
 
Table 3 presents the results of one latent class model as it was dictated by likelihood ratio 
tests.  Specifically, this model and denoted in table as ‘LC Model 1’ is a latent class 
model where measurement invariance was found to hold among males and females.  
Because of the measurement invariance found here, we obtain a common set of 
specificities and sensitivities for both males and females.  The best diagnostic test for the 
detection of the prevalence of S. haematobium infection among the five diagnostic tests 
examined here was microscopy with a specificity estimated as 97.9 % and a sensitivity 
estimated as 92.5 %.  In addition, ‘LC Model 1’ yielded quite high specificities and 
sensitivities for haematuria and ultrasound.  From this same model estimates of 
prevalence of S. haematobium infection by sex were also obtained.  It is estimated that 
the prevalence of S. haematobium infection was highest among males (20.6 %) compared 
to females (9.7 %). 
 
‘LC Model 2’ in Table 4 is a latent class analysis model where measurement invariance 
was found to hold among different village locations as this is again the reason why we 
obtain only a set of specificities and sensitivities for this group of sampled subjects. 
Results of this model agree with results of LC Model 1 in Table 3. The best diagnostic 
test for the detection of the prevalence of S. haematobium infection was again 
microscopy with specificity estimated as 94.6 % and sensitivity as 100.0 %.  In addition, 
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‘LC Model 2’ yielded quite high specificities and sensitivities also for haematuria and 
ultrasound.  Furthermore, ‘LC Model 2’ also indicated Chento village as the one with the 
highest prevalence of S. haematobium infection (38.9 %) among the three examined 
villages here. 
 
Finally, ‘LC Model 3’ in Table 5 is a latent class model where measurement non-
invariance was found for different age groups and this is the reason why different 
specificities and sensitivities are calculated for each of these groups.  Using this model, 
diagnostic tests which could be characterized as acceptable for the detection of the 
prevalence of S. haematobium infection were those of ultrasound, haematuria and 
microscopy in the age groups of 19--29 and 40--49 years old; haematuria and microscopy 
were indicated as good diagnostic tests in the age group of 30--39 years as they both gave 
quite high specificities and sensitivities at the same time.  Finally, in the age group of >60 
years old the estimates of specificity and sensitivity were sufficiently high (93.2 % and 
100.0 % respectively) only for haematuria, whilst for the age group of 50--59 years old, 
when taking into consideration both estimates of specificity and sensitivity, none of the 
diagnostic tests examined here was indicated as appropriate.  From this same model 
estimates of prevalence of S. haematobium infection by age group were also obtained.  
‘LC model 3’ shows that the highest prevalence of active, i.e. by egg passage S. 
haematobium infection was determined among the youngest age group of the sampled 
individuals of this study (29.8 %).  
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DISCUSSION 
Current estimates of the prevalence of schistosomiasis depend on the use of well-
established, but imperfect, diagnostic tests.29  Appropriate schistosomiasis diagnosis 
becomes increasingly important for several reasons.  For example, clinical diagnosis 
might lose its value because of lack of specificity and mass treatment might only remain 
cost effective through the use of appropriate diagnostic tools to only target further drug 
treatment to those groups of people actually infected.10  The purpose of the 
epidemiological survey reported here was to assess the performance of five diagnostic 
tests for S. haematobium infection and examine if the prevalence of this infection varied 
across different age and sex groups of sampled individuals from three villages northwest 
of Accra in Ghana where there has been reported previously medium S. haematobium 
prevalence.30  We have addressed this specific problem by taking into account the 
absence of a gold standard diagnostic test for S. haematobium infection and  by fitting 
latent class models with a frequentist approach to these data obtained from adults in 
northwest of Accra in Ghana.  Although latent class models have been used extensively 
in the epidemiological literature of several infectious diseases,31-36 they have rarely been 
used in parasite epidemiology and particularly in the area of schistosomiasis.  More 
precisely, to our knowledge, only two previously published studies, both based within 
Côte d’ Ivoire, have used latent class models through a Bayesian approach in order to 
assess performance of the Kato-Katz technique in diagnosing S. mansoni and hookworm 
co-infections as well as to estimate reduction of prevalence and intensity for hookworm 
infection in humans post-praziquantel treatment37, 38, while only one study in the 
Philippines has provided estimates of sensitivity and specificity of a faecal examination 
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method for Schistosoma japonicum infection in mammals, using also a statistical 
modelling approach within a Bayesian framework.39   
 
Our study therefore provides the first, to our knowledge, evaluation of the performance of 
multiple diagnostic criteria and estimation of the prevalence of S. haematobium infection 
in Africa which raises important implications to consider with reference to reliable tests 
for the diagnosis of urinary schistosomiasis.  Such findings should be also of direct 
relevance and application to current mass chemotherapeutic control programmes.  
Nevertheless, as the current dataset focuses on adults, we would recommend additional 
similar studies aimed to assess the application of such latent class models on data from 
school-aged children across varying schistosomiasis endemic regions within sub-Saharan 
Africa since school children form the major target age group of current mass 
chemotherapeutic control in human helminthiasis40 
 
The results of this study clearly demonstrate that in adults the microscopic detection of 
the parasite's eggs in the urine is the best currently available diagnostic tool for S. 
haematobium infection (results in Tables 3, 4 and 5 support this argument) with the 
exception for the age group of >50 years old where very low specificities were estimated 
(Table 5).  Standard errors of the estimates were larger for the older age groups compared 
to the young age groups due to the smaller sample sizes here (Table 1) and therefore such 
results should be interpreted cautiously. Based on these findings, we would thus 
recommend the inclusion of microscopic examination in the monitoring process of human 
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mass chemotherapy programs whenever financial resources allow for this option, mainly 
because of its relatively low operational cost compared to other urinary schistosomiasis 
diagnostic techniques and its feasibility under most conditions. Furthermore, as 
microscopic examination can quantify the intensity of the S. haematobium infection, it 
enables evaluation of important indicators in the control planning, such as possible risk 
factors, presence of severe clinical forms, degree of transmission and reinfection in the 
area, and intervals for necessary re-treatments.  
In addition, this study confirms that haematuria dipsticks can be sufficiently sensitive and 
specific indicators (results in Tables 3, 4 and 5 support this argument with the exception 
of results in Table 5 where for the age group of 50--59 years old haematuria dipsticks 
yielded a very low sensitivity (45%)) for detection of S. haematobium infection in 
endemic areas, and therefore we would also recommend their inclusion in the monitoring 
process of human mass chemotherapy program.  Indeed, in recent studies we have also 
found that semiquantitative reading of dipsticks correlates well with intensity of S. 
haematobium infection and ultrasound pathology.2, 41  
 
On the other hand, whilst the urine antigen detection test showed similar sensitivity to 
microscopy (results in Tables 3, 4 and 5 support this argument), it was also suggested that 
false-positive urine antigen detection tests may be more common than previously 
reported.23  One potential explanation for the low specificity of this test might be that 
potentially cross-reactive parasites are more prevalent in the age group studied here and 
polyparasitism is of course common in these areas. Indeed, Dunyo et al. 1996 42 found 
filarial infections in the towns or in the villages east of Accra in a similar age group and 
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we would thus recommend further studies to define both the prevalence of such parasites 
in this same endemic area and examine any potential cross-reactivity between helminth 
species within the urine antigen detection test.  Results from the current study suggests 
that the urine-antigen detection tests we evaluated should perhaps not be used for the 
identification of high risk groups which, due to the possibility of false positive reactions 
produced by such tests, could artificially inflate the actual numbers of people targeted for 
mass chemotherapy.  Furthermore, estimates from all latent class models presented here 
yielded low sensitivities and specificities for the serology anti-IgG tests. The observation 
here that antibody detection lacks specificity is consistent with findings of other 
epidemiological studies which reported that antibody is often found without concomitant 
parasitological evidence of infection.43, 44 
Furthermore, antigen detection methods are generally more expensive than antibody 
ones.45 On the other hand, microscopy and haematuria dipsticks require relatively 
unsophisticated equipment and, in areas of high endemicity, personnel with only basic 
training. These two latter diagnostic tests could therefore constitute the lowest cost option 
when technical assistance is plentiful. Thus the current findings, if combined with 
consideration of costs involved, which is a critical issue in the economically developing 
countries, leads us to the conclusion that antibody and antigen detection tests should not 
be used in the determination of the prevalence of long term urinary schistosomiasis 
infections. 
 
With reference to the detection of urinary schistosomiasis infection through ultrasound 
examination, the results of this study indicated that the performance of this diagnostic 
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tool was quite acceptable in all age groups except in those of 30--39 years old and >50 
years old.  An explanation for the variability in these results among different age groups 
might be that successive episodes of infection would result in recrudescence of urinary 
tract abnormalities and more severe pathology caused by urinary schistosomiasis would 
be expected to be observed because of continuing reinfection. Thus, we would conclude 
that ultrasound examination is not a reasonable substitute for microscopy or dipsticks in 
regards to determining the prevalence of S. haematobium infection. Nevertheless, we 
would still support the argument that the best currently available diagnostic tool for 
morbidity assessment in S. haematobium infections is the visualization of urinary tract 
pathology through ultrasound examination . 
 
Finally, with statistical analysis alone, one can never be certain about the validity of a 
dependence model as it is not known from the observed data how each of the examined 
diagnostic tests relates to the others conditional on disease status.46 Consequently, we 
recognize that the results of this study depend upon the assumption of conditional 
independence assumed by the models fitted here. In addition, latent class models based 
on current assumptions may not be appropriate for some similar alternative datasets as 
very large correlations (if these are present after accounting for latent class membership 
i.e. the true infection status) could potentially bias parameter estimates and result in an 
underestimation of the error rates of the examined tests.47  
 
Through the use of latent class models we assessed the prevalence of S. haematobium 
infection, because accurate sensitive and specific measures for this indicator are 
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imperative, particularly at later stages of successful mass chemotherapy control 
programmes.  We demonstrate that latent class models proved a useful tool for validation 
research in the absence of a perfect gold-standard diagnostic technique. These models 
have suggested microscopy and haematuria dipsticks as sensitive and specific indicators 
of prevalence of S. haematobium infection in Ghanaian adults.  In addition,  they have 
provided estimated prevalences of S. haematobium infection that fit well with those 
previously obtained by those such as Nsowah-Nuamah and colleagues48 in Southern 
Ghana, and Amankwa  and colleagues49 in upper-east region of Ghana as well as the 
focality of this infection even within small areas of the same country.  However, it must 
be also considered that in the general context of chemotherapy programs, if monitoring 
and evaluation results are based exclusively on determining infection prevalence, the 
impact data obtained may inaccurately reflect the success of any programme.  Therefore, 
it is fundamental to also monitor the impact of such control programmes on the intensity 
of the infection and morbidity changes in the treated population, particularly as modern 
day chemotherapy programs are aimed at reducing morbidity and hence intensity and 
further research in this area is thereby warranted.  
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 TABLE 1 
Participation by age class, sex and village  
 
Variable Number of 
individuals who 
consented to 
participate and 
had complete 
data   
(%)  
Number of 
individuals who 
dropped out or 
did not have 
complete data  
 
(%)  
p-value* 
Age class 
19--29 years old 
30--39 years old 
40--49 years old 
50--59 years old 
≥60 years old 
 
 51 (29.8) 
57 (42.5) 
56 (57.1) 
33 (52.4) 
23 (37.7) 
 
 120 (70.2) 
77 (57.5) 
42 (42.9) 
      30 (47.6) 
38 (62.3) 
 
<0.001 
Sex 
Female 
Male 
 
117 (40.8) 
103 (42.9) 
 
170 (59.2) 
137 (57.1) 
 
0.618 
Village location 
 
Ayiki Doblo 
Chento 
Ntoaso 
 
 
102 (49.0) 
39 (26.2) 
      79 (46.5) 
 
 
106 (51.0) 
110 (73.8) 
91 (53.5) 
 
 
<0.001 
Total n 220 307  
     *p-value for chi-square test. 
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TABLE 2 
Positive results expressed as percentages by each of the five diagnostic tests among the 
220 Ghanaian adults studied 
Diagnostic tests Positive results expressed as % with (95 % 
CI)* 
Urine-antigen detection  68.6 (62.5-74.8) 
Serology anti-IgG 44.1 (37.5 50.7) 
Ultrasound 31.8 (25.7-38.0) 
Haematuria 21.8 (16.4-27.3) 
Microscopy 15.5 (10.7 -20.2) 
* CIs are based on normal approximation methods
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TABLE 3 
Sensitivity and specificity of diagnostic tests as estimated from latent class model 1 when measurement invariance was imposed across 
males and females 
LC 
Model 
1 
 Diagnostic tests 
Urine-antigen detection Serology anti-IgG 
 
Ultrasound 
 
Haematuria 
 
Microscopy 
 
 S.  
haematobium 
prevalence  
(%) 
 
Specificity 
(%) 
 
Sensitivity 
(%)  
 
Specificity 
(%) 
 
Sensitivity 
(%) 
 
Specificity 
(%) 
 
Sensitivity 
(%) 
 
Specificity 
(%) 
 
Sensitivity 
(%) 
 
Specificity 
(%) 
 
Sensitivity 
(%) 
Sex            
Male   21 
Female 10 
36 98 57 48 74 65 87 73 98 93 
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TABLE 4 
Sensitivity and specificity of diagnostic tests as estimated from latent class model 2 when measurement invariance was imposed across 
different village locations 
LC 
Model 
2 
 Diagnostic tests 
 S.  
haematobium 
prevalence (%) 
Urine antigen detection 
 
Serology anti-IgG 
 
Ultrasound 
 
Haematuria 
 
Microscopy 
 
Village 
location  
 
 
Specificity 
(%) 
 
Sensitivity 
(%) 
 
Specificity 
(%) 
 
Sensitivity 
(%) 
 
Specificity 
(%) 
 
Sensitivity 
(%) 
 
Specificity 
(%) 
 
Sensitivity 
(%) 
 
Specificity 
(%) 
 
Sensitivity 
(%) 
Ayiki 
Doblo 
7 
Chento 39 
Ntoaso 2 
 
35 
 
 
100 
 
56 
 
47 
 
73 
 
70 
 
86 
 
91 
 
95 
 
100 
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TABLE 5 
Sensitivity and specificity of diagnostic tests as estimated from latent class model 3 when measurement invariance was not imposed 
across different age groups 
LC 
Model 
3 
 Diagnostic tests 
 S.  
haematobium 
prevalence (%) 
Urine antigen detection 
 
Serology anti-IgG 
 
Ultrasound 
 
Haematuria 
 
Microscopy 
 
Age 
group 
(in 
years)  
 
 
Specificity 
(%) 
 
Sensitivity 
(%) 
 
Specificity 
(%) 
 
Sensitivity 
(%) 
 
Specificity 
(%) 
 
Sensitivity 
(%) 
 
Specificity 
(%) 
 
Sensitivity 
(%) 
 
Specificity 
(%) 
 
Sensitivity 
(%) 
19--29  30 36 100 43 82 89 74 88 84 93 82 
30--39  9 31 81 50 0 77 41 86 100 94 99 
40--49  14 31 100 58 13 73 75 88 75 100 100 
50--59  20 61 100 78 20 72 53 100 45 100 45 
>=60  11 39 100 60 71 46 0 93 100 100 0 
                                                     
 
